data_1h95_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1h95 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.554 HG11 ' H ' ' A' ' 65' ' ' GLU . 4.3 m . . . . . 0 N--CA 1.43 -1.432 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -91.37 -61.49 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 O-C-N 120.135 -1.603 . . . . 0.0 108.833 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -164.84 173.21 11.98 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -174.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.2 p -109.47 160.17 16.43 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.962 2.505 . . . . 0.0 109.755 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.7 mttt 59.99 49.76 7.35 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.585 2.068 . . . . 0.0 116.585 174.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.57 143.78 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.301 1.84 . . . . 0.0 109.295 -166.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -106.69 149.85 26.84 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.222 1.01 . . . . 0.0 110.323 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.35 -167.04 37.38 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.306 -1.496 . . . . 0.0 111.383 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.7 m -116.44 120.94 40.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.657 -0.908 . . . . 0.0 109.758 -164.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.2 t -87.77 130.44 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 120.89 -1.131 . . . . 0.0 110.456 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -133.04 159.71 39.27 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 120.828 -1.17 . . . . 0.0 111.461 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.4 t90 37.11 63.67 0.68 Allowed 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 118.395 2.739 . . . . 0.0 118.395 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -79.51 118.17 21.13 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.461 -1.4 . . . . 0.0 110.39 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -95.12 107.16 19.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.648 -1.283 . . . . 0.0 108.441 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.9 t -71.32 -33.98 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 126.3 1.84 . . . . 0.0 112.493 -173.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -65.38 -38.38 89.83 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.191 -1.568 . . . . 0.0 113.566 -172.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -95.13 -35.04 12.05 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.739 -1.225 . . . . 0.0 111.931 169.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.89 40.71 3.04 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.518 -1.364 . . . . 0.0 113.858 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -132.93 146.39 51.75 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.471 1.509 . . . . 0.0 109.591 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -149.88 -171.75 18.64 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 170.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -141.32 153.42 45.14 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 123.389 1.566 . . . . 0.0 111.776 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mt -112.36 141.53 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.335 1.054 . . . . 0.0 108.341 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -91.92 91.23 7.79 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 172.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.12 110.89 2.68 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 125.968 1.707 . . . . 0.0 113.753 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.331 38.7 p30 -54.14 -47.55 71.78 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 121.084 3.735 . . . . 0.0 121.084 -158.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -56.64 -49.11 75.99 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.771 2.878 . . . . 0.0 118.771 -169.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -136.25 35.73 2.76 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.19 -2.194 . . . . 0.0 106.837 173.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? 57.32 63.34 1.9 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.875 1.67 . . . . 0.0 113.278 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -107.83 151.35 25.86 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.965 -1.71 . . . . 0.0 110.531 -168.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -84.65 112.16 20.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.381 1.086 . . . . 0.0 111.943 -169.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.9 t -113.91 111.92 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -88.31 134.86 33.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.634 -1.916 . . . . 0.0 110.616 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.4 p -130.85 133.58 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.882 -1.136 . . . . 0.0 110.283 -173.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -117.43 154.73 30.87 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.011 1.724 . . . . 0.0 111.625 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -54.12 -31.05 51.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 117.794 2.516 . . . . 0.0 117.794 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.5 p -75.85 -12.14 60.11 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.516 -1.99 . . . . 0.0 114.334 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.48 -15.24 33.51 Favored 'General case' 0 CA--C 1.489 -1.37 0 O-C-N 120.766 -1.209 . . . . 0.0 112.369 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.2 mm -74.18 133.02 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 125.463 1.505 . . . . 0.0 111.116 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp . . . . . 0 N--CA 1.43 -1.441 0 O-C-N 119.267 -2.146 . . . . 0.0 115.09 -179.283 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.799 0 N-CA-C 107.782 -2.127 . . . . 0.0 107.782 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -80.77 146.92 30.74 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 118.895 1.347 . . . . 0.0 111.843 173.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.2 45.3 62.15 Favored Glycine 0 N--CA 1.431 -1.675 0 O-C-N 120.469 -1.394 . . . . 0.0 115.597 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -75.03 152.54 38.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.489 1.137 . . . . 0.0 113.268 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 m -97.86 138.25 35.49 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.217 1.008 . . . . 0.0 109.667 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -143.28 151.53 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -172.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -98.28 143.27 28.95 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 119.589 1.086 . . . . 0.0 110.455 171.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -157.94 160.97 38.15 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 121.79 0.805 . . . . 0.0 109.247 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -88.62 142.81 27.38 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.838 -1.789 . . . . 0.0 107.207 166.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.3 t -100.66 97.6 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 119.48 -2.012 . . . . 0.0 106.811 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.421 ' HA ' ' HB ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -123.24 144.93 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 O-C-N 120.609 -1.307 . . . . 0.0 110.101 -163.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.554 ' H ' HG11 ' A' ' 4' ' ' VAL . 16.7 tt0 -59.63 111.63 1.5 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.476 2.084 . . . . 0.0 113.269 -170.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.14 -128.03 3.19 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 111.747 -2.478 . . . . 0.0 112.641 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -100.35 -71.23 0.71 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 124.129 0.971 . . . . 0.0 109.326 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -83.0 -26.25 31.43 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.783 -1.198 . . . . 0.0 112.111 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.59 -88.96 0.07 OUTLIER Glycine 0 N--CA 1.429 -1.783 0 O-C-N 121.278 -0.889 . . . . 0.0 111.055 -167.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.28 149.08 35.7 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.508 1.623 . . . . 0.0 114.867 -173.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -122.37 -162.86 1.03 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.543 1.937 . . . . 0.0 110.464 168.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -146.77 133.4 19.89 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.349 -1.47 . . . . 0.0 110.161 -169.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -133.14 162.01 32.89 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.95 1.3 . . . . 0.0 108.687 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 51.04 51.63 16.66 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.731 1.613 . . . . 0.0 115.019 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.8 t -92.94 129.92 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 123.905 0.882 . . . . 0.0 112.016 -165.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.2 p -96.32 -134.27 0.22 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.417 1.087 . . . . 0.0 112.97 -175.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.716 0 O-C-N 119.709 -1.869 . . . . 0.0 108.702 178.419 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.7 m . . . . . 0 N--CA 1.43 -1.435 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.3 mp -95.61 -72.87 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.503 -1.998 . . . . 0.0 107.685 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -158.05 171.95 19.31 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -168.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -107.47 156.02 19.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.593 2.357 . . . . 0.0 111.115 168.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt 53.73 57.2 6.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 176.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.6 t -105.46 144.94 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 128.179 2.591 . . . . 0.0 107.728 -175.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -105.41 150.0 25.64 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.385 -1.447 . . . . 0.0 109.945 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -168.61 -179.84 41.1 Favored Glycine 0 N--CA 1.43 -1.712 0 O-C-N 120.529 -1.357 . . . . 0.0 110.399 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 m -115.56 133.64 55.84 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 124.221 1.009 . . . . 0.0 111.486 -167.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.7 p -109.95 142.25 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 123.901 0.881 . . . . 0.0 111.332 174.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -100.32 -87.29 0.38 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.697 -1.877 . . . . 0.0 110.027 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -112.11 128.81 56.32 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 124.873 1.269 . . . . 0.0 109.469 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -139.66 155.21 47.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.144 -0.972 . . . . 0.0 110.731 172.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -86.43 104.06 15.56 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.284 -1.51 . . . . 0.0 111.353 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.16 -34.65 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -62.66 -45.52 92.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.267 -1.521 . . . . 0.0 114.066 -173.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -83.49 -42.47 16.84 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.914 -1.116 . . . . 0.0 110.367 168.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.53 53.53 1.55 Allowed Glycine 0 N--CA 1.43 -1.745 0 O-C-N 120.255 -1.528 . . . . 0.0 110.277 -172.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -135.91 151.69 50.24 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 123.561 0.744 . . . . 0.0 109.898 -169.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.77 -158.03 26.95 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 121.236 -0.915 . . . . 0.0 111.687 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -144.86 154.04 42.22 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 123.159 1.456 . . . . 0.0 112.84 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.3 mm -109.46 162.36 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.389 1.476 . . . . 0.0 107.166 -178.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -102.3 100.61 10.79 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 120.921 -1.112 . . . . 0.0 109.442 170.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -57.92 124.96 21.05 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.049 1.74 . . . . 0.0 114.359 168.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -55.12 -47.93 74.34 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 119.273 3.064 . . . . 0.0 119.273 -168.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -68.05 -46.9 69.82 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -168.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.1 t -137.69 23.97 2.88 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 119.77 -1.831 . . . . 0.0 107.491 -170.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.61 49.77 6.22 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.941 1.696 . . . . 0.0 113.922 166.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -104.81 156.3 18.13 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 123.298 1.523 . . . . 0.0 112.807 -168.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -86.05 119.44 26.35 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.625 -171.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.4 t -108.63 103.32 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -169.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -82.73 131.83 35.19 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 122.975 1.369 . . . . 0.0 113.781 -173.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.4 t -128.88 135.39 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 124.657 1.183 . . . . 0.0 108.019 -172.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.8 176.91 6.29 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.324 1.05 . . . . 0.0 109.08 169.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -61.58 -21.64 64.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.987 2.217 . . . . 0.0 116.987 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -71.82 -26.02 62.22 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.501 1.521 . . . . 0.0 113.732 173.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.41 -22.06 26.78 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.849 -2.407 . . . . 0.0 113.011 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.8 mt -81.57 104.44 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 125.531 1.533 . . . . 0.0 109.819 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.251 50.3 mttm . . . . . 0 N--CA 1.431 -1.402 0 C-N-CA 125.529 1.532 . . . . 0.0 114.3 -173.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.773 0 CA-C-O 122.223 0.902 . . . . 0.0 113.576 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.11 140.1 48.71 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.023 -1.869 . . . . 0.0 114.403 -177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.73 11.39 79.66 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 119.741 -1.849 . . . . 0.0 113.425 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -79.69 153.29 29.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.279 1.514 . . . . 0.0 113.617 177.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 p -97.45 142.68 29.0 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 125.433 1.493 . . . . 0.0 114.678 -177.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.02 154.3 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 124.679 1.192 . . . . 0.0 109.594 -174.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.53 145.39 30.37 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.347 -1.471 . . . . 0.0 113.054 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -156.38 172.31 18.73 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.031 1.332 . . . . 0.0 110.171 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -94.8 154.07 17.44 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.592 -1.942 . . . . 0.0 108.094 165.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.5 t -110.97 96.97 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 119.139 -2.225 . . . . 0.0 108.011 174.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.27 111.87 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 120.183 -1.573 . . . . 0.0 109.553 -167.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -95.44 123.66 39.08 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.756 -1.84 . . . . 0.0 113.587 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -123.82 -45.63 0.28 Allowed Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 125.156 1.36 . . . . 0.0 112.809 170.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -95.37 -136.61 0.22 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.004 1.322 . . . . 0.0 111.386 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -78.76 -32.12 46.44 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.617 -1.927 . . . . 0.0 113.19 -174.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -141.07 165.84 26.15 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 105.997 -2.841 . . . . 0.0 105.997 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.71 152.22 21.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.206 1.479 . . . . 0.0 114.676 -168.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -107.01 -166.71 1.19 Allowed 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.423 -1.423 . . . . 0.0 109.947 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.33 156.23 42.72 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -173.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.58 162.41 36.68 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 56.45 40.31 29.66 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.628 1.571 . . . . 0.0 114.414 173.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 t -76.21 109.61 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 125.948 1.699 . . . . 0.0 110.62 -172.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.7 m -125.96 -121.85 0.25 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 123.8 0.84 . . . . 0.0 110.165 -161.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.787 0 O-C-N 119.335 -2.103 . . . . 0.0 111.691 -178.238 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.429 -1.509 0 CA-C-O 121.14 0.495 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.1 mp -80.74 -72.08 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 119.952 -1.718 . . . . 0.0 113.116 -166.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.19 167.89 28.86 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -160.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.9 p -110.96 134.37 52.64 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 128.188 2.595 . . . . 0.0 109.661 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.279 25.8 ttmt 59.18 75.67 0.39 Allowed 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.683 1.993 . . . . 0.0 116.046 -172.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.6 t -121.06 149.96 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 130.311 3.444 . . . . 0.0 105.739 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.7 mp -114.84 168.06 10.23 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 123.638 1.685 . . . . 0.0 112.232 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.73 -172.78 44.17 Favored Glycine 0 N--CA 1.43 -1.751 0 O-C-N 119.333 -2.104 . . . . 0.0 113.115 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.0 m -116.68 131.42 56.95 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 123.773 0.829 . . . . 0.0 109.511 -168.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.84 135.7 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 O-C-N 120.093 -1.63 . . . . 0.0 113.83 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -95.39 -56.08 2.83 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 120.098 -1.626 . . . . 0.0 109.841 173.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -156.46 130.66 8.61 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 123.972 0.909 . . . . 0.0 110.438 177.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -101.71 123.36 45.56 Favored 'General case' 0 N--CA 1.431 -1.384 0 O-C-N 120.607 -1.308 . . . . 0.0 107.965 164.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -102.52 76.9 1.57 Allowed 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.407 -1.433 . . . . 0.0 110.471 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 t -75.82 -7.5 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 123.523 1.63 . . . . 0.0 112.437 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -64.55 -30.07 71.1 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 128.814 2.846 . . . . 0.0 112.85 173.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -127.83 -46.06 1.42 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.728 -1.857 . . . . 0.0 111.444 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.45 -57.38 0.21 Allowed Glycine 0 N--CA 1.429 -1.779 0 O-C-N 119.475 -2.015 . . . . 0.0 115.929 -174.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -79.57 169.42 18.04 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.847 1.784 . . . . 0.0 114.916 -166.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.26 167.78 31.33 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 118.913 -2.367 . . . . 0.0 109.479 169.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -147.06 141.59 26.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 123.012 1.387 . . . . 0.0 111.923 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 mm -113.26 160.76 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 126.812 2.045 . . . . 0.0 108.926 -169.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -109.77 99.82 8.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.551 -1.343 . . . . 0.0 110.927 161.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.76 138.41 47.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.276 2.23 . . . . 0.0 114.93 170.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -62.48 84.95 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.607 2.447 . . . . 0.0 117.607 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -159.42 -76.12 0.07 Allowed 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.403 -2.061 . . . . 0.0 109.251 177.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.6 t -139.67 30.05 2.11 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 55.65 81.76 0.11 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.0 2.12 . . . . 0.0 114.202 -165.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -101.78 137.21 40.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.85 -1.781 . . . . 0.0 108.189 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -79.98 110.11 15.05 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 121.626 0.727 . . . . 0.0 109.925 -171.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.3 t -111.73 117.21 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -89.28 144.26 26.22 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.14 0.972 . . . . 0.0 112.957 -176.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -133.01 128.47 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 122.635 1.207 . . . . 0.0 110.847 -172.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -95.96 154.84 17.02 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.571 -1.331 . . . . 0.0 110.338 173.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -64.1 -26.1 68.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.235 -2.166 . . . . 0.0 116.443 -171.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.0 p -69.39 -27.31 65.19 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.543 -1.348 . . . . 0.0 113.755 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.83 -19.52 40.9 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.452 -1.405 . . . . 0.0 113.175 -174.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.6 mt -75.02 117.32 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 C-N-CA 126.751 2.02 . . . . 0.0 111.768 -178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.4 mttm . . . . . 0 N--CA 1.429 -1.492 0 O-C-N 120.543 -1.348 . . . . 0.0 112.423 178.779 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.736 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -76.75 117.39 18.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.171 1.462 . . . . 0.0 112.95 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.56 55.14 21.97 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 116.734 1.454 . . . . 0.0 116.734 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -73.18 150.77 41.87 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 119.184 1.492 . . . . 0.0 113.06 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 m -99.6 145.16 27.86 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.996 -1.065 . . . . 0.0 110.904 -172.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.1 m -143.08 163.14 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 125.866 1.666 . . . . 0.0 108.028 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -113.58 153.57 28.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.234 1.414 . . . . 0.0 110.461 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -164.7 172.91 12.48 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.976 0.893 . . . . 0.0 110.632 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -92.32 152.59 19.7 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.887 -2.383 . . . . 0.0 108.662 162.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.3 t -112.11 100.71 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 119.535 -1.978 . . . . 0.0 107.547 173.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 m -132.96 128.27 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 120.412 -1.43 . . . . 0.0 108.316 -168.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -96.31 150.77 20.2 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.905 -2.372 . . . . 0.0 114.4 -163.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -151.11 -68.55 0.01 OUTLIER Glycine 0 N--CA 1.432 -1.622 0 O-C-N 121.116 -0.99 . . . . 0.0 111.549 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -78.3 -145.37 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.4 1.48 . . . . 0.0 114.46 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -62.87 -22.42 66.69 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 119.841 -1.787 . . . . 0.0 115.579 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.72 -167.61 13.48 Favored Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 127.245 2.355 . . . . 0.0 108.383 175.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.11 161.31 15.15 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.09 -168.1 1.61 Allowed 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.838 -1.164 . . . . 0.0 110.626 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.06 155.68 44.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.87 1.319 . . . . 0.0 112.136 -166.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.1 166.02 24.35 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.593 1.957 . . . . 0.0 106.531 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.336 0.4 OUTLIER 34.51 63.36 0.45 Allowed 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 117.845 2.535 . . . . 0.0 117.845 -178.513 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.1 t -92.15 98.11 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 C-N-CA 125.097 1.359 . . . . 0.0 111.017 -168.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.94 155.63 22.38 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.607 1.163 . . . . 0.0 110.612 -174.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.763 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 168.93 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.1 t . . . . . 0 N--CA 1.43 -1.446 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.9 mp -86.38 -53.03 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 119.664 -1.898 . . . . 0.0 111.159 -165.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.92 160.5 24.94 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.5 p -115.5 148.4 39.53 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.575 1.55 . . . . 0.0 108.522 166.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.264 26.9 mmmt 53.38 83.01 0.07 Allowed 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.42 2.288 . . . . 0.0 115.512 -168.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.2 t -128.43 143.8 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 126.581 1.953 . . . . 0.0 107.153 -164.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.2 148.55 28.76 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.693 1.235 . . . . 0.0 109.613 174.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.12 179.79 41.59 Favored Glycine 0 N--CA 1.429 -1.788 0 O-C-N 120.796 -1.19 . . . . 0.0 111.376 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.9 m -115.26 135.3 54.3 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 124.635 1.174 . . . . 0.0 109.129 -169.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 50.2 t -84.27 124.8 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 120.387 -1.446 . . . . 0.0 109.441 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -97.41 -57.74 2.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.482 -1.386 . . . . 0.0 108.986 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.9 t-105 -144.56 96.42 2.87 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.0 0.92 . . . . 0.0 109.16 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -98.1 129.7 44.91 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.805 -1.184 . . . . 0.0 108.013 167.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -100.18 105.84 17.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.269 -1.519 . . . . 0.0 109.781 -177.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.4 t -77.23 -26.02 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 126.006 1.722 . . . . 0.0 112.144 -173.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -66.06 -45.87 79.79 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.233 -1.542 . . . . 0.0 112.815 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -78.59 -45.9 20.59 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.936 -1.728 . . . . 0.0 110.74 164.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.96 49.23 1.5 Allowed Glycine 0 N--CA 1.43 -1.723 0 CA-C-O 122.948 1.305 . . . . 0.0 110.287 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -155.71 152.6 28.78 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -162.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.32 -151.22 18.73 Favored Glycine 0 N--CA 1.43 -1.709 0 O-C-N 120.125 -1.61 . . . . 0.0 109.82 169.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -140.15 167.03 23.08 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.449 -1.03 . . . . 0.0 110.263 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.5 mm -109.63 155.81 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 170.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -92.25 104.93 17.24 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.416 -1.428 . . . . 0.0 109.305 161.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.0 ttt85 -66.22 114.75 5.55 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.548 -1.345 . . . . 0.0 109.573 153.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -64.81 -39.02 92.9 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -167.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -43.82 -52.45 6.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 128.585 2.754 . . . . 0.0 117.126 -169.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -143.22 33.89 1.34 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.862 -1.774 . . . . 0.0 106.565 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 57.38 58.51 3.8 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.57 1.548 . . . . 0.0 115.016 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -102.62 132.01 49.01 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.271 1.429 . . . . 0.0 109.025 -168.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -90.16 106.38 18.44 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 123.525 0.73 . . . . 0.0 110.135 -167.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t -105.53 109.04 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 121.027 -1.046 . . . . 0.0 110.37 -171.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -81.32 133.62 35.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.161 -1.587 . . . . 0.0 114.282 -171.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.1 p -129.7 133.3 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 120.37 -1.456 . . . . 0.0 111.92 -175.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -108.58 148.25 30.6 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.815 1.646 . . . . 0.0 108.66 173.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -58.1 -17.84 20.97 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 119.437 3.125 . . . . 0.0 119.437 -172.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.0 t -81.7 -12.06 58.79 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.386 -1.446 . . . . 0.0 113.268 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.73 -15.73 58.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.868 -2.395 . . . . 0.0 112.028 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.6 mt -82.48 124.41 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 126.062 1.745 . . . . 0.0 110.07 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -171.312 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.685 0 CA-C-O 122.089 0.827 . . . . 0.0 111.792 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -78.47 126.51 30.86 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.333 -1.686 . . . . 0.0 113.002 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.9 35.72 44.0 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 120.184 -1.573 . . . . 0.0 114.51 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.25 152.56 34.62 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.803 1.287 . . . . 0.0 113.337 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.1 p -94.11 146.09 24.22 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.726 1.611 . . . . 0.0 112.48 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.4 t -139.21 140.79 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -93.54 141.64 28.24 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.382 1.086 . . . . 0.0 111.749 165.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -156.06 172.73 17.91 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.873 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -99.07 156.53 16.89 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 162.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.67 89.89 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 119.876 -1.765 . . . . 0.0 107.381 172.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 m -124.85 139.34 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 120.816 -1.177 . . . . 0.0 108.026 -164.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -59.06 128.16 35.84 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.404 -2.06 . . . . 0.0 115.516 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -116.75 -112.33 2.69 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 125.319 1.437 . . . . 0.0 111.09 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -107.82 -89.57 0.45 Allowed 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 124.911 1.285 . . . . 0.0 112.561 -175.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -79.2 10.07 3.95 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 118.922 -2.361 . . . . 0.0 115.122 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.36 -167.09 38.11 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 107.057 -2.417 . . . . 0.0 107.057 -172.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.29 156.22 28.16 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.295 -1.121 . . . . 0.0 113.755 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -124.85 -172.36 2.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.557 1.543 . . . . 0.0 111.252 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.38 140.36 30.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.757 1.265 . . . . 0.0 110.24 -162.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -138.33 149.37 45.56 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.626 -172.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 52.96 50.94 16.86 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.367 2.267 . . . . 0.0 113.839 -176.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.1 t -78.26 124.04 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 120.652 -1.28 . . . . 0.0 111.603 -165.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.0 m -113.52 -122.09 0.29 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.227 -0.921 . . . . 0.0 110.713 -169.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.7 0 O-C-N 119.85 -1.781 . . . . 0.0 112.544 -170.873 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 71.7 t . . . . . 0 N--CA 1.431 -1.421 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -92.75 -54.85 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 119.875 -1.766 . . . . 0.0 110.299 -168.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -160.58 151.9 19.27 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.731 1.253 . . . . 0.0 113.603 -177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.5 p -108.06 150.02 27.69 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.282 1.833 . . . . 0.0 112.562 168.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.258 83.2 mttt 56.95 70.0 0.69 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.215 1.806 . . . . 0.0 114.872 -173.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.2 t -122.47 143.7 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 126.69 1.996 . . . . 0.0 108.732 -163.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.8 mp -128.97 168.69 15.64 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 122.318 1.056 . . . . 0.0 110.832 171.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -165.07 -147.61 5.19 Favored Glycine 0 N--CA 1.431 -1.696 0 O-C-N 120.326 -1.484 . . . . 0.0 110.168 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.3 m -118.51 133.21 56.04 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 172.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.2 t -95.65 126.15 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 120.318 -1.489 . . . . 0.0 110.437 173.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -118.25 -60.2 1.81 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.797 -1.189 . . . . 0.0 110.309 167.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -85.99 109.39 18.75 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.506 -1.371 . . . . 0.0 112.357 -175.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -151.86 129.29 11.36 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.382 -1.449 . . . . 0.0 109.018 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -97.65 107.25 19.71 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.549 1.539 . . . . 0.0 107.61 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.8 t -82.99 -45.5 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 120.319 -1.488 . . . . 0.0 113.747 -155.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -55.11 -61.2 2.47 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.225 1.41 . . . . 0.0 112.041 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -66.14 -44.89 82.88 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 172.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.2 62.15 0.92 Allowed Glycine 0 N--CA 1.429 -1.77 0 O-C-N 121.248 -0.908 . . . . 0.0 113.831 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -149.15 159.63 44.07 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 121.372 -1.075 . . . . 0.0 110.82 173.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.26 -153.71 23.45 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 120.205 -1.56 . . . . 0.0 111.349 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -147.18 151.02 36.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.841 1.305 . . . . 0.0 111.237 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 mt -105.51 159.51 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 120.206 -1.559 . . . . 0.0 108.475 -173.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -117.05 92.22 3.8 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.38 1.562 . . . . 0.0 109.721 167.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -63.48 149.35 46.33 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.427 1.891 . . . . 0.0 113.686 172.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -71.86 -19.65 61.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -76.25 -81.33 0.08 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.505 -1.997 . . . . 0.0 115.627 -163.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 t -114.17 -1.51 13.64 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.096 1.426 . . . . 0.0 108.652 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.3 mptt 77.57 62.29 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.845 3.258 . . . . 0.0 108.251 171.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -102.82 131.65 49.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 112.878 -1.965 . . . . 0.0 107.439 -165.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -85.72 109.46 18.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.967 -1.708 . . . . 0.0 110.854 -164.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.424 ' CG1' ' HB2' ' A' ' 72' ' ' ALA . 48.4 t -105.65 111.26 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.752 1.621 . . . . 0.0 107.39 -169.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -90.78 145.88 24.42 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.744 1.218 . . . . 0.0 111.606 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.34 133.85 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.566 1.65 . . . . 0.0 109.74 -174.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -119.58 162.5 18.84 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.574 1.55 . . . . 0.0 112.276 -175.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -43.26 -55.65 3.9 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 129.301 3.04 . . . . 0.0 117.575 -173.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.6 t -80.96 -9.74 59.8 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.589 -1.319 . . . . 0.0 114.089 -172.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.38 -20.8 46.82 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.687 -1.883 . . . . 0.0 112.695 174.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.4 mt -79.03 124.15 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 126.005 1.722 . . . . 0.0 110.583 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt . . . . . 0 N--CA 1.43 -1.455 0 O-C-N 120.544 -1.347 . . . . 0.0 112.297 -176.866 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.784 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -74.04 107.1 6.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.599 -1.53 . . . . 0.0 110.522 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.08 39.75 31.6 Favored Glycine 0 N--CA 1.431 -1.684 0 O-C-N 120.582 -1.323 . . . . 0.0 114.513 -170.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.1 156.76 28.17 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 120.696 -1.473 . . . . 0.0 114.898 -175.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.43 148.1 31.7 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.705 2.002 . . . . 0.0 111.022 -175.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.8 p -155.15 145.36 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.325 1.85 . . . . 0.0 106.56 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -91.8 144.46 25.47 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 120.315 1.416 . . . . 0.0 111.88 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -151.08 169.85 20.83 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.899 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -112.94 133.17 55.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 168.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.4 t -89.32 87.12 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 120.353 -1.467 . . . . 0.0 109.585 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -130.06 107.35 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 120.282 -1.511 . . . . 0.0 109.396 -168.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -139.95 -111.29 0.15 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.61 -1.306 . . . . 0.0 109.456 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 137.28 -55.15 0.7 Allowed Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 114.059 0.384 . . . . 0.0 114.059 -169.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -101.75 -69.78 0.77 Allowed 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.324 -1.103 . . . . 0.0 112.624 -172.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -87.09 57.28 4.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.392 -1.443 . . . . 0.0 114.6 -170.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.43 -117.29 4.49 Favored Glycine 0 N--CA 1.43 -1.719 0 O-C-N 119.43 -2.044 . . . . 0.0 110.642 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.46 169.65 13.42 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 122.899 1.333 . . . . 0.0 112.951 169.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.401 ' HG3' ' H ' ' A' ' 72' ' ' ALA . 6.2 tt0 -145.84 178.8 7.9 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.405 2.282 . . . . 0.0 105.169 -176.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.424 ' HB2' ' CG1' ' A' ' 34' ' ' VAL . . . -147.14 125.36 12.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.973 2.109 . . . . 0.0 107.061 -173.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.76 160.18 33.33 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 124.378 1.071 . . . . 0.0 108.296 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 60.1 45.76 11.45 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.936 2.094 . . . . 0.0 112.952 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.6 t -87.59 104.16 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-O 122.108 0.956 . . . . 0.0 111.806 -162.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.83 148.65 50.22 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.003 0.921 . . . . 0.0 109.51 -169.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.724 0 O-C-N 120.212 -1.555 . . . . 0.0 111.968 -176.324 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.533 ' CG1' ' H ' ' A' ' 65' ' ' GLU . 9.4 m . . . . . 0 N--CA 1.43 -1.436 0 CA-C-O 119.216 -0.421 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -87.64 -65.34 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 119.468 -2.02 . . . . 0.0 111.082 -174.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.32 161.46 24.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.9 p -110.66 143.13 41.59 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.36 1.464 . . . . 0.0 110.22 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.27 92.2 mttt 60.95 73.15 0.49 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.225 2.21 . . . . 0.0 115.446 -170.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.7 t -126.11 159.22 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 129.557 3.143 . . . . 0.0 107.564 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.8 170.55 12.64 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.128 -1.608 . . . . 0.0 111.662 170.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.76 -170.26 34.0 Favored Glycine 0 N--CA 1.43 -1.725 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.7 m -116.98 127.89 54.64 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.821 1.296 . . . . 0.0 109.874 -166.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 t -91.85 147.32 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 127.015 2.126 . . . . 0.0 110.437 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -105.37 -86.95 0.46 Allowed 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.055 -1.653 . . . . 0.0 109.78 164.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 22.6 t-105 -155.1 140.29 17.54 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.725 -1.234 . . . . 0.0 108.317 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -97.77 155.84 16.85 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.791 -1.193 . . . . 0.0 113.614 -175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -95.22 93.39 7.28 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.53 -1.356 . . . . 0.0 109.04 174.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.9 m -73.32 -30.64 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -172.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -56.49 -65.08 0.67 Allowed 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 125.312 1.445 . . . . 0.0 112.37 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -72.01 -35.17 69.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.546 -1.971 . . . . 0.0 113.174 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.84 51.61 1.63 Allowed Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -129.93 140.43 50.94 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 121.325 -1.103 . . . . 0.0 108.405 -170.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.05 161.15 32.98 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.503 -1.373 . . . . 0.0 111.147 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -142.09 157.84 44.44 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.946 -0.738 . . . . 0.0 109.464 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.3 mm -109.24 147.34 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 124.907 1.283 . . . . 0.0 108.634 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -92.93 93.89 8.62 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.907 -1.121 . . . . 0.0 109.037 169.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.19 133.56 37.75 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 174.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -82.54 48.0 1.25 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -171.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.95 -68.45 0.7 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.692 -1.88 . . . . 0.0 109.474 163.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -150.34 35.33 0.64 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 57.87 75.99 0.35 Allowed 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 127.234 2.214 . . . . 0.0 112.856 -159.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -103.06 128.35 49.96 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.561 -1.962 . . . . 0.0 106.675 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -82.11 122.14 27.47 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.651 1.691 . . . . 0.0 110.252 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.07 108.38 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 O-C-N 120.568 -1.333 . . . . 0.0 108.407 -173.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -76.06 140.05 41.72 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.76 -1.213 . . . . 0.0 113.661 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.8 t -128.44 126.2 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.766 -1.209 . . . . 0.0 108.416 -177.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -111.92 165.6 11.95 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.01 1.324 . . . . 0.0 110.592 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.1 mm100 -59.58 -36.98 77.32 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 m -69.86 -14.63 62.84 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.727 -1.858 . . . . 0.0 113.433 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.19 -25.4 58.22 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.536 -2.602 . . . . 0.0 114.909 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 89.1 mt -79.44 126.02 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 125.741 1.616 . . . . 0.0 111.597 -175.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 83.5 mttt . . . . . 0 N--CA 1.431 -1.392 0 O-C-N 120.615 -1.303 . . . . 0.0 112.678 -179.453 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.7 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -71.04 111.39 6.37 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.977 1.311 . . . . 0.0 109.753 174.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.75 -20.5 5.15 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 121.176 -0.952 . . . . 0.0 114.361 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.71 155.16 38.0 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.107 -1.819 . . . . 0.0 115.104 -174.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.72 143.31 39.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.719 2.008 . . . . 0.0 110.734 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.06 146.86 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -92.85 144.44 25.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -158.44 170.76 21.48 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.321 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -94.78 141.6 28.44 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.834 -1.791 . . . . 0.0 107.845 168.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.8 t -95.51 106.38 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 O-C-N 119.197 -2.19 . . . . 0.0 108.806 171.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.65 136.72 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 120.879 -1.138 . . . . 0.0 108.06 -170.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.533 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 23.4 tt0 -120.64 166.33 13.83 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.631 -1.918 . . . . 0.0 111.407 -166.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.54 -44.68 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.892 -1.13 . . . . 0.0 111.791 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -123.67 -145.47 0.34 Allowed 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 124.682 1.193 . . . . 0.0 113.322 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -74.37 -18.85 60.62 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.88 -1.762 . . . . 0.0 114.476 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.99 139.07 8.7 Favored Glycine 0 N--CA 1.429 -1.79 0 O-C-N 120.413 -1.429 . . . . 0.0 109.551 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.22 164.32 22.38 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -172.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -120.53 -168.04 1.57 Allowed 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.872 2.069 . . . . 0.0 111.222 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.11 155.86 43.57 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -169.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -152.51 161.91 41.93 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -174.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 56.13 51.01 12.48 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 125.138 1.375 . . . . 0.0 114.522 170.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.1 t -95.07 108.5 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 124.569 1.148 . . . . 0.0 109.14 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.7 m -83.03 -82.85 0.14 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.301 -1.499 . . . . 0.0 111.729 -176.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.733 0 C-N-CA 126.248 1.88 . . . . 0.0 112.979 -177.195 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.4 t . . . . . 0 N--CA 1.429 -1.487 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 mp -84.56 -69.6 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 119.35 -2.094 . . . . 0.0 107.505 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -149.67 153.78 37.54 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -171.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.9 p -110.59 149.31 30.59 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.29 2.236 . . . . 0.0 110.508 170.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.267 87.7 mttt 53.44 67.81 0.94 Allowed 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.567 1.692 . . . . 0.0 115.567 -172.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.8 t -120.39 142.73 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 127.742 2.417 . . . . 0.0 109.123 -163.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.19 149.43 24.67 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.678 1.228 . . . . 0.0 112.051 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.23 171.44 44.46 Favored Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.6 m -112.3 136.93 51.14 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.115 0.966 . . . . 0.0 110.876 -163.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.5 t -103.39 122.86 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 124.527 1.131 . . . . 0.0 108.53 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -154.53 99.74 2.2 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.144 -1.597 . . . . 0.0 109.195 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . 0.312 37.2 m95 77.83 154.11 0.14 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.908 2.083 . . . . 0.0 113.956 -170.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.81 -167.79 2.1 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.775 -1.203 . . . . 0.0 111.286 -165.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -127.41 64.1 1.34 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.442 -1.411 . . . . 0.0 109.781 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 m -67.57 -23.8 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 126.929 2.091 . . . . 0.0 115.704 -174.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -58.89 -48.77 80.26 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.438 -2.039 . . . . 0.0 114.393 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -93.25 -37.4 12.08 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.681 -1.262 . . . . 0.0 111.317 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.93 57.12 0.43 Allowed Glycine 0 N--CA 1.43 -1.709 0 O-C-N 120.064 -1.647 . . . . 0.0 113.162 173.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -139.43 166.89 23.36 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 124.522 1.129 . . . . 0.0 108.09 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -127.81 161.34 21.79 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 120.929 -1.107 . . . . 0.0 110.971 174.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -140.78 146.57 37.83 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 121.257 -1.143 . . . . 0.0 109.376 170.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mt -108.81 147.8 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 125.747 1.619 . . . . 0.0 108.427 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -101.73 95.2 6.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.096 0.95 . . . . 0.0 109.442 169.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -69.04 128.88 38.25 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.275 14.9 p30 -74.57 107.16 6.52 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -176.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -166.97 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.234 1.414 . . . . 0.0 108.224 173.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.0 t -139.84 43.14 1.96 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 102.725 -3.065 . . . . 0.0 102.725 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.6 mptt 51.12 73.39 0.3 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.177 2.191 . . . . 0.0 114.101 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -103.05 133.59 47.91 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.814 -1.804 . . . . 0.0 110.056 -169.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.89 114.28 26.8 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 123.761 0.824 . . . . 0.0 110.22 -164.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.5 t -114.04 113.2 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -173.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . 0.264 0.1 OUTLIER -85.81 145.26 27.3 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.054 -1.654 . . . . 0.0 112.296 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.3 p -137.45 142.82 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 122.449 1.119 . . . . 0.0 110.759 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -98.79 140.99 32.16 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.39 1.876 . . . . 0.0 108.558 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -56.42 -36.84 69.41 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -171.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 t -66.8 -18.01 65.16 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.43 -21.4 38.9 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.406 -2.059 . . . . 0.0 112.347 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.1 mt -83.75 145.48 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 125.653 1.581 . . . . 0.0 108.497 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.492 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.74 0 CA-C-O 121.427 0.459 . . . . 0.0 113.32 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -72.36 90.69 1.29 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.315 1.446 . . . . 0.0 110.261 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.04 12.84 17.11 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.189 -1.569 . . . . 0.0 113.616 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -77.51 158.32 29.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.249 -1.736 . . . . 0.0 115.397 171.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.81 148.47 24.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 121.013 -1.054 . . . . 0.0 109.407 175.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 m -138.37 157.74 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 125.573 1.549 . . . . 0.0 109.473 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -102.08 142.58 33.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.061 1.344 . . . . 0.0 111.634 171.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -161.35 -176.45 5.39 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 124.072 0.949 . . . . 0.0 110.704 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -113.67 148.17 36.82 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 120.559 -1.338 . . . . 0.0 108.106 168.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.8 t -100.89 85.54 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 119.361 -2.087 . . . . 0.0 109.846 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 m -136.12 85.56 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.484 -2.635 . . . . 0.0 115.406 -157.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -144.26 -77.82 0.21 Allowed 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.844 -2.41 . . . . 0.0 112.564 170.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.71 -49.19 0.87 Allowed Glycine 0 N--CA 1.431 -1.694 0 O-C-N 120.979 -1.075 . . . . 0.0 114.476 175.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -68.25 -54.82 15.02 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.457 -1.613 . . . . 0.0 113.67 -169.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -92.18 -59.17 2.16 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.451 -1.406 . . . . 0.0 109.673 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.13 -103.79 0.19 Allowed Glycine 0 N--CA 1.43 -1.715 0 O-C-N 120.527 -1.358 . . . . 0.0 110.528 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.93 149.83 50.63 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.967 -1.314 . . . . 0.0 113.275 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.9 -177.89 4.48 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 124.745 1.218 . . . . 0.0 108.994 161.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.09 154.08 44.64 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 121.947 0.879 . . . . 0.0 111.274 -168.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.37 143.8 32.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.423 1.089 . . . . 0.0 109.482 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 53.43 59.66 4.22 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.102 2.561 . . . . 0.0 115.21 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.6 t -92.17 127.81 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 120.959 -1.088 . . . . 0.0 111.752 -164.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.1 t -155.07 -179.39 8.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.412 1.101 . . . . 0.0 110.508 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.734 0 CA-C-O 117.246 -1.863 . . . . 0.0 112.02 -176.976 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.8 t . . . . . 0 N--CA 1.43 -1.463 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -90.43 -50.55 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 119.762 -1.836 . . . . 0.0 111.051 -171.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.31 165.89 14.91 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.658 0.742 . . . . 0.0 112.492 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.1 p -107.79 159.71 16.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.203 1.801 . . . . 0.0 109.17 165.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.4 tptt 48.53 65.76 1.26 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -175.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 88.7 t -112.04 151.22 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 128.096 2.558 . . . . 0.0 108.158 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -108.78 156.88 19.11 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.862 1.792 . . . . 0.0 110.247 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.09 179.25 41.9 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 120.172 -1.58 . . . . 0.0 109.628 173.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 m -113.7 130.93 56.34 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.708 0.803 . . . . 0.0 110.335 -169.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.0 t -98.06 122.56 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 125.766 1.627 . . . . 0.0 110.986 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -110.95 -59.54 1.95 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.063 -1.648 . . . . 0.0 110.612 174.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.9 t90 -69.83 -79.29 0.06 Allowed 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.569 1.548 . . . . 0.0 114.798 -166.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.8 t80 75.1 114.69 0.06 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.718 2.407 . . . . 0.0 113.249 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -110.99 124.64 52.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.064 -1.648 . . . . 0.0 109.822 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.1 t -107.96 -47.58 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 120.684 -1.26 . . . . 0.0 110.769 171.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -63.77 -30.79 71.85 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -167.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -107.53 -25.29 11.44 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 121.345 -0.847 . . . . 0.0 111.851 166.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.56 -43.69 1.62 Allowed Glycine 0 N--CA 1.43 -1.709 0 O-C-N 118.983 -2.323 . . . . 0.0 114.236 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -75.71 105.72 6.9 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 124.792 1.237 . . . . 0.0 112.8 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.13 175.45 21.3 Favored Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 124.84 1.209 . . . . 0.0 111.325 -176.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -143.26 145.57 32.86 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 123.021 1.391 . . . . 0.0 113.433 171.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.2 mt -107.75 147.79 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 125.054 1.342 . . . . 0.0 108.964 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -93.92 87.85 5.52 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 122.674 1.226 . . . . 0.0 108.951 173.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -66.52 112.82 4.3 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.925 -1.734 . . . . 0.0 114.522 172.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -85.41 25.78 0.99 Allowed 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 117.43 2.382 . . . . 0.0 117.43 -160.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -73.37 -51.14 18.45 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.46 -1.4 . . . . 0.0 111.416 170.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.3 t -146.4 24.59 1.26 Allowed 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.09 76.37 0.29 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 127.516 2.327 . . . . 0.0 111.153 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -109.85 133.15 53.48 Favored 'General case' 0 N--CA 1.428 -1.525 0 O-C-N 120.555 -1.34 . . . . 0.0 109.383 -176.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -81.87 110.82 17.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.493 1.616 . . . . 0.0 110.021 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.46 112.78 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.71 -1.244 . . . . 0.0 108.224 -171.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -85.18 129.28 34.83 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -172.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.4 t -127.41 123.19 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 124.994 1.318 . . . . 0.0 110.451 -168.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -93.12 160.79 14.69 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.183 -0.948 . . . . 0.0 112.001 171.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -60.41 -29.32 68.9 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.0 m -61.89 -33.37 74.09 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 125.843 1.657 . . . . 0.0 113.475 175.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.41 -17.17 60.84 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.193 -1.567 . . . . 0.0 114.294 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 72.7 mt -88.25 112.49 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 125.24 1.416 . . . . 0.0 110.261 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt . . . . . 0 N--CA 1.43 -1.428 0 C-N-CA 124.741 1.216 . . . . 0.0 110.983 176.739 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.733 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -108.48 158.8 17.21 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 166.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.46 8.3 49.83 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 120.079 -1.638 . . . . 0.0 114.518 -177.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -75.71 166.5 23.46 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.334 1.454 . . . . 0.0 114.551 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.98 148.85 22.21 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.43 1.892 . . . . 0.0 112.776 175.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 p -147.2 153.14 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 126.995 2.118 . . . . 0.0 106.05 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -104.3 147.86 27.02 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 120.104 1.32 . . . . 0.0 110.707 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -159.78 169.67 23.13 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.256 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -97.28 147.47 24.11 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.051 -1.656 . . . . 0.0 107.202 170.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.0 t -106.86 95.71 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 O-C-N 119.204 -2.185 . . . . 0.0 109.323 175.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.62 100.89 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 120.444 -1.41 . . . . 0.0 110.488 -162.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -160.25 -122.5 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.232 -1.542 . . . . 0.0 112.699 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.25 -145.48 4.14 Favored Glycine 0 N--CA 1.43 -1.723 0 C-N-CA 127.307 2.384 . . . . 0.0 110.036 -162.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -94.98 -34.87 12.2 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.72 -1.459 . . . . 0.0 114.208 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -66.08 -37.73 86.52 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.81 -1.182 . . . . 0.0 114.033 -167.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -162.81 -156.35 8.49 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 174.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.01 158.56 39.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.028 -1.278 . . . . 0.0 111.778 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -138.47 172.82 12.33 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 127.489 2.316 . . . . 0.0 106.374 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.03 154.63 42.72 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.702 -1.874 . . . . 0.0 107.762 -168.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -149.89 162.67 39.86 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 55.23 54.47 8.7 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.261 1.824 . . . . 0.0 113.563 173.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.3 t -87.69 127.49 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.796 -1.19 . . . . 0.0 110.353 -170.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.0 p -94.44 -176.28 3.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.987 1.375 . . . . 0.0 114.05 -168.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.687 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 171.667 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 78.0 t . . . . . 0 N--CA 1.431 -1.409 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.3 mp -90.91 -57.46 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 119.633 -1.917 . . . . 0.0 110.392 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.49 160.74 26.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -168.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.8 p -106.58 157.59 17.57 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.592 2.757 . . . . 0.0 112.093 163.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.8 mttp 57.79 57.76 4.03 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.128 2.171 . . . . 0.0 114.602 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 t -115.97 152.19 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 C-N-CA 128.72 2.808 . . . . 0.0 107.741 -169.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -128.11 164.79 21.67 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 123.696 1.712 . . . . 0.0 114.15 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -168.79 -173.86 36.92 Favored Glycine 0 N--CA 1.431 -1.685 0 O-C-N 121.018 -1.051 . . . . 0.0 110.57 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.7 m -115.98 129.55 56.43 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.463 1.601 . . . . 0.0 108.365 -172.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.3 p -87.19 147.51 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 120.567 -1.333 . . . . 0.0 112.474 -177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.8 mmtt -102.47 -99.14 0.28 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 162.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -147.29 -170.82 3.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 172.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -124.58 166.61 15.78 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 126.157 1.783 . . . . 0.0 108.305 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -87.9 91.37 8.74 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 162.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.9 m -68.12 -31.0 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 126.965 2.106 . . . . 0.0 113.794 -171.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -62.04 -43.58 98.53 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 124.622 1.169 . . . . 0.0 112.68 -175.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -92.01 -36.53 13.34 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 119.144 -2.223 . . . . 0.0 113.603 166.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.57 34.64 3.03 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 121.521 -0.737 . . . . 0.0 114.198 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -123.65 162.61 22.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.783 -1.422 . . . . 0.0 110.411 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.42 171.67 36.78 Favored Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 169.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -118.23 155.6 30.25 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 118.146 0.973 . . . . 0.0 112.077 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.8 mm -104.47 155.87 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 169.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -110.81 96.67 6.31 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 119.637 1.108 . . . . 0.0 110.589 168.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -36.12 147.65 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 131.158 3.783 . . . . 0.0 117.446 164.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -66.0 -7.03 14.76 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.818 2.525 . . . . 0.0 117.818 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -82.94 -78.51 0.21 Allowed 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.875 -1.765 . . . . 0.0 112.502 -171.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 t -120.55 10.52 11.12 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 121.857 2.117 . . . . 0.0 107.244 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.2 mptt 60.09 67.53 0.85 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.714 2.406 . . . . 0.0 112.049 -174.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -107.73 159.4 16.51 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.064 -1.023 . . . . 0.0 109.452 -168.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -84.71 95.11 8.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 124.44 1.096 . . . . 0.0 112.643 -172.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.8 t -109.85 110.6 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -85.16 148.7 25.98 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 120.473 -1.392 . . . . 0.0 113.574 -168.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 81.8 t -136.68 133.59 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 125.097 1.359 . . . . 0.0 109.138 -171.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -114.47 165.2 12.99 Favored 'General case' 0 N--CA 1.432 -1.366 0 C-N-CA 125.247 1.419 . . . . 0.0 111.057 172.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -63.51 -36.52 84.04 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -169.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.0 m -74.99 -19.81 59.93 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.958 1.303 . . . . 0.0 112.107 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.26 -26.59 60.31 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.519 -1.988 . . . . 0.0 112.79 173.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.0 mt -76.45 114.65 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.702 1.601 . . . . 0.0 109.713 170.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.4 mttt . . . . . 0 N--CA 1.431 -1.409 0 O-C-N 120.778 -1.201 . . . . 0.0 109.353 -178.413 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.657 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.0 t70 66.71 -137.98 0.14 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.825 1.25 . . . . 0.0 109.907 -169.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.79 87.17 0.47 Allowed Glycine 0 N--CA 1.43 -1.753 0 O-C-N 120.814 -1.179 . . . . 0.0 112.43 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -64.17 169.58 4.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.094 -1.827 . . . . 0.0 114.545 171.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.12 136.75 36.16 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 122.207 1.003 . . . . 0.0 110.814 172.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.3 m -123.06 151.01 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -100.14 152.61 20.06 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 121.169 -0.957 . . . . 0.0 110.254 171.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -161.21 -179.31 7.34 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.844 0.83 . . . . 0.0 110.358 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -105.06 154.48 20.09 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 164.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 64.0 t -112.61 90.3 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 119.675 -1.891 . . . . 0.0 106.632 174.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.81 87.69 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 124.217 1.961 . . . . 0.0 107.174 -165.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -85.56 124.59 32.28 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.584 -1.322 . . . . 0.0 113.738 -171.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -124.16 -41.94 0.38 Allowed Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 125.239 1.4 . . . . 0.0 112.797 173.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -89.45 -136.23 0.11 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.322 1.449 . . . . 0.0 111.826 -172.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -85.06 -13.82 49.21 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 126.523 1.929 . . . . 0.0 112.245 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -166.46 167.61 39.58 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 105.574 -3.011 . . . . 0.0 105.574 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.67 165.41 15.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -162.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -115.84 -174.83 2.6 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.037 -1.04 . . . . 0.0 111.221 164.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.93 144.95 31.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.543 1.164 . . . . 0.0 108.687 -169.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.74 160.68 38.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 55.85 48.62 17.72 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.011 1.724 . . . . 0.0 114.309 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.1 t -88.05 138.79 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 124.332 1.053 . . . . 0.0 111.026 -165.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.0 p -109.14 -158.53 0.65 Allowed 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 124.18 1.943 . . . . 0.0 113.011 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.781 0 O-C-N 119.559 -1.963 . . . . 0.0 109.68 176.834 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.43 -1.458 0 CA-C-O 120.753 0.311 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -97.56 -50.24 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 O-C-N 119.629 -1.92 . . . . 0.0 106.436 165.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -158.3 161.49 37.68 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 123.356 0.662 . . . . 0.0 111.408 171.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.5 p -120.87 149.42 42.62 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.586 -1.321 . . . . 0.0 110.597 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.265 54.9 mttp 59.06 73.12 0.49 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.185 2.194 . . . . 0.0 113.866 -171.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.49 149.71 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 126.892 2.077 . . . . 0.0 109.2 -163.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -109.05 159.63 16.69 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 123.787 1.756 . . . . 0.0 112.798 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.73 -178.36 44.55 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.4 m -117.14 129.51 56.01 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -172.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.6 t -72.23 135.87 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 120.796 -1.19 . . . . 0.0 111.435 -175.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -95.14 -100.69 0.16 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.347 -1.47 . . . . 0.0 110.202 173.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -130.16 157.17 43.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.871 -1.768 . . . . 0.0 111.37 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -104.03 142.09 35.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.51 1.524 . . . . 0.0 109.921 172.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -118.15 100.54 7.59 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.945 1.698 . . . . 0.0 109.058 -175.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.17 -29.81 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 120.645 -1.284 . . . . 0.0 113.409 -158.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -58.39 -59.8 4.78 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.83 -1.794 . . . . 0.0 113.34 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -78.48 -37.79 42.48 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.763 -1.211 . . . . 0.0 113.223 174.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.93 53.45 0.8 Allowed Glycine 0 N--CA 1.43 -1.735 0 CA-C-N 119.768 1.167 . . . . 0.0 114.17 175.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -125.32 175.02 7.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.723 -0.869 . . . . 0.0 110.253 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.9 176.28 35.77 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 107.64 -2.184 . . . . 0.0 107.64 163.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -149.86 153.76 37.26 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 122.699 1.238 . . . . 0.0 112.949 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mt -124.28 147.33 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 125.634 1.574 . . . . 0.0 109.324 -172.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -99.29 93.81 6.13 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 168.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -67.03 130.51 43.37 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -82.66 68.04 8.96 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.221 1.409 . . . . 0.0 114.631 -167.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -132.42 -72.57 0.52 Allowed 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 120.427 -1.42 . . . . 0.0 109.253 170.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.0 t -131.91 38.63 3.52 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.4 mptt 57.83 69.71 0.71 Allowed 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.981 1.712 . . . . 0.0 114.227 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -103.02 141.94 34.95 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.515 -1.99 . . . . 0.0 109.623 -166.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -93.85 104.71 16.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -162.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.1 t -108.95 116.5 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.69 -1.256 . . . . 0.0 109.119 -167.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -81.12 134.47 35.65 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 125.111 1.364 . . . . 0.0 112.743 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.42 123.1 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 120.438 -1.414 . . . . 0.0 111.013 -175.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -100.63 170.11 8.59 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.351 1.46 . . . . 0.0 112.305 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -68.85 -22.41 64.22 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.6 -1.938 . . . . 0.0 114.892 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.5 p -71.11 -25.15 62.47 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.74 2.016 . . . . 0.0 113.392 175.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.39 -32.33 29.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.611 -1.306 . . . . 0.0 113.195 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.83 139.82 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 C-N-CA 126.481 1.912 . . . . 0.0 113.275 -175.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.2 pttm . . . . . 0 N--CA 1.431 -1.422 0 N-CA-C 119.04 2.978 . . . . 0.0 119.04 -173.899 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.691 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -86.88 102.88 14.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.696 -1.473 . . . . 0.0 109.779 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.3 21.22 20.65 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 121.406 -0.809 . . . . 0.0 113.179 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -76.21 158.38 31.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.995 -1.297 . . . . 0.0 112.947 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 p -103.1 160.09 14.95 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.616 1.567 . . . . 0.0 113.487 -175.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -154.93 141.35 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 O-C-N 121.385 -0.822 . . . . 0.0 109.547 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -93.04 142.96 26.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.743 1.258 . . . . 0.0 112.7 165.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -155.59 172.11 18.82 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.974 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -102.88 138.28 39.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 166.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.7 t -96.22 91.93 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 119.676 -1.89 . . . . 0.0 109.524 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.99 90.47 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 118.607 -2.558 . . . . 0.0 111.785 -159.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -144.81 -60.3 0.36 Allowed 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 122.659 1.219 . . . . 0.0 110.931 165.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.9 -48.38 1.32 Allowed Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 115.617 1.007 . . . . 0.0 115.617 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -80.12 -85.26 0.09 Allowed 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 -172.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -86.13 -30.47 22.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.285 -1.509 . . . . 0.0 114.333 -167.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -162.92 -127.53 0.88 Allowed Glycine 0 N--CA 1.43 -1.763 0 O-C-N 119.953 -1.717 . . . . 0.0 110.56 170.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.48 137.37 26.88 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 122.246 1.022 . . . . 0.0 113.119 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -117.83 -166.81 1.24 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.943 -1.098 . . . . 0.0 109.725 165.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.06 153.49 42.99 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 123.018 1.39 . . . . 0.0 110.863 -170.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.44 157.76 44.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 175.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 50.72 59.32 4.68 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 36.4 t -93.97 100.26 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 120.672 -1.268 . . . . 0.0 109.073 -170.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.0 p -99.32 -103.39 0.22 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.074 1.35 . . . . 0.0 111.951 -171.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.726 0 C-N-CA 125.531 1.539 . . . . 0.0 110.194 -173.206 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.489 -1.4 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -72.03 -61.33 1.83 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.921 -1.737 . . . . 0.0 115.046 -169.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -116.64 -98.61 0.45 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.379 -1.451 . . . . 0.0 110.535 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.554 HG11 ' H ' ' A' ' 65' ' ' GLU . 4.3 m -82.94 167.02 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.407 -1.433 . . . . 0.0 112.217 -176.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -91.37 -61.49 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 O-C-N 120.135 -1.603 . . . . 0.0 108.833 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -164.84 173.21 11.98 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -174.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.2 p -109.47 160.17 16.43 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.962 2.505 . . . . 0.0 109.755 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.7 mttt 59.99 49.76 7.35 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.585 2.068 . . . . 0.0 116.585 174.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.57 143.78 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.301 1.84 . . . . 0.0 109.295 -166.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -106.69 149.85 26.84 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.222 1.01 . . . . 0.0 110.323 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.35 -167.04 37.38 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.306 -1.496 . . . . 0.0 111.383 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.7 m -116.44 120.94 40.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.657 -0.908 . . . . 0.0 109.758 -164.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.2 t -87.77 130.44 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 120.89 -1.131 . . . . 0.0 110.456 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -133.04 159.71 39.27 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 120.828 -1.17 . . . . 0.0 111.461 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.4 t90 37.11 63.67 0.68 Allowed 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 118.395 2.739 . . . . 0.0 118.395 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -79.51 118.17 21.13 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.461 -1.4 . . . . 0.0 110.39 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -95.12 107.16 19.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.648 -1.283 . . . . 0.0 108.441 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.9 t -71.32 -33.98 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 126.3 1.84 . . . . 0.0 112.493 -173.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -65.38 -38.38 89.83 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.191 -1.568 . . . . 0.0 113.566 -172.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -95.13 -35.04 12.05 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.739 -1.225 . . . . 0.0 111.931 169.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.89 40.71 3.04 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.518 -1.364 . . . . 0.0 113.858 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -132.93 146.39 51.75 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.471 1.509 . . . . 0.0 109.591 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -149.88 -171.75 18.64 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 170.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -141.32 153.42 45.14 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 123.389 1.566 . . . . 0.0 111.776 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mt -112.36 141.53 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.335 1.054 . . . . 0.0 108.341 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -91.92 91.23 7.79 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 172.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.12 110.89 2.68 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 125.968 1.707 . . . . 0.0 113.753 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.331 38.7 p30 -54.14 -47.55 71.78 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 121.084 3.735 . . . . 0.0 121.084 -158.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -56.64 -49.11 75.99 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.771 2.878 . . . . 0.0 118.771 -169.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -136.25 35.73 2.76 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.19 -2.194 . . . . 0.0 106.837 173.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? 57.32 63.34 1.9 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.875 1.67 . . . . 0.0 113.278 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -107.83 151.35 25.86 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.965 -1.71 . . . . 0.0 110.531 -168.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -84.65 112.16 20.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.381 1.086 . . . . 0.0 111.943 -169.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.9 t -113.91 111.92 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -88.31 134.86 33.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.634 -1.916 . . . . 0.0 110.616 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.4 p -130.85 133.58 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.882 -1.136 . . . . 0.0 110.283 -173.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -117.43 154.73 30.87 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.011 1.724 . . . . 0.0 111.625 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -54.12 -31.05 51.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 117.794 2.516 . . . . 0.0 117.794 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.5 p -75.85 -12.14 60.11 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.516 -1.99 . . . . 0.0 114.334 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.48 -15.24 33.51 Favored 'General case' 0 CA--C 1.489 -1.37 0 O-C-N 120.766 -1.209 . . . . 0.0 112.369 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.2 mm -74.18 133.02 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 125.463 1.505 . . . . 0.0 111.116 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -72.64 168.28 19.01 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.267 -2.146 . . . . 0.0 115.09 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . 0.256 30.6 ttpt 56.75 -118.54 1.18 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.469 2.307 . . . . 0.0 116.095 171.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -151.93 142.36 22.55 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.97 1.708 . . . . 0.0 106.565 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -118.64 107.72 42.29 Favored Pre-proline 0 N--CA 1.43 -1.447 0 C-N-CA 124.723 1.209 . . . . 0.0 108.237 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.31 176.6 9.74 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 CA-C-N 123.622 2.329 . . . . 0.0 113.523 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -112.19 60.07 0.63 Allowed 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.466 1.127 . . . . 0.0 110.97 -171.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -156.79 173.09 17.5 Favored 'General case' 0 N--CA 1.432 -1.374 0 O-C-N 119.913 -1.742 . . . . 0.0 112.3 -173.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.8 t80 70.77 144.38 0.06 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.482 2.313 . . . . 0.0 115.753 175.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.6 tp -93.29 -81.3 0.36 Allowed 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 120.297 -1.502 . . . . 0.0 112.665 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -78.8 107.72 11.72 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 -163.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.7 t -117.22 -67.87 0.96 Allowed 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.563 -1.336 . . . . 0.0 109.328 172.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.2 t -128.27 -77.88 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 C-N-CA 124.858 1.263 . . . . 0.0 108.14 172.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 145.61 -144.22 12.71 Favored Glycine 0 N--CA 1.429 -1.799 0 N-CA-C 107.782 -2.127 . . . . 0.0 107.782 -174.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -80.77 146.92 30.74 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 118.895 1.347 . . . . 0.0 111.843 173.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.2 45.3 62.15 Favored Glycine 0 N--CA 1.431 -1.675 0 O-C-N 120.469 -1.394 . . . . 0.0 115.597 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -75.03 152.54 38.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.489 1.137 . . . . 0.0 113.268 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 m -97.86 138.25 35.49 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.217 1.008 . . . . 0.0 109.667 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -143.28 151.53 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -172.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -98.28 143.27 28.95 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 119.589 1.086 . . . . 0.0 110.455 171.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -157.94 160.97 38.15 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 121.79 0.805 . . . . 0.0 109.247 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -88.62 142.81 27.38 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.838 -1.789 . . . . 0.0 107.207 166.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.3 t -100.66 97.6 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 119.48 -2.012 . . . . 0.0 106.811 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.421 ' HA ' ' HB ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -123.24 144.93 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 O-C-N 120.609 -1.307 . . . . 0.0 110.101 -163.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.554 ' H ' HG11 ' A' ' 4' ' ' VAL . 16.7 tt0 -59.63 111.63 1.5 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.476 2.084 . . . . 0.0 113.269 -170.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.14 -128.03 3.19 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 111.747 -2.478 . . . . 0.0 112.641 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -100.35 -71.23 0.71 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 124.129 0.971 . . . . 0.0 109.326 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -83.0 -26.25 31.43 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.783 -1.198 . . . . 0.0 112.111 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.59 -88.96 0.07 OUTLIER Glycine 0 N--CA 1.429 -1.783 0 O-C-N 121.278 -0.889 . . . . 0.0 111.055 -167.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.28 149.08 35.7 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.508 1.623 . . . . 0.0 114.867 -173.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -122.37 -162.86 1.03 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.543 1.937 . . . . 0.0 110.464 168.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -146.77 133.4 19.89 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.349 -1.47 . . . . 0.0 110.161 -169.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -133.14 162.01 32.89 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.95 1.3 . . . . 0.0 108.687 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 51.04 51.63 16.66 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.731 1.613 . . . . 0.0 115.019 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.8 t -92.94 129.92 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 123.905 0.882 . . . . 0.0 112.016 -165.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.2 p -96.32 -134.27 0.22 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.417 1.087 . . . . 0.0 112.97 -175.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.46 176.77 45.79 Favored Glycine 0 N--CA 1.43 -1.716 0 O-C-N 119.709 -1.869 . . . . 0.0 108.702 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -71.13 -2.31 10.92 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 C-N-CA 123.222 2.615 . . . . 0.0 117.238 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.794 0 CA-C-N 120.742 1.61 . . . . 0.0 110.807 -175.036 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.9 ttp . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -124.4 149.68 46.43 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.717 1.607 . . . . 0.0 109.785 -176.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -95.84 -59.99 1.74 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.489 -1.382 . . . . 0.0 111.824 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.7 m -72.66 151.19 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 120.841 -1.162 . . . . 0.0 112.966 -173.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.3 mp -95.61 -72.87 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.503 -1.998 . . . . 0.0 107.685 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -158.05 171.95 19.31 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -168.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -107.47 156.02 19.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.593 2.357 . . . . 0.0 111.115 168.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt 53.73 57.2 6.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 176.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.6 t -105.46 144.94 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 128.179 2.591 . . . . 0.0 107.728 -175.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -105.41 150.0 25.64 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.385 -1.447 . . . . 0.0 109.945 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -168.61 -179.84 41.1 Favored Glycine 0 N--CA 1.43 -1.712 0 O-C-N 120.529 -1.357 . . . . 0.0 110.399 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 m -115.56 133.64 55.84 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 124.221 1.009 . . . . 0.0 111.486 -167.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.7 p -109.95 142.25 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 123.901 0.881 . . . . 0.0 111.332 174.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -100.32 -87.29 0.38 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.697 -1.877 . . . . 0.0 110.027 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -112.11 128.81 56.32 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 124.873 1.269 . . . . 0.0 109.469 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -139.66 155.21 47.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.144 -0.972 . . . . 0.0 110.731 172.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -86.43 104.06 15.56 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.284 -1.51 . . . . 0.0 111.353 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.16 -34.65 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -62.66 -45.52 92.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.267 -1.521 . . . . 0.0 114.066 -173.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -83.49 -42.47 16.84 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.914 -1.116 . . . . 0.0 110.367 168.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.53 53.53 1.55 Allowed Glycine 0 N--CA 1.43 -1.745 0 O-C-N 120.255 -1.528 . . . . 0.0 110.277 -172.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -135.91 151.69 50.24 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 123.561 0.744 . . . . 0.0 109.898 -169.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.77 -158.03 26.95 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 121.236 -0.915 . . . . 0.0 111.687 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -144.86 154.04 42.22 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 123.159 1.456 . . . . 0.0 112.84 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.3 mm -109.46 162.36 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.389 1.476 . . . . 0.0 107.166 -178.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -102.3 100.61 10.79 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 120.921 -1.112 . . . . 0.0 109.442 170.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -57.92 124.96 21.05 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.049 1.74 . . . . 0.0 114.359 168.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -55.12 -47.93 74.34 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 119.273 3.064 . . . . 0.0 119.273 -168.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -68.05 -46.9 69.82 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -168.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.1 t -137.69 23.97 2.88 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 119.77 -1.831 . . . . 0.0 107.491 -170.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.61 49.77 6.22 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.941 1.696 . . . . 0.0 113.922 166.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -104.81 156.3 18.13 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 123.298 1.523 . . . . 0.0 112.807 -168.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -86.05 119.44 26.35 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.625 -171.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.4 t -108.63 103.32 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -169.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -82.73 131.83 35.19 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 122.975 1.369 . . . . 0.0 113.781 -173.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.4 t -128.88 135.39 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 124.657 1.183 . . . . 0.0 108.019 -172.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.8 176.91 6.29 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.324 1.05 . . . . 0.0 109.08 169.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -61.58 -21.64 64.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.987 2.217 . . . . 0.0 116.987 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -71.82 -26.02 62.22 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.501 1.521 . . . . 0.0 113.732 173.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.41 -22.06 26.78 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.849 -2.407 . . . . 0.0 113.011 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.8 mt -81.57 104.44 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 125.531 1.533 . . . . 0.0 109.819 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.251 50.3 mttm 65.34 -172.53 0.18 Allowed 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 125.529 1.532 . . . . 0.0 114.3 -173.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.61 119.52 6.2 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 118.708 -2.495 . . . . 0.0 109.755 177.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . 0.282 11.5 t-20 53.21 -86.98 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 127.776 2.43 . . . . 0.0 116.23 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -70.49 121.86 84.77 Favored Pre-proline 0 N--CA 1.43 -1.435 0 O-C-N 119.867 -1.771 . . . . 0.0 113.061 -177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.53 170.91 19.03 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 CA-C-N 123.453 2.269 . . . . 0.0 114.073 -177.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -142.68 81.27 1.73 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 122.364 1.078 . . . . 0.0 109.469 176.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.257 45.6 mttp 66.74 -157.44 0.24 Allowed 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.1 2.16 . . . . 0.0 115.184 -173.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -113.02 151.65 30.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.836 -1.165 . . . . 0.0 110.484 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 tp -88.14 106.04 17.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.168 -1.582 . . . . 0.0 108.495 162.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -95.17 -58.52 2.12 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.783 -1.198 . . . . 0.0 112.545 -171.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.0 t -117.55 146.6 43.47 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 124.307 1.043 . . . . 0.0 111.572 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.3 m -120.91 156.51 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 124.618 1.167 . . . . 0.0 111.507 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -137.33 140.22 11.16 Favored Glycine 0 N--CA 1.429 -1.773 0 O-C-N 120.554 -1.341 . . . . 0.0 113.576 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.11 140.1 48.71 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.023 -1.869 . . . . 0.0 114.403 -177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.73 11.39 79.66 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 119.741 -1.849 . . . . 0.0 113.425 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -79.69 153.29 29.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.279 1.514 . . . . 0.0 113.617 177.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 p -97.45 142.68 29.0 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 125.433 1.493 . . . . 0.0 114.678 -177.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.02 154.3 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 124.679 1.192 . . . . 0.0 109.594 -174.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.53 145.39 30.37 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.347 -1.471 . . . . 0.0 113.054 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -156.38 172.31 18.73 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.031 1.332 . . . . 0.0 110.171 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -94.8 154.07 17.44 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.592 -1.942 . . . . 0.0 108.094 165.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.5 t -110.97 96.97 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 119.139 -2.225 . . . . 0.0 108.011 174.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.27 111.87 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 120.183 -1.573 . . . . 0.0 109.553 -167.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -95.44 123.66 39.08 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.756 -1.84 . . . . 0.0 113.587 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -123.82 -45.63 0.28 Allowed Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 125.156 1.36 . . . . 0.0 112.809 170.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -95.37 -136.61 0.22 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.004 1.322 . . . . 0.0 111.386 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -78.76 -32.12 46.44 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.617 -1.927 . . . . 0.0 113.19 -174.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -141.07 165.84 26.15 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 105.997 -2.841 . . . . 0.0 105.997 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.71 152.22 21.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.206 1.479 . . . . 0.0 114.676 -168.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -107.01 -166.71 1.19 Allowed 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.423 -1.423 . . . . 0.0 109.947 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.33 156.23 42.72 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -173.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.58 162.41 36.68 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 56.45 40.31 29.66 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.628 1.571 . . . . 0.0 114.414 173.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 t -76.21 109.61 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 125.948 1.699 . . . . 0.0 110.62 -172.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.7 m -125.96 -121.85 0.25 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 123.8 0.84 . . . . 0.0 110.165 -161.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 119.88 162.84 12.02 Favored Glycine 0 N--CA 1.429 -1.787 0 O-C-N 119.335 -2.103 . . . . 0.0 111.691 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.77 156.52 48.59 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 123.363 2.709 . . . . 0.0 113.009 176.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.716 0 CA-C-O 117.821 -1.544 . . . . 0.0 112.35 178.784 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 CA--C 1.49 -1.365 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -90.58 -76.52 0.43 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.436 1.095 . . . . 0.0 113.297 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -67.95 130.07 41.83 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -166.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 t 70.73 86.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 127.336 2.255 . . . . 0.0 110.87 175.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.1 mp -80.74 -72.08 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 119.952 -1.718 . . . . 0.0 113.116 -166.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.19 167.89 28.86 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -160.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.9 p -110.96 134.37 52.64 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 128.188 2.595 . . . . 0.0 109.661 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.279 25.8 ttmt 59.18 75.67 0.39 Allowed 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.683 1.993 . . . . 0.0 116.046 -172.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.6 t -121.06 149.96 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 130.311 3.444 . . . . 0.0 105.739 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.7 mp -114.84 168.06 10.23 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 123.638 1.685 . . . . 0.0 112.232 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.73 -172.78 44.17 Favored Glycine 0 N--CA 1.43 -1.751 0 O-C-N 119.333 -2.104 . . . . 0.0 113.115 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.0 m -116.68 131.42 56.95 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 123.773 0.829 . . . . 0.0 109.511 -168.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.84 135.7 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 O-C-N 120.093 -1.63 . . . . 0.0 113.83 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -95.39 -56.08 2.83 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 120.098 -1.626 . . . . 0.0 109.841 173.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -156.46 130.66 8.61 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 123.972 0.909 . . . . 0.0 110.438 177.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -101.71 123.36 45.56 Favored 'General case' 0 N--CA 1.431 -1.384 0 O-C-N 120.607 -1.308 . . . . 0.0 107.965 164.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -102.52 76.9 1.57 Allowed 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.407 -1.433 . . . . 0.0 110.471 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 t -75.82 -7.5 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 123.523 1.63 . . . . 0.0 112.437 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -64.55 -30.07 71.1 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 128.814 2.846 . . . . 0.0 112.85 173.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -127.83 -46.06 1.42 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.728 -1.857 . . . . 0.0 111.444 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.45 -57.38 0.21 Allowed Glycine 0 N--CA 1.429 -1.779 0 O-C-N 119.475 -2.015 . . . . 0.0 115.929 -174.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -79.57 169.42 18.04 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.847 1.784 . . . . 0.0 114.916 -166.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.26 167.78 31.33 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 118.913 -2.367 . . . . 0.0 109.479 169.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -147.06 141.59 26.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 123.012 1.387 . . . . 0.0 111.923 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 mm -113.26 160.76 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 126.812 2.045 . . . . 0.0 108.926 -169.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -109.77 99.82 8.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.551 -1.343 . . . . 0.0 110.927 161.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.76 138.41 47.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.276 2.23 . . . . 0.0 114.93 170.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -62.48 84.95 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.607 2.447 . . . . 0.0 117.607 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -159.42 -76.12 0.07 Allowed 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.403 -2.061 . . . . 0.0 109.251 177.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.6 t -139.67 30.05 2.11 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 55.65 81.76 0.11 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.0 2.12 . . . . 0.0 114.202 -165.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -101.78 137.21 40.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.85 -1.781 . . . . 0.0 108.189 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -79.98 110.11 15.05 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 121.626 0.727 . . . . 0.0 109.925 -171.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.3 t -111.73 117.21 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -89.28 144.26 26.22 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.14 0.972 . . . . 0.0 112.957 -176.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -133.01 128.47 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 122.635 1.207 . . . . 0.0 110.847 -172.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -95.96 154.84 17.02 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.571 -1.331 . . . . 0.0 110.338 173.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -64.1 -26.1 68.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.235 -2.166 . . . . 0.0 116.443 -171.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.0 p -69.39 -27.31 65.19 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.543 -1.348 . . . . 0.0 113.755 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.83 -19.52 40.9 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.452 -1.405 . . . . 0.0 113.175 -174.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.6 mt -75.02 117.32 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 C-N-CA 126.751 2.02 . . . . 0.0 111.768 -178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -81.37 92.56 6.43 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.543 -1.348 . . . . 0.0 112.423 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -83.25 128.54 34.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.507 -1.371 . . . . 0.0 109.169 168.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -128.75 -39.91 1.59 Allowed 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 121.116 -0.99 . . . . 0.0 112.526 -173.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -107.58 138.26 19.93 Favored Pre-proline 0 N--CA 1.429 -1.48 0 O-C-N 121.189 -0.944 . . . . 0.0 111.11 -165.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.8 -15.96 14.83 Favored 'Trans proline' 0 N--CA 1.434 -1.979 0 C-N-CA 122.795 2.33 . . . . 0.0 113.605 177.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -100.3 162.9 12.66 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 119.624 1.102 . . . . 0.0 111.635 -171.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.281 31.9 mtmm 59.32 -156.52 0.34 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.44 1.896 . . . . 0.0 115.336 -173.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.2 t80 51.31 65.92 1.34 Allowed 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 127.505 2.322 . . . . 0.0 114.947 -172.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.3 mt -88.32 -143.21 0.13 Allowed 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.748 -1.22 . . . . 0.0 112.444 -171.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -75.87 -63.54 1.28 Allowed 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.654 -1.904 . . . . 0.0 112.486 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 65.4 m -77.04 145.81 37.73 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 124.945 1.298 . . . . 0.0 112.12 -177.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 m -106.52 157.8 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 120.486 -1.383 . . . . 0.0 112.842 -172.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.11 143.65 21.33 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 120.504 -1.373 . . . . 0.0 109.938 172.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -76.75 117.39 18.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.171 1.462 . . . . 0.0 112.95 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.56 55.14 21.97 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 116.734 1.454 . . . . 0.0 116.734 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -73.18 150.77 41.87 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 119.184 1.492 . . . . 0.0 113.06 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 m -99.6 145.16 27.86 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.996 -1.065 . . . . 0.0 110.904 -172.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.1 m -143.08 163.14 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 125.866 1.666 . . . . 0.0 108.028 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -113.58 153.57 28.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.234 1.414 . . . . 0.0 110.461 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -164.7 172.91 12.48 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.976 0.893 . . . . 0.0 110.632 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -92.32 152.59 19.7 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.887 -2.383 . . . . 0.0 108.662 162.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.3 t -112.11 100.71 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 119.535 -1.978 . . . . 0.0 107.547 173.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 m -132.96 128.27 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 120.412 -1.43 . . . . 0.0 108.316 -168.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -96.31 150.77 20.2 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.905 -2.372 . . . . 0.0 114.4 -163.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -151.11 -68.55 0.01 OUTLIER Glycine 0 N--CA 1.432 -1.622 0 O-C-N 121.116 -0.99 . . . . 0.0 111.549 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -78.3 -145.37 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.4 1.48 . . . . 0.0 114.46 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -62.87 -22.42 66.69 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 119.841 -1.787 . . . . 0.0 115.579 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.72 -167.61 13.48 Favored Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 127.245 2.355 . . . . 0.0 108.383 175.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.11 161.31 15.15 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.09 -168.1 1.61 Allowed 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.838 -1.164 . . . . 0.0 110.626 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.06 155.68 44.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.87 1.319 . . . . 0.0 112.136 -166.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.1 166.02 24.35 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.593 1.957 . . . . 0.0 106.531 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.336 0.4 OUTLIER 34.51 63.36 0.45 Allowed 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 117.845 2.535 . . . . 0.0 117.845 -178.513 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.1 t -92.15 98.11 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 C-N-CA 125.097 1.359 . . . . 0.0 111.017 -168.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.94 155.63 22.38 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.607 1.163 . . . . 0.0 110.612 -174.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -136.13 155.23 22.31 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 168.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -79.74 178.61 7.11 Favored 'Trans proline' 0 N--CA 1.434 -1.997 0 C-N-CA 123.273 2.649 . . . . 0.0 111.702 170.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.735 0 CA-C-O 118.704 -1.053 . . . . 0.0 111.046 171.913 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ttt . . . . . 0 CA--C 1.49 -1.34 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -80.89 -54.03 5.95 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.003 -1.685 . . . . 0.0 111.896 175.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -69.63 -67.99 0.44 Allowed 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -167.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.1 t -97.16 104.57 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 120.66 -1.275 . . . . 0.0 107.845 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.9 mp -86.38 -53.03 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 119.664 -1.898 . . . . 0.0 111.159 -165.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.92 160.5 24.94 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.5 p -115.5 148.4 39.53 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.575 1.55 . . . . 0.0 108.522 166.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.264 26.9 mmmt 53.38 83.01 0.07 Allowed 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.42 2.288 . . . . 0.0 115.512 -168.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.2 t -128.43 143.8 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 126.581 1.953 . . . . 0.0 107.153 -164.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.2 148.55 28.76 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.693 1.235 . . . . 0.0 109.613 174.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.12 179.79 41.59 Favored Glycine 0 N--CA 1.429 -1.788 0 O-C-N 120.796 -1.19 . . . . 0.0 111.376 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.9 m -115.26 135.3 54.3 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 124.635 1.174 . . . . 0.0 109.129 -169.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 50.2 t -84.27 124.8 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 120.387 -1.446 . . . . 0.0 109.441 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -97.41 -57.74 2.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.482 -1.386 . . . . 0.0 108.986 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.9 t-105 -144.56 96.42 2.87 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.0 0.92 . . . . 0.0 109.16 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -98.1 129.7 44.91 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.805 -1.184 . . . . 0.0 108.013 167.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -100.18 105.84 17.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.269 -1.519 . . . . 0.0 109.781 -177.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.4 t -77.23 -26.02 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 126.006 1.722 . . . . 0.0 112.144 -173.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -66.06 -45.87 79.79 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.233 -1.542 . . . . 0.0 112.815 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -78.59 -45.9 20.59 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.936 -1.728 . . . . 0.0 110.74 164.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.96 49.23 1.5 Allowed Glycine 0 N--CA 1.43 -1.723 0 CA-C-O 122.948 1.305 . . . . 0.0 110.287 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -155.71 152.6 28.78 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -162.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.32 -151.22 18.73 Favored Glycine 0 N--CA 1.43 -1.709 0 O-C-N 120.125 -1.61 . . . . 0.0 109.82 169.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -140.15 167.03 23.08 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.449 -1.03 . . . . 0.0 110.263 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.5 mm -109.63 155.81 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 170.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -92.25 104.93 17.24 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.416 -1.428 . . . . 0.0 109.305 161.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.0 ttt85 -66.22 114.75 5.55 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.548 -1.345 . . . . 0.0 109.573 153.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -64.81 -39.02 92.9 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -167.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -43.82 -52.45 6.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 128.585 2.754 . . . . 0.0 117.126 -169.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -143.22 33.89 1.34 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.862 -1.774 . . . . 0.0 106.565 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 57.38 58.51 3.8 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.57 1.548 . . . . 0.0 115.016 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -102.62 132.01 49.01 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.271 1.429 . . . . 0.0 109.025 -168.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -90.16 106.38 18.44 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 123.525 0.73 . . . . 0.0 110.135 -167.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t -105.53 109.04 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 121.027 -1.046 . . . . 0.0 110.37 -171.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -81.32 133.62 35.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.161 -1.587 . . . . 0.0 114.282 -171.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.1 p -129.7 133.3 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 120.37 -1.456 . . . . 0.0 111.92 -175.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -108.58 148.25 30.6 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.815 1.646 . . . . 0.0 108.66 173.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -58.1 -17.84 20.97 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 119.437 3.125 . . . . 0.0 119.437 -172.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.0 t -81.7 -12.06 58.79 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.386 -1.446 . . . . 0.0 113.268 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.73 -15.73 58.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.868 -2.395 . . . . 0.0 112.028 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.6 mt -82.48 124.41 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 126.062 1.745 . . . . 0.0 110.07 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -74.06 168.48 19.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -171.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -94.46 -50.66 5.11 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.351 -2.093 . . . . 0.0 112.766 -169.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -74.89 148.24 40.31 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 120.528 -1.358 . . . . 0.0 112.892 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -152.87 155.58 32.34 Favored Pre-proline 0 N--CA 1.43 -1.457 0 O-C-N 120.461 -1.4 . . . . 0.0 108.656 174.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.9 -34.81 1.62 Allowed 'Trans proline' 0 N--CA 1.434 -1.99 0 CA-C-N 122.905 2.073 . . . . 0.0 111.592 169.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -163.61 160.52 23.02 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 126.016 1.726 . . . . 0.0 108.642 173.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -155.81 173.08 17.26 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.401 ' HB3' ' H ' ' A' ' 50' ' ' LEU . 38.6 m-85 -86.81 -147.64 0.13 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.458 -1.401 . . . . 0.0 111.454 170.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.401 ' H ' ' HB3' ' A' ' 49' ' ' TYR . 1.2 tm? -75.61 -55.74 5.36 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.93 -1.731 . . . . 0.0 108.278 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 -139.71 -83.21 0.26 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 121.326 -0.859 . . . . 0.0 109.499 160.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.6 p -90.22 174.44 7.6 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -167.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.4 t -106.07 -49.73 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 C-N-CA 126.13 1.772 . . . . 0.0 108.808 -175.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 162.68 -148.22 14.93 Favored Glycine 0 N--CA 1.431 -1.685 0 O-C-N 120.295 -1.503 . . . . 0.0 111.792 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -78.47 126.51 30.86 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.333 -1.686 . . . . 0.0 113.002 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.9 35.72 44.0 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 120.184 -1.573 . . . . 0.0 114.51 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.25 152.56 34.62 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.803 1.287 . . . . 0.0 113.337 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.1 p -94.11 146.09 24.22 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.726 1.611 . . . . 0.0 112.48 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.4 t -139.21 140.79 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -93.54 141.64 28.24 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.382 1.086 . . . . 0.0 111.749 165.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -156.06 172.73 17.91 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.873 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -99.07 156.53 16.89 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 162.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.67 89.89 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 119.876 -1.765 . . . . 0.0 107.381 172.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 m -124.85 139.34 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 120.816 -1.177 . . . . 0.0 108.026 -164.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -59.06 128.16 35.84 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.404 -2.06 . . . . 0.0 115.516 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -116.75 -112.33 2.69 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 125.319 1.437 . . . . 0.0 111.09 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -107.82 -89.57 0.45 Allowed 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 124.911 1.285 . . . . 0.0 112.561 -175.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -79.2 10.07 3.95 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 118.922 -2.361 . . . . 0.0 115.122 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.36 -167.09 38.11 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 107.057 -2.417 . . . . 0.0 107.057 -172.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.29 156.22 28.16 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.295 -1.121 . . . . 0.0 113.755 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -124.85 -172.36 2.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.557 1.543 . . . . 0.0 111.252 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.38 140.36 30.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.757 1.265 . . . . 0.0 110.24 -162.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -138.33 149.37 45.56 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.626 -172.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 52.96 50.94 16.86 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.367 2.267 . . . . 0.0 113.839 -176.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.1 t -78.26 124.04 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 120.652 -1.28 . . . . 0.0 111.603 -165.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.0 m -113.52 -122.09 0.29 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.227 -0.921 . . . . 0.0 110.713 -169.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.0 -84.12 0.37 Allowed Glycine 0 N--CA 1.43 -1.7 0 O-C-N 119.85 -1.781 . . . . 0.0 112.544 -170.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.41 161.6 39.85 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 121.804 2.802 . . . . 0.0 113.153 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.823 0 CA-C-O 118.93 -0.928 . . . . 0.0 111.839 -173.478 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 CA--C 1.489 -1.368 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -132.11 -168.3 2.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.275 -1.515 . . . . 0.0 109.027 171.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.264 57.8 mtpt 75.38 -98.9 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.245 1.818 . . . . 0.0 115.494 169.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 71.7 t -99.72 105.51 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 120.047 -1.658 . . . . 0.0 106.799 167.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -92.75 -54.85 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 119.875 -1.766 . . . . 0.0 110.299 -168.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -160.58 151.9 19.27 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.731 1.253 . . . . 0.0 113.603 -177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.5 p -108.06 150.02 27.69 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.282 1.833 . . . . 0.0 112.562 168.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.258 83.2 mttt 56.95 70.0 0.69 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.215 1.806 . . . . 0.0 114.872 -173.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.2 t -122.47 143.7 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 126.69 1.996 . . . . 0.0 108.732 -163.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.8 mp -128.97 168.69 15.64 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 122.318 1.056 . . . . 0.0 110.832 171.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -165.07 -147.61 5.19 Favored Glycine 0 N--CA 1.431 -1.696 0 O-C-N 120.326 -1.484 . . . . 0.0 110.168 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.3 m -118.51 133.21 56.04 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 172.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.2 t -95.65 126.15 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 120.318 -1.489 . . . . 0.0 110.437 173.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -118.25 -60.2 1.81 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.797 -1.189 . . . . 0.0 110.309 167.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -85.99 109.39 18.75 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.506 -1.371 . . . . 0.0 112.357 -175.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -151.86 129.29 11.36 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.382 -1.449 . . . . 0.0 109.018 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -97.65 107.25 19.71 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.549 1.539 . . . . 0.0 107.61 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.8 t -82.99 -45.5 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 120.319 -1.488 . . . . 0.0 113.747 -155.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -55.11 -61.2 2.47 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.225 1.41 . . . . 0.0 112.041 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -66.14 -44.89 82.88 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 172.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.2 62.15 0.92 Allowed Glycine 0 N--CA 1.429 -1.77 0 O-C-N 121.248 -0.908 . . . . 0.0 113.831 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -149.15 159.63 44.07 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 121.372 -1.075 . . . . 0.0 110.82 173.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.26 -153.71 23.45 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 120.205 -1.56 . . . . 0.0 111.349 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -147.18 151.02 36.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.841 1.305 . . . . 0.0 111.237 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 mt -105.51 159.51 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 120.206 -1.559 . . . . 0.0 108.475 -173.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -117.05 92.22 3.8 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.38 1.562 . . . . 0.0 109.721 167.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -63.48 149.35 46.33 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.427 1.891 . . . . 0.0 113.686 172.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -71.86 -19.65 61.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -76.25 -81.33 0.08 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.505 -1.997 . . . . 0.0 115.627 -163.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 t -114.17 -1.51 13.64 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.096 1.426 . . . . 0.0 108.652 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.3 mptt 77.57 62.29 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.845 3.258 . . . . 0.0 108.251 171.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -102.82 131.65 49.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 112.878 -1.965 . . . . 0.0 107.439 -165.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -85.72 109.46 18.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.967 -1.708 . . . . 0.0 110.854 -164.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.424 ' CG1' ' HB2' ' A' ' 72' ' ' ALA . 48.4 t -105.65 111.26 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.752 1.621 . . . . 0.0 107.39 -169.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -90.78 145.88 24.42 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.744 1.218 . . . . 0.0 111.606 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.34 133.85 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.566 1.65 . . . . 0.0 109.74 -174.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -119.58 162.5 18.84 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.574 1.55 . . . . 0.0 112.276 -175.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -43.26 -55.65 3.9 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 129.301 3.04 . . . . 0.0 117.575 -173.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.6 t -80.96 -9.74 59.8 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.589 -1.319 . . . . 0.0 114.089 -172.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.38 -20.8 46.82 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.687 -1.883 . . . . 0.0 112.695 174.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.4 mt -79.03 124.15 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 126.005 1.722 . . . . 0.0 110.583 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -94.71 133.09 38.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.544 -1.347 . . . . 0.0 112.297 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -145.96 132.88 20.18 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.454 1.102 . . . . 0.0 110.05 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -76.73 -80.39 0.1 Allowed 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.442 1.497 . . . . 0.0 109.575 169.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -106.35 117.96 55.92 Favored Pre-proline 0 N--CA 1.431 -1.419 0 O-C-N 120.727 -1.233 . . . . 0.0 108.046 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.59 89.05 1.31 Allowed 'Trans proline' 0 C--N 1.3 -2.019 0 C-N-CA 123.065 2.51 . . . . 0.0 112.524 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -107.77 174.15 6.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 124.348 1.059 . . . . 0.0 109.927 175.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -61.83 -53.35 57.03 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.544 1.537 . . . . 0.0 115.074 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 66.32 159.74 0.13 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.239 2.616 . . . . 0.0 114.34 -171.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.3 tp -88.84 147.46 24.39 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.706 -1.871 . . . . 0.0 108.881 168.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -85.16 107.53 17.27 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.151 -1.593 . . . . 0.0 110.665 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.6 t -96.26 -55.77 2.84 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.928 1.291 . . . . 0.0 108.73 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.5 m -108.54 154.09 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 122.533 1.158 . . . . 0.0 109.295 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.1 -70.23 0.03 OUTLIER Glycine 0 N--CA 1.429 -1.784 0 O-C-N 119.887 -1.758 . . . . 0.0 111.351 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -74.04 107.1 6.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.599 -1.53 . . . . 0.0 110.522 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.08 39.75 31.6 Favored Glycine 0 N--CA 1.431 -1.684 0 O-C-N 120.582 -1.323 . . . . 0.0 114.513 -170.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.1 156.76 28.17 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 120.696 -1.473 . . . . 0.0 114.898 -175.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.43 148.1 31.7 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.705 2.002 . . . . 0.0 111.022 -175.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.8 p -155.15 145.36 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.325 1.85 . . . . 0.0 106.56 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -91.8 144.46 25.47 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 120.315 1.416 . . . . 0.0 111.88 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -151.08 169.85 20.83 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.899 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -112.94 133.17 55.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 168.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.4 t -89.32 87.12 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 120.353 -1.467 . . . . 0.0 109.585 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -130.06 107.35 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 120.282 -1.511 . . . . 0.0 109.396 -168.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -139.95 -111.29 0.15 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.61 -1.306 . . . . 0.0 109.456 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 137.28 -55.15 0.7 Allowed Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 114.059 0.384 . . . . 0.0 114.059 -169.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -101.75 -69.78 0.77 Allowed 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.324 -1.103 . . . . 0.0 112.624 -172.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -87.09 57.28 4.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.392 -1.443 . . . . 0.0 114.6 -170.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.43 -117.29 4.49 Favored Glycine 0 N--CA 1.43 -1.719 0 O-C-N 119.43 -2.044 . . . . 0.0 110.642 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.46 169.65 13.42 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 122.899 1.333 . . . . 0.0 112.951 169.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.401 ' HG3' ' H ' ' A' ' 72' ' ' ALA . 6.2 tt0 -145.84 178.8 7.9 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.405 2.282 . . . . 0.0 105.169 -176.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.424 ' HB2' ' CG1' ' A' ' 34' ' ' VAL . . . -147.14 125.36 12.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.973 2.109 . . . . 0.0 107.061 -173.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.76 160.18 33.33 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 124.378 1.071 . . . . 0.0 108.296 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 60.1 45.76 11.45 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.936 2.094 . . . . 0.0 112.952 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.6 t -87.59 104.16 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-O 122.108 0.956 . . . . 0.0 111.806 -162.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.83 148.65 50.22 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.003 0.921 . . . . 0.0 109.51 -169.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -136.87 -172.81 12.66 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 120.212 -1.555 . . . . 0.0 111.968 -176.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.36 160.01 29.23 Favored 'Trans proline' 0 N--CA 1.434 -1.99 0 C-N-CA 123.081 2.521 . . . . 0.0 113.522 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.795 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 178.655 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ttt . . . . . 0 CA--C 1.489 -1.371 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.7 ptmm? -78.08 -29.24 49.01 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.223 -1.548 . . . . 0.0 112.549 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -78.25 150.12 33.48 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.334 -1.479 . . . . 0.0 111.934 169.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.533 ' CG1' ' H ' ' A' ' 65' ' ' GLU . 9.4 m -123.28 165.8 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 121.048 -1.032 . . . . 0.0 110.179 -176.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -87.64 -65.34 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 119.468 -2.02 . . . . 0.0 111.082 -174.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.32 161.46 24.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.9 p -110.66 143.13 41.59 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.36 1.464 . . . . 0.0 110.22 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.27 92.2 mttt 60.95 73.15 0.49 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.225 2.21 . . . . 0.0 115.446 -170.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.7 t -126.11 159.22 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 129.557 3.143 . . . . 0.0 107.564 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.8 170.55 12.64 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.128 -1.608 . . . . 0.0 111.662 170.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.76 -170.26 34.0 Favored Glycine 0 N--CA 1.43 -1.725 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.7 m -116.98 127.89 54.64 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.821 1.296 . . . . 0.0 109.874 -166.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 t -91.85 147.32 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 127.015 2.126 . . . . 0.0 110.437 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -105.37 -86.95 0.46 Allowed 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.055 -1.653 . . . . 0.0 109.78 164.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 22.6 t-105 -155.1 140.29 17.54 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.725 -1.234 . . . . 0.0 108.317 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -97.77 155.84 16.85 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.791 -1.193 . . . . 0.0 113.614 -175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -95.22 93.39 7.28 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.53 -1.356 . . . . 0.0 109.04 174.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.9 m -73.32 -30.64 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -172.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -56.49 -65.08 0.67 Allowed 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 125.312 1.445 . . . . 0.0 112.37 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -72.01 -35.17 69.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.546 -1.971 . . . . 0.0 113.174 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.84 51.61 1.63 Allowed Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -129.93 140.43 50.94 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 121.325 -1.103 . . . . 0.0 108.405 -170.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.05 161.15 32.98 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.503 -1.373 . . . . 0.0 111.147 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -142.09 157.84 44.44 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.946 -0.738 . . . . 0.0 109.464 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.3 mm -109.24 147.34 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 124.907 1.283 . . . . 0.0 108.634 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -92.93 93.89 8.62 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.907 -1.121 . . . . 0.0 109.037 169.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.19 133.56 37.75 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 174.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -82.54 48.0 1.25 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -171.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.95 -68.45 0.7 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.692 -1.88 . . . . 0.0 109.474 163.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -150.34 35.33 0.64 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 57.87 75.99 0.35 Allowed 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 127.234 2.214 . . . . 0.0 112.856 -159.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -103.06 128.35 49.96 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.561 -1.962 . . . . 0.0 106.675 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -82.11 122.14 27.47 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.651 1.691 . . . . 0.0 110.252 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.07 108.38 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 O-C-N 120.568 -1.333 . . . . 0.0 108.407 -173.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -76.06 140.05 41.72 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.76 -1.213 . . . . 0.0 113.661 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.8 t -128.44 126.2 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.766 -1.209 . . . . 0.0 108.416 -177.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -111.92 165.6 11.95 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.01 1.324 . . . . 0.0 110.592 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.1 mm100 -59.58 -36.98 77.32 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 m -69.86 -14.63 62.84 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.727 -1.858 . . . . 0.0 113.433 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.19 -25.4 58.22 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.536 -2.602 . . . . 0.0 114.909 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 89.1 mt -79.44 126.02 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 125.741 1.616 . . . . 0.0 111.597 -175.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -73.43 -74.91 0.16 Allowed 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 120.615 -1.303 . . . . 0.0 112.678 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -91.59 128.47 37.43 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 121.059 -1.025 . . . . 0.0 110.813 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -90.13 138.2 31.71 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.598 -1.314 . . . . 0.0 112.277 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -108.9 158.33 34.48 Favored Pre-proline 0 N--CA 1.431 -1.397 0 C-N-CA 125.625 1.57 . . . . 0.0 114.076 -163.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -83.18 -170.88 0.98 Allowed 'Trans proline' 0 C--N 1.3 -2.026 0 C-N-CA 122.59 2.193 . . . . 0.0 112.616 170.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -106.99 134.16 50.56 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 161.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -123.4 136.34 54.58 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -97.93 56.82 1.26 Allowed 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.505 -1.372 . . . . 0.0 110.899 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.4 tp -105.34 149.61 25.92 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.321 -1.487 . . . . 0.0 109.517 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -101.49 79.79 2.0 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.882 -1.762 . . . . 0.0 110.359 173.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.3 p -107.02 -85.57 0.51 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.82 1.248 . . . . 0.0 110.399 -172.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 m -108.42 -106.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 126.434 1.894 . . . . 0.0 111.983 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.58 -114.59 4.29 Favored Glycine 0 N--CA 1.43 -1.7 0 C-N-CA 124.926 1.25 . . . . 0.0 110.76 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -71.04 111.39 6.37 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.977 1.311 . . . . 0.0 109.753 174.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.75 -20.5 5.15 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 121.176 -0.952 . . . . 0.0 114.361 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.71 155.16 38.0 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.107 -1.819 . . . . 0.0 115.104 -174.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.72 143.31 39.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.719 2.008 . . . . 0.0 110.734 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.06 146.86 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -92.85 144.44 25.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -158.44 170.76 21.48 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.321 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -94.78 141.6 28.44 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.834 -1.791 . . . . 0.0 107.845 168.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.8 t -95.51 106.38 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 O-C-N 119.197 -2.19 . . . . 0.0 108.806 171.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.65 136.72 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 120.879 -1.138 . . . . 0.0 108.06 -170.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.533 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 23.4 tt0 -120.64 166.33 13.83 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.631 -1.918 . . . . 0.0 111.407 -166.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.54 -44.68 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.892 -1.13 . . . . 0.0 111.791 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -123.67 -145.47 0.34 Allowed 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 124.682 1.193 . . . . 0.0 113.322 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -74.37 -18.85 60.62 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.88 -1.762 . . . . 0.0 114.476 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.99 139.07 8.7 Favored Glycine 0 N--CA 1.429 -1.79 0 O-C-N 120.413 -1.429 . . . . 0.0 109.551 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.22 164.32 22.38 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -172.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -120.53 -168.04 1.57 Allowed 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.872 2.069 . . . . 0.0 111.222 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.11 155.86 43.57 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -169.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -152.51 161.91 41.93 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -174.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 56.13 51.01 12.48 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 125.138 1.375 . . . . 0.0 114.522 170.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.1 t -95.07 108.5 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 124.569 1.148 . . . . 0.0 109.14 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.7 m -83.03 -82.85 0.14 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.301 -1.499 . . . . 0.0 111.729 -176.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.43 101.39 0.45 Allowed Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 126.248 1.88 . . . . 0.0 112.979 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.87 158.89 45.93 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 CA-C-N 123.985 3.893 . . . . 0.0 113.55 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.802 0 C-N-CA 124.37 0.986 . . . . 0.0 112.406 -179.513 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptm . . . . . 0 CA--C 1.489 -1.386 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.251 20.1 tptm 60.83 -72.2 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 118.129 2.64 . . . . 0.0 118.129 175.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.269 90.9 mttt 76.79 88.27 0.08 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.979 2.112 . . . . 0.0 114.642 174.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.4 t -113.97 -72.54 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 121.02 -1.05 . . . . 0.0 113.574 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 mp -84.56 -69.6 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 119.35 -2.094 . . . . 0.0 107.505 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -149.67 153.78 37.54 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -171.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.9 p -110.59 149.31 30.59 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.29 2.236 . . . . 0.0 110.508 170.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.267 87.7 mttt 53.44 67.81 0.94 Allowed 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.567 1.692 . . . . 0.0 115.567 -172.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.8 t -120.39 142.73 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 127.742 2.417 . . . . 0.0 109.123 -163.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.19 149.43 24.67 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.678 1.228 . . . . 0.0 112.051 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.23 171.44 44.46 Favored Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.6 m -112.3 136.93 51.14 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.115 0.966 . . . . 0.0 110.876 -163.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.5 t -103.39 122.86 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 124.527 1.131 . . . . 0.0 108.53 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -154.53 99.74 2.2 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.144 -1.597 . . . . 0.0 109.195 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . 0.312 37.2 m95 77.83 154.11 0.14 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.908 2.083 . . . . 0.0 113.956 -170.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.81 -167.79 2.1 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.775 -1.203 . . . . 0.0 111.286 -165.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -127.41 64.1 1.34 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.442 -1.411 . . . . 0.0 109.781 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 m -67.57 -23.8 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 126.929 2.091 . . . . 0.0 115.704 -174.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -58.89 -48.77 80.26 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.438 -2.039 . . . . 0.0 114.393 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -93.25 -37.4 12.08 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.681 -1.262 . . . . 0.0 111.317 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.93 57.12 0.43 Allowed Glycine 0 N--CA 1.43 -1.709 0 O-C-N 120.064 -1.647 . . . . 0.0 113.162 173.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -139.43 166.89 23.36 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 124.522 1.129 . . . . 0.0 108.09 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -127.81 161.34 21.79 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 120.929 -1.107 . . . . 0.0 110.971 174.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -140.78 146.57 37.83 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 121.257 -1.143 . . . . 0.0 109.376 170.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mt -108.81 147.8 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 125.747 1.619 . . . . 0.0 108.427 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -101.73 95.2 6.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.096 0.95 . . . . 0.0 109.442 169.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -69.04 128.88 38.25 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.275 14.9 p30 -74.57 107.16 6.52 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -176.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -166.97 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.234 1.414 . . . . 0.0 108.224 173.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.0 t -139.84 43.14 1.96 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 102.725 -3.065 . . . . 0.0 102.725 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.6 mptt 51.12 73.39 0.3 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.177 2.191 . . . . 0.0 114.101 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -103.05 133.59 47.91 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.814 -1.804 . . . . 0.0 110.056 -169.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.89 114.28 26.8 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 123.761 0.824 . . . . 0.0 110.22 -164.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.5 t -114.04 113.2 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -173.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . 0.264 0.1 OUTLIER -85.81 145.26 27.3 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.054 -1.654 . . . . 0.0 112.296 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.3 p -137.45 142.82 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 122.449 1.119 . . . . 0.0 110.759 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -98.79 140.99 32.16 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.39 1.876 . . . . 0.0 108.558 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -56.42 -36.84 69.41 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -171.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 t -66.8 -18.01 65.16 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.43 -21.4 38.9 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.406 -2.059 . . . . 0.0 112.347 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.1 mt -83.75 145.48 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 125.653 1.581 . . . . 0.0 108.497 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.68 143.95 4.76 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -157.27 168.19 28.11 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.596 -1.315 . . . . 0.0 110.833 -165.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.4 m120 69.53 -49.13 0.61 Allowed 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 127.696 2.399 . . . . 0.0 116.025 175.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -75.68 109.71 8.71 Favored Pre-proline 0 N--CA 1.431 -1.41 0 O-C-N 120.427 -1.42 . . . . 0.0 110.858 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.37 164.8 26.14 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-N 122.65 1.982 . . . . 0.0 111.884 -171.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -121.52 93.33 3.97 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.149 0.976 . . . . 0.0 108.896 173.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -92.85 70.49 4.72 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.192 1.397 . . . . 0.0 113.793 -162.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -108.49 -171.62 1.89 Allowed 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 120.055 -1.653 . . . . 0.0 108.056 169.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.4 mt -82.16 -86.83 0.1 Allowed 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.97 -1.706 . . . . 0.0 109.068 167.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -91.12 136.44 33.08 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.06 -1.65 . . . . 0.0 113.513 -176.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.4 t -133.22 -169.38 2.26 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 124.692 1.197 . . . . 0.0 109.706 168.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.8 m -119.12 169.99 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 127.118 2.167 . . . . 0.0 110.41 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.26 -58.63 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.74 0 O-C-N 119.757 -1.839 . . . . 0.0 113.32 177.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -72.36 90.69 1.29 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.315 1.446 . . . . 0.0 110.261 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.04 12.84 17.11 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.189 -1.569 . . . . 0.0 113.616 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -77.51 158.32 29.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.249 -1.736 . . . . 0.0 115.397 171.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.81 148.47 24.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 121.013 -1.054 . . . . 0.0 109.407 175.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 m -138.37 157.74 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 125.573 1.549 . . . . 0.0 109.473 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -102.08 142.58 33.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.061 1.344 . . . . 0.0 111.634 171.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -161.35 -176.45 5.39 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 124.072 0.949 . . . . 0.0 110.704 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -113.67 148.17 36.82 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 120.559 -1.338 . . . . 0.0 108.106 168.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.8 t -100.89 85.54 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 119.361 -2.087 . . . . 0.0 109.846 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 m -136.12 85.56 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.484 -2.635 . . . . 0.0 115.406 -157.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -144.26 -77.82 0.21 Allowed 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.844 -2.41 . . . . 0.0 112.564 170.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.71 -49.19 0.87 Allowed Glycine 0 N--CA 1.431 -1.694 0 O-C-N 120.979 -1.075 . . . . 0.0 114.476 175.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -68.25 -54.82 15.02 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.457 -1.613 . . . . 0.0 113.67 -169.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -92.18 -59.17 2.16 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.451 -1.406 . . . . 0.0 109.673 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.13 -103.79 0.19 Allowed Glycine 0 N--CA 1.43 -1.715 0 O-C-N 120.527 -1.358 . . . . 0.0 110.528 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.93 149.83 50.63 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.967 -1.314 . . . . 0.0 113.275 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.9 -177.89 4.48 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 124.745 1.218 . . . . 0.0 108.994 161.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.09 154.08 44.64 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 121.947 0.879 . . . . 0.0 111.274 -168.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.37 143.8 32.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.423 1.089 . . . . 0.0 109.482 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 53.43 59.66 4.22 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.102 2.561 . . . . 0.0 115.21 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.6 t -92.17 127.81 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 120.959 -1.088 . . . . 0.0 111.752 -164.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.1 t -155.07 -179.39 8.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.412 1.101 . . . . 0.0 110.508 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -86.63 147.93 21.57 Favored Glycine 0 N--CA 1.43 -1.734 0 CA-C-O 117.246 -1.863 . . . . 0.0 112.02 -176.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -66.87 148.22 81.96 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 CA-C-N 123.328 3.564 . . . . 0.0 116.094 -172.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.801 0 CA-C-O 118.635 -1.092 . . . . 0.0 110.701 179.007 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.1 ttm . . . . . 0 CA--C 1.489 -1.371 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -107.77 168.74 9.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.345 -1.472 . . . . 0.0 110.032 158.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -48.45 103.29 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 129.494 3.117 . . . . 0.0 117.705 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.8 t 61.9 103.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 127.373 2.269 . . . . 0.0 113.784 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -90.43 -50.55 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 119.762 -1.836 . . . . 0.0 111.051 -171.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.31 165.89 14.91 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.658 0.742 . . . . 0.0 112.492 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.1 p -107.79 159.71 16.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.203 1.801 . . . . 0.0 109.17 165.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.4 tptt 48.53 65.76 1.26 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -175.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 88.7 t -112.04 151.22 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 128.096 2.558 . . . . 0.0 108.158 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -108.78 156.88 19.11 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.862 1.792 . . . . 0.0 110.247 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.09 179.25 41.9 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 120.172 -1.58 . . . . 0.0 109.628 173.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 m -113.7 130.93 56.34 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.708 0.803 . . . . 0.0 110.335 -169.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.0 t -98.06 122.56 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 125.766 1.627 . . . . 0.0 110.986 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -110.95 -59.54 1.95 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.063 -1.648 . . . . 0.0 110.612 174.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.9 t90 -69.83 -79.29 0.06 Allowed 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.569 1.548 . . . . 0.0 114.798 -166.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.8 t80 75.1 114.69 0.06 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.718 2.407 . . . . 0.0 113.249 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -110.99 124.64 52.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.064 -1.648 . . . . 0.0 109.822 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.1 t -107.96 -47.58 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 120.684 -1.26 . . . . 0.0 110.769 171.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -63.77 -30.79 71.85 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -167.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -107.53 -25.29 11.44 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 121.345 -0.847 . . . . 0.0 111.851 166.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.56 -43.69 1.62 Allowed Glycine 0 N--CA 1.43 -1.709 0 O-C-N 118.983 -2.323 . . . . 0.0 114.236 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -75.71 105.72 6.9 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 124.792 1.237 . . . . 0.0 112.8 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.13 175.45 21.3 Favored Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 124.84 1.209 . . . . 0.0 111.325 -176.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -143.26 145.57 32.86 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 123.021 1.391 . . . . 0.0 113.433 171.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.2 mt -107.75 147.79 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 125.054 1.342 . . . . 0.0 108.964 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -93.92 87.85 5.52 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 122.674 1.226 . . . . 0.0 108.951 173.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -66.52 112.82 4.3 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.925 -1.734 . . . . 0.0 114.522 172.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -85.41 25.78 0.99 Allowed 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 117.43 2.382 . . . . 0.0 117.43 -160.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -73.37 -51.14 18.45 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.46 -1.4 . . . . 0.0 111.416 170.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.3 t -146.4 24.59 1.26 Allowed 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.09 76.37 0.29 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 127.516 2.327 . . . . 0.0 111.153 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -109.85 133.15 53.48 Favored 'General case' 0 N--CA 1.428 -1.525 0 O-C-N 120.555 -1.34 . . . . 0.0 109.383 -176.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -81.87 110.82 17.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.493 1.616 . . . . 0.0 110.021 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.46 112.78 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.71 -1.244 . . . . 0.0 108.224 -171.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -85.18 129.28 34.83 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -172.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.4 t -127.41 123.19 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 124.994 1.318 . . . . 0.0 110.451 -168.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -93.12 160.79 14.69 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.183 -0.948 . . . . 0.0 112.001 171.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -60.41 -29.32 68.9 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.0 m -61.89 -33.37 74.09 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 125.843 1.657 . . . . 0.0 113.475 175.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.41 -17.17 60.84 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.193 -1.567 . . . . 0.0 114.294 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 72.7 mt -88.25 112.49 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 125.24 1.416 . . . . 0.0 110.261 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -126.16 142.97 51.31 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 124.741 1.216 . . . . 0.0 110.983 176.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -144.9 127.72 16.33 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.55 -1.344 . . . . 0.0 110.817 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -89.76 -44.84 9.71 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 121.095 -1.003 . . . . 0.0 112.96 176.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -100.56 108.77 54.92 Favored Pre-proline 0 N--CA 1.43 -1.426 0 O-C-N 120.421 -1.424 . . . . 0.0 112.783 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.16 127.31 14.88 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 CA-C-N 124.051 2.483 . . . . 0.0 111.198 159.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -100.54 156.11 17.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.855 1.662 . . . . 0.0 110.962 -165.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -72.16 123.01 21.99 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.366 -2.084 . . . . 0.0 116.192 -167.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . 0.27 4.8 t80 75.85 166.81 0.27 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.751 2.82 . . . . 0.0 113.81 174.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.11 139.94 30.06 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 119.68 -1.887 . . . . 0.0 111.097 177.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.268 41.7 mtm105 71.4 112.76 0.06 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.257 1.823 . . . . 0.0 114.614 -174.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.4 t -81.23 -70.37 0.54 Allowed 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.35 -1.469 . . . . 0.0 110.792 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 83.5 t -110.63 -53.01 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 O-C-N 120.457 -1.402 . . . . 0.0 108.303 168.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 166.81 -124.65 1.24 Allowed Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -108.48 158.8 17.21 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 166.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.46 8.3 49.83 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 120.079 -1.638 . . . . 0.0 114.518 -177.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -75.71 166.5 23.46 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.334 1.454 . . . . 0.0 114.551 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.98 148.85 22.21 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.43 1.892 . . . . 0.0 112.776 175.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 p -147.2 153.14 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 126.995 2.118 . . . . 0.0 106.05 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -104.3 147.86 27.02 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 120.104 1.32 . . . . 0.0 110.707 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -159.78 169.67 23.13 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.256 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -97.28 147.47 24.11 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.051 -1.656 . . . . 0.0 107.202 170.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.0 t -106.86 95.71 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 O-C-N 119.204 -2.185 . . . . 0.0 109.323 175.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.62 100.89 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 120.444 -1.41 . . . . 0.0 110.488 -162.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -160.25 -122.5 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.232 -1.542 . . . . 0.0 112.699 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.25 -145.48 4.14 Favored Glycine 0 N--CA 1.43 -1.723 0 C-N-CA 127.307 2.384 . . . . 0.0 110.036 -162.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -94.98 -34.87 12.2 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.72 -1.459 . . . . 0.0 114.208 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -66.08 -37.73 86.52 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.81 -1.182 . . . . 0.0 114.033 -167.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -162.81 -156.35 8.49 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 174.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.01 158.56 39.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.028 -1.278 . . . . 0.0 111.778 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -138.47 172.82 12.33 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 127.489 2.316 . . . . 0.0 106.374 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.03 154.63 42.72 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.702 -1.874 . . . . 0.0 107.762 -168.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -149.89 162.67 39.86 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 55.23 54.47 8.7 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.261 1.824 . . . . 0.0 113.563 173.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.3 t -87.69 127.49 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.796 -1.19 . . . . 0.0 110.353 -170.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.0 p -94.44 -176.28 3.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.987 1.375 . . . . 0.0 114.05 -168.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -150.72 75.33 0.25 Allowed Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 171.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.08 162.58 31.63 Favored 'Trans proline' 0 N--CA 1.433 -2.075 0 C-N-CA 122.52 2.147 . . . . 0.0 112.861 -170.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.796 0 CA-C-O 117.951 -1.472 . . . . 0.0 110.635 179.358 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptm . . . . . 0 CA--C 1.489 -1.385 0 N-CA-C 120.188 3.403 . . . . 0.0 120.188 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -72.36 -51.18 21.73 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.312 -2.118 . . . . 0.0 114.288 -168.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -79.14 -97.16 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.435 -1.416 . . . . 0.0 112.087 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 78.0 t 65.61 117.15 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 126.364 1.866 . . . . 0.0 115.498 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.3 mp -90.91 -57.46 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 119.633 -1.917 . . . . 0.0 110.392 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.49 160.74 26.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -168.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.8 p -106.58 157.59 17.57 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.592 2.757 . . . . 0.0 112.093 163.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.8 mttp 57.79 57.76 4.03 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.128 2.171 . . . . 0.0 114.602 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 t -115.97 152.19 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 C-N-CA 128.72 2.808 . . . . 0.0 107.741 -169.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -128.11 164.79 21.67 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 123.696 1.712 . . . . 0.0 114.15 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -168.79 -173.86 36.92 Favored Glycine 0 N--CA 1.431 -1.685 0 O-C-N 121.018 -1.051 . . . . 0.0 110.57 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.7 m -115.98 129.55 56.43 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.463 1.601 . . . . 0.0 108.365 -172.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.3 p -87.19 147.51 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 120.567 -1.333 . . . . 0.0 112.474 -177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.8 mmtt -102.47 -99.14 0.28 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 162.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -147.29 -170.82 3.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 172.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -124.58 166.61 15.78 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 126.157 1.783 . . . . 0.0 108.305 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -87.9 91.37 8.74 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 162.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.9 m -68.12 -31.0 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 126.965 2.106 . . . . 0.0 113.794 -171.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -62.04 -43.58 98.53 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 124.622 1.169 . . . . 0.0 112.68 -175.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -92.01 -36.53 13.34 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 119.144 -2.223 . . . . 0.0 113.603 166.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.57 34.64 3.03 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 121.521 -0.737 . . . . 0.0 114.198 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -123.65 162.61 22.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.783 -1.422 . . . . 0.0 110.411 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.42 171.67 36.78 Favored Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 169.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -118.23 155.6 30.25 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 118.146 0.973 . . . . 0.0 112.077 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.8 mm -104.47 155.87 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 169.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -110.81 96.67 6.31 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 119.637 1.108 . . . . 0.0 110.589 168.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -36.12 147.65 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 131.158 3.783 . . . . 0.0 117.446 164.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -66.0 -7.03 14.76 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.818 2.525 . . . . 0.0 117.818 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -82.94 -78.51 0.21 Allowed 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.875 -1.765 . . . . 0.0 112.502 -171.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 t -120.55 10.52 11.12 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 121.857 2.117 . . . . 0.0 107.244 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.2 mptt 60.09 67.53 0.85 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.714 2.406 . . . . 0.0 112.049 -174.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -107.73 159.4 16.51 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.064 -1.023 . . . . 0.0 109.452 -168.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -84.71 95.11 8.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 124.44 1.096 . . . . 0.0 112.643 -172.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.8 t -109.85 110.6 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -85.16 148.7 25.98 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 120.473 -1.392 . . . . 0.0 113.574 -168.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 81.8 t -136.68 133.59 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 125.097 1.359 . . . . 0.0 109.138 -171.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -114.47 165.2 12.99 Favored 'General case' 0 N--CA 1.432 -1.366 0 C-N-CA 125.247 1.419 . . . . 0.0 111.057 172.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -63.51 -36.52 84.04 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -169.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.0 m -74.99 -19.81 59.93 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.958 1.303 . . . . 0.0 112.107 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.26 -26.59 60.31 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.519 -1.988 . . . . 0.0 112.79 173.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.0 mt -76.45 114.65 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.702 1.601 . . . . 0.0 109.713 170.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -108.34 132.91 53.24 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.778 -1.201 . . . . 0.0 109.353 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -85.59 90.26 7.94 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.797 -1.189 . . . . 0.0 110.894 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -88.01 -60.85 1.85 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.915 -1.116 . . . . 0.0 108.824 177.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -118.53 68.58 7.92 Favored Pre-proline 0 N--CA 1.43 -1.445 0 C-N-CA 124.656 1.182 . . . . 0.0 112.956 -177.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.0 104.32 1.88 Allowed 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 123.869 2.418 . . . . 0.0 113.427 -177.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.8 mmm-85 -107.72 154.0 22.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.554 1.169 . . . . 0.0 112.897 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -92.5 -93.38 0.15 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 124.984 1.314 . . . . 0.0 111.078 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.1 t80 60.04 52.34 5.22 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.647 2.379 . . . . 0.0 115.369 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.5 tp 74.2 -60.51 0.52 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.46 2.304 . . . . 0.0 114.477 177.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -134.72 146.95 49.92 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.358 1.463 . . . . 0.0 108.924 175.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.3 m -88.76 -63.53 1.28 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.077 1.751 . . . . 0.0 107.473 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.4 m -105.85 -177.74 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 C-N-CA 124.889 1.275 . . . . 0.0 111.646 -170.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 148.59 124.61 1.4 Allowed Glycine 0 N--CA 1.431 -1.657 0 O-C-N 120.64 -1.287 . . . . 0.0 109.953 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.0 t70 66.71 -137.98 0.14 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.825 1.25 . . . . 0.0 109.907 -169.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.79 87.17 0.47 Allowed Glycine 0 N--CA 1.43 -1.753 0 O-C-N 120.814 -1.179 . . . . 0.0 112.43 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -64.17 169.58 4.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.094 -1.827 . . . . 0.0 114.545 171.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.12 136.75 36.16 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 122.207 1.003 . . . . 0.0 110.814 172.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.3 m -123.06 151.01 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -100.14 152.61 20.06 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 121.169 -0.957 . . . . 0.0 110.254 171.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -161.21 -179.31 7.34 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.844 0.83 . . . . 0.0 110.358 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -105.06 154.48 20.09 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 164.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 64.0 t -112.61 90.3 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 119.675 -1.891 . . . . 0.0 106.632 174.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.81 87.69 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 124.217 1.961 . . . . 0.0 107.174 -165.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -85.56 124.59 32.28 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.584 -1.322 . . . . 0.0 113.738 -171.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -124.16 -41.94 0.38 Allowed Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 125.239 1.4 . . . . 0.0 112.797 173.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -89.45 -136.23 0.11 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.322 1.449 . . . . 0.0 111.826 -172.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -85.06 -13.82 49.21 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 126.523 1.929 . . . . 0.0 112.245 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -166.46 167.61 39.58 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 105.574 -3.011 . . . . 0.0 105.574 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.67 165.41 15.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -162.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -115.84 -174.83 2.6 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.037 -1.04 . . . . 0.0 111.221 164.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.93 144.95 31.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.543 1.164 . . . . 0.0 108.687 -169.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.74 160.68 38.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 55.85 48.62 17.72 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.011 1.724 . . . . 0.0 114.309 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.1 t -88.05 138.79 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 124.332 1.053 . . . . 0.0 111.026 -165.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.0 p -109.14 -158.53 0.65 Allowed 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 124.18 1.943 . . . . 0.0 113.011 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 168.62 -173.99 43.28 Favored Glycine 0 N--CA 1.429 -1.781 0 O-C-N 119.559 -1.963 . . . . 0.0 109.68 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.76 -32.14 6.04 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 123.402 2.735 . . . . 0.0 111.857 168.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.748 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.002 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.9 mtp . . . . . 0 CA--C 1.489 -1.368 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.474 ' HZ1' ' CD ' ' A' ' 67' ' ' GLU . 58.7 mttm 62.82 46.05 5.31 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -145.78 -28.65 0.43 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.988 -1.07 . . . . 0.0 113.693 -175.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.26 141.22 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.824 -1.798 . . . . 0.0 110.986 -160.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -97.56 -50.24 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 O-C-N 119.629 -1.92 . . . . 0.0 106.436 165.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -158.3 161.49 37.68 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 123.356 0.662 . . . . 0.0 111.408 171.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.5 p -120.87 149.42 42.62 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.586 -1.321 . . . . 0.0 110.597 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.265 54.9 mttp 59.06 73.12 0.49 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.185 2.194 . . . . 0.0 113.866 -171.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.49 149.71 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 126.892 2.077 . . . . 0.0 109.2 -163.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -109.05 159.63 16.69 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 123.787 1.756 . . . . 0.0 112.798 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.73 -178.36 44.55 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.4 m -117.14 129.51 56.01 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -172.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.6 t -72.23 135.87 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 120.796 -1.19 . . . . 0.0 111.435 -175.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -95.14 -100.69 0.16 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.347 -1.47 . . . . 0.0 110.202 173.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -130.16 157.17 43.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.871 -1.768 . . . . 0.0 111.37 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -104.03 142.09 35.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.51 1.524 . . . . 0.0 109.921 172.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -118.15 100.54 7.59 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.945 1.698 . . . . 0.0 109.058 -175.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.17 -29.81 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 120.645 -1.284 . . . . 0.0 113.409 -158.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -58.39 -59.8 4.78 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.83 -1.794 . . . . 0.0 113.34 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -78.48 -37.79 42.48 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.763 -1.211 . . . . 0.0 113.223 174.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.93 53.45 0.8 Allowed Glycine 0 N--CA 1.43 -1.735 0 CA-C-N 119.768 1.167 . . . . 0.0 114.17 175.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -125.32 175.02 7.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.723 -0.869 . . . . 0.0 110.253 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.9 176.28 35.77 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 107.64 -2.184 . . . . 0.0 107.64 163.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -149.86 153.76 37.26 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 122.699 1.238 . . . . 0.0 112.949 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mt -124.28 147.33 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 125.634 1.574 . . . . 0.0 109.324 -172.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -99.29 93.81 6.13 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 168.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -67.03 130.51 43.37 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -82.66 68.04 8.96 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.221 1.409 . . . . 0.0 114.631 -167.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -132.42 -72.57 0.52 Allowed 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 120.427 -1.42 . . . . 0.0 109.253 170.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.0 t -131.91 38.63 3.52 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.4 mptt 57.83 69.71 0.71 Allowed 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.981 1.712 . . . . 0.0 114.227 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -103.02 141.94 34.95 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.515 -1.99 . . . . 0.0 109.623 -166.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -93.85 104.71 16.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -162.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.1 t -108.95 116.5 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.69 -1.256 . . . . 0.0 109.119 -167.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -81.12 134.47 35.65 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 125.111 1.364 . . . . 0.0 112.743 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.42 123.1 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 120.438 -1.414 . . . . 0.0 111.013 -175.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -100.63 170.11 8.59 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.351 1.46 . . . . 0.0 112.305 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -68.85 -22.41 64.22 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.6 -1.938 . . . . 0.0 114.892 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.5 p -71.11 -25.15 62.47 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.74 2.016 . . . . 0.0 113.392 175.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.39 -32.33 29.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.611 -1.306 . . . . 0.0 113.195 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.83 139.82 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 C-N-CA 126.481 1.912 . . . . 0.0 113.275 -175.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -49.85 -51.86 37.03 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 119.04 2.978 . . . . 0.0 119.04 -173.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -139.12 141.07 38.1 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.275 -1.516 . . . . 0.0 108.652 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -124.82 143.13 50.98 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 121.292 -0.88 . . . . 0.0 110.724 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -107.28 115.43 59.75 Favored Pre-proline 0 N--CA 1.431 -1.404 0 C-N-CA 124.98 1.312 . . . . 0.0 110.357 -173.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -66.9 -41.37 10.4 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 C-N-CA 123.451 2.768 . . . . 0.0 114.289 171.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -107.54 -81.25 0.56 Allowed 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 118.763 0.71 . . . . 0.0 112.176 -173.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 173.9 10.67 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -165.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -69.38 164.27 23.33 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 -170.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.8 tp -89.09 166.2 14.02 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 125.1 1.36 . . . . 0.0 112.947 -175.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -72.2 160.57 32.2 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.308 -1.495 . . . . 0.0 112.078 170.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.8 m -72.27 147.06 46.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.411 -1.43 . . . . 0.0 113.699 -175.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.9 m -110.32 160.59 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 120.632 -1.292 . . . . 0.0 110.087 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.24 149.63 17.29 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 125.031 1.3 . . . . 0.0 111.396 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -86.88 102.88 14.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.696 -1.473 . . . . 0.0 109.779 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.3 21.22 20.65 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 121.406 -0.809 . . . . 0.0 113.179 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -76.21 158.38 31.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.995 -1.297 . . . . 0.0 112.947 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 p -103.1 160.09 14.95 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.616 1.567 . . . . 0.0 113.487 -175.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -154.93 141.35 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 O-C-N 121.385 -0.822 . . . . 0.0 109.547 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -93.04 142.96 26.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.743 1.258 . . . . 0.0 112.7 165.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -155.59 172.11 18.82 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.974 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -102.88 138.28 39.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 166.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.7 t -96.22 91.93 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 119.676 -1.89 . . . . 0.0 109.524 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.99 90.47 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 118.607 -2.558 . . . . 0.0 111.785 -159.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -144.81 -60.3 0.36 Allowed 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 122.659 1.219 . . . . 0.0 110.931 165.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.9 -48.38 1.32 Allowed Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 115.617 1.007 . . . . 0.0 115.617 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.474 ' CD ' ' HZ1' ' A' ' 2' ' ' LYS . 6.9 mm-40 -80.12 -85.26 0.09 Allowed 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 -172.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -86.13 -30.47 22.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.285 -1.509 . . . . 0.0 114.333 -167.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -162.92 -127.53 0.88 Allowed Glycine 0 N--CA 1.43 -1.763 0 O-C-N 119.953 -1.717 . . . . 0.0 110.56 170.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.48 137.37 26.88 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 122.246 1.022 . . . . 0.0 113.119 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -117.83 -166.81 1.24 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.943 -1.098 . . . . 0.0 109.725 165.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.06 153.49 42.99 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 123.018 1.39 . . . . 0.0 110.863 -170.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.44 157.76 44.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 175.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 50.72 59.32 4.68 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 36.4 t -93.97 100.26 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 120.672 -1.268 . . . . 0.0 109.073 -170.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.0 p -99.32 -103.39 0.22 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.074 1.35 . . . . 0.0 111.951 -171.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.07 -168.95 31.83 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 125.531 1.539 . . . . 0.0 110.194 -173.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -71.28 168.88 22.15 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 C-N-CA 123.096 2.531 . . . . 0.0 112.619 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.731 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.337 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.938 HG12 ' H ' ' A' ' 65' ' ' GLU . 4.3 m . . . . . 0 N--CA 1.43 -1.432 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.426 HD13 HG12 ' A' ' 63' ' ' VAL . 4.8 mp -91.37 -61.49 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 O-C-N 120.135 -1.603 . . . . 0.0 108.833 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -164.84 173.21 11.98 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -174.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.2 p -109.47 160.17 16.43 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.962 2.505 . . . . 0.0 109.755 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.7 mttt 59.99 49.76 7.35 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.585 2.068 . . . . 0.0 116.585 174.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.57 143.78 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.301 1.84 . . . . 0.0 109.295 -166.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -106.69 149.85 26.84 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.222 1.01 . . . . 0.0 110.323 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.35 -167.04 37.38 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.306 -1.496 . . . . 0.0 111.383 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.7 m -116.44 120.94 40.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.657 -0.908 . . . . 0.0 109.758 -164.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.2 t -87.77 130.44 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 120.89 -1.131 . . . . 0.0 110.456 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -133.04 159.71 39.27 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 120.828 -1.17 . . . . 0.0 111.461 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.4 t90 37.11 63.67 0.68 Allowed 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 118.395 2.739 . . . . 0.0 118.395 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -79.51 118.17 21.13 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.461 -1.4 . . . . 0.0 110.39 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -95.12 107.16 19.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.648 -1.283 . . . . 0.0 108.441 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.9 t -71.32 -33.98 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 126.3 1.84 . . . . 0.0 112.493 -173.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -65.38 -38.38 89.83 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.191 -1.568 . . . . 0.0 113.566 -172.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -95.13 -35.04 12.05 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.739 -1.225 . . . . 0.0 111.931 169.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.89 40.71 3.04 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.518 -1.364 . . . . 0.0 113.858 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -132.93 146.39 51.75 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.471 1.509 . . . . 0.0 109.591 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -149.88 -171.75 18.64 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 170.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -141.32 153.42 45.14 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 123.389 1.566 . . . . 0.0 111.776 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mt -112.36 141.53 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.335 1.054 . . . . 0.0 108.341 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -91.92 91.23 7.79 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 172.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.12 110.89 2.68 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 125.968 1.707 . . . . 0.0 113.753 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.331 38.7 p30 -54.14 -47.55 71.78 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 121.084 3.735 . . . . 0.0 121.084 -158.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -56.64 -49.11 75.99 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.771 2.878 . . . . 0.0 118.771 -169.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -136.25 35.73 2.76 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.19 -2.194 . . . . 0.0 106.837 173.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? 57.32 63.34 1.9 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.875 1.67 . . . . 0.0 113.278 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -107.83 151.35 25.86 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.965 -1.71 . . . . 0.0 110.531 -168.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -84.65 112.16 20.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.381 1.086 . . . . 0.0 111.943 -169.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.9 t -113.91 111.92 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -88.31 134.86 33.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.634 -1.916 . . . . 0.0 110.616 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.4 p -130.85 133.58 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.882 -1.136 . . . . 0.0 110.283 -173.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -117.43 154.73 30.87 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.011 1.724 . . . . 0.0 111.625 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -54.12 -31.05 51.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 117.794 2.516 . . . . 0.0 117.794 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.5 p -75.85 -12.14 60.11 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.516 -1.99 . . . . 0.0 114.334 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.48 -15.24 33.51 Favored 'General case' 0 CA--C 1.489 -1.37 0 O-C-N 120.766 -1.209 . . . . 0.0 112.369 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.2 mm -74.18 133.02 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 125.463 1.505 . . . . 0.0 111.116 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp . . . . . 0 N--CA 1.43 -1.441 0 O-C-N 119.267 -2.146 . . . . 0.0 115.09 -179.283 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.799 0 N-CA-C 107.782 -2.127 . . . . 0.0 107.782 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -80.77 146.92 30.74 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 118.895 1.347 . . . . 0.0 111.843 173.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.2 45.3 62.15 Favored Glycine 0 N--CA 1.431 -1.675 0 O-C-N 120.469 -1.394 . . . . 0.0 115.597 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -75.03 152.54 38.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.489 1.137 . . . . 0.0 113.268 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 m -97.86 138.25 35.49 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.217 1.008 . . . . 0.0 109.667 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -143.28 151.53 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -172.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -98.28 143.27 28.95 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 119.589 1.086 . . . . 0.0 110.455 171.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -157.94 160.97 38.15 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 121.79 0.805 . . . . 0.0 109.247 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -88.62 142.81 27.38 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.838 -1.789 . . . . 0.0 107.207 166.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.426 HG12 HD13 ' A' ' 5' ' ' ILE . 85.3 t -100.66 97.6 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 119.48 -2.012 . . . . 0.0 106.811 175.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.402 ' HA ' ' HB ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -123.24 144.93 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 O-C-N 120.609 -1.307 . . . . 0.0 110.101 -163.331 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.938 ' H ' HG12 ' A' ' 4' ' ' VAL . 16.7 tt0 -59.63 111.63 1.5 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.476 2.084 . . . . 0.0 113.269 -170.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.14 -128.03 3.19 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 111.747 -2.478 . . . . 0.0 112.641 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -100.35 -71.23 0.71 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 124.129 0.971 . . . . 0.0 109.326 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -83.0 -26.25 31.43 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.783 -1.198 . . . . 0.0 112.111 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.59 -88.96 0.07 OUTLIER Glycine 0 N--CA 1.429 -1.783 0 O-C-N 121.278 -0.889 . . . . 0.0 111.055 -167.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.28 149.08 35.7 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.508 1.623 . . . . 0.0 114.867 -173.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -122.37 -162.86 1.03 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.543 1.937 . . . . 0.0 110.464 168.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -146.77 133.4 19.89 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.349 -1.47 . . . . 0.0 110.161 -169.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -133.14 162.01 32.89 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.95 1.3 . . . . 0.0 108.687 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 51.04 51.63 16.66 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.731 1.613 . . . . 0.0 115.019 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.8 t -92.94 129.92 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 123.905 0.882 . . . . 0.0 112.016 -165.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.2 p -96.32 -134.27 0.22 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.417 1.087 . . . . 0.0 112.97 -175.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.716 0 O-C-N 119.709 -1.869 . . . . 0.0 108.702 178.419 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.403 ' HA ' ' H ' ' A' ' 65' ' ' GLU . 12.7 m . . . . . 0 N--CA 1.43 -1.435 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.704 HD13 HG12 ' A' ' 63' ' ' VAL . 2.3 mp -95.61 -72.87 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.503 -1.998 . . . . 0.0 107.685 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -158.05 171.95 19.31 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -168.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -107.47 156.02 19.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.593 2.357 . . . . 0.0 111.115 168.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt 53.73 57.2 6.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 176.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.6 t -105.46 144.94 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 128.179 2.591 . . . . 0.0 107.728 -175.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -105.41 150.0 25.64 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.385 -1.447 . . . . 0.0 109.945 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -168.61 -179.84 41.1 Favored Glycine 0 N--CA 1.43 -1.712 0 O-C-N 120.529 -1.357 . . . . 0.0 110.399 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 m -115.56 133.64 55.84 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 124.221 1.009 . . . . 0.0 111.486 -167.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.7 p -109.95 142.25 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 123.901 0.881 . . . . 0.0 111.332 174.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -100.32 -87.29 0.38 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.697 -1.877 . . . . 0.0 110.027 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -112.11 128.81 56.32 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 124.873 1.269 . . . . 0.0 109.469 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -139.66 155.21 47.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.144 -0.972 . . . . 0.0 110.731 172.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -86.43 104.06 15.56 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.284 -1.51 . . . . 0.0 111.353 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.16 -34.65 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -62.66 -45.52 92.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.267 -1.521 . . . . 0.0 114.066 -173.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -83.49 -42.47 16.84 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.914 -1.116 . . . . 0.0 110.367 168.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.53 53.53 1.55 Allowed Glycine 0 N--CA 1.43 -1.745 0 O-C-N 120.255 -1.528 . . . . 0.0 110.277 -172.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -135.91 151.69 50.24 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 123.561 0.744 . . . . 0.0 109.898 -169.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.77 -158.03 26.95 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 121.236 -0.915 . . . . 0.0 111.687 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -144.86 154.04 42.22 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 123.159 1.456 . . . . 0.0 112.84 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.3 mm -109.46 162.36 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.389 1.476 . . . . 0.0 107.166 -178.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -102.3 100.61 10.79 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 120.921 -1.112 . . . . 0.0 109.442 170.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -57.92 124.96 21.05 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.049 1.74 . . . . 0.0 114.359 168.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -55.12 -47.93 74.34 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 119.273 3.064 . . . . 0.0 119.273 -168.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -68.05 -46.9 69.82 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -168.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.1 t -137.69 23.97 2.88 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 119.77 -1.831 . . . . 0.0 107.491 -170.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.61 49.77 6.22 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.941 1.696 . . . . 0.0 113.922 166.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -104.81 156.3 18.13 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 123.298 1.523 . . . . 0.0 112.807 -168.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -86.05 119.44 26.35 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.625 -171.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.4 t -108.63 103.32 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -169.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -82.73 131.83 35.19 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 122.975 1.369 . . . . 0.0 113.781 -173.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.4 t -128.88 135.39 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 124.657 1.183 . . . . 0.0 108.019 -172.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.8 176.91 6.29 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.324 1.05 . . . . 0.0 109.08 169.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -61.58 -21.64 64.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.987 2.217 . . . . 0.0 116.987 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -71.82 -26.02 62.22 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.501 1.521 . . . . 0.0 113.732 173.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.41 -22.06 26.78 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.849 -2.407 . . . . 0.0 113.011 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.8 mt -81.57 104.44 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 125.531 1.533 . . . . 0.0 109.819 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.251 50.3 mttm . . . . . 0 N--CA 1.431 -1.402 0 C-N-CA 125.529 1.532 . . . . 0.0 114.3 -173.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.773 0 CA-C-O 122.223 0.902 . . . . 0.0 113.576 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.11 140.1 48.71 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.023 -1.869 . . . . 0.0 114.403 -177.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.73 11.39 79.66 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 119.741 -1.849 . . . . 0.0 113.425 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -79.69 153.29 29.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.279 1.514 . . . . 0.0 113.617 177.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 p -97.45 142.68 29.0 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 125.433 1.493 . . . . 0.0 114.678 -177.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.02 154.3 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 124.679 1.192 . . . . 0.0 109.594 -174.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.53 145.39 30.37 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.347 -1.471 . . . . 0.0 113.054 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.432 ' HB2' ' HB1' ' A' ' 72' ' ' ALA . 13.9 p90 -156.38 172.31 18.73 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.031 1.332 . . . . 0.0 110.171 -178.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -94.8 154.07 17.44 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.592 -1.942 . . . . 0.0 108.094 165.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.704 HG12 HD13 ' A' ' 5' ' ' ILE . 61.5 t -110.97 96.97 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 119.139 -2.225 . . . . 0.0 108.011 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.27 111.87 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 120.183 -1.573 . . . . 0.0 109.553 -167.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.403 ' H ' ' HA ' ' A' ' 4' ' ' VAL . 28.3 tt0 -95.44 123.66 39.08 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.756 -1.84 . . . . 0.0 113.587 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -123.82 -45.63 0.28 Allowed Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 125.156 1.36 . . . . 0.0 112.809 170.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -95.37 -136.61 0.22 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.004 1.322 . . . . 0.0 111.386 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -78.76 -32.12 46.44 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.617 -1.927 . . . . 0.0 113.19 -174.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -141.07 165.84 26.15 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 105.997 -2.841 . . . . 0.0 105.997 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.71 152.22 21.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.206 1.479 . . . . 0.0 114.676 -168.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -107.01 -166.71 1.19 Allowed 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.423 -1.423 . . . . 0.0 109.947 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' A' ' 61' ' ' PHE . . . -147.33 156.23 42.72 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -173.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.58 162.41 36.68 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 56.45 40.31 29.66 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.628 1.571 . . . . 0.0 114.414 173.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 t -76.21 109.61 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 125.948 1.699 . . . . 0.0 110.62 -172.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.7 m -125.96 -121.85 0.25 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 123.8 0.84 . . . . 0.0 110.165 -161.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.787 0 O-C-N 119.335 -2.103 . . . . 0.0 111.691 -178.238 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.429 -1.509 0 CA-C-O 121.14 0.495 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.1 mp -80.74 -72.08 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 119.952 -1.718 . . . . 0.0 113.116 -166.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.19 167.89 28.86 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -160.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.9 p -110.96 134.37 52.64 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 128.188 2.595 . . . . 0.0 109.661 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.279 25.8 ttmt 59.18 75.67 0.39 Allowed 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.683 1.993 . . . . 0.0 116.046 -172.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.6 t -121.06 149.96 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 130.311 3.444 . . . . 0.0 105.739 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.7 mp -114.84 168.06 10.23 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 123.638 1.685 . . . . 0.0 112.232 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.73 -172.78 44.17 Favored Glycine 0 N--CA 1.43 -1.751 0 O-C-N 119.333 -2.104 . . . . 0.0 113.115 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.0 m -116.68 131.42 56.95 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 123.773 0.829 . . . . 0.0 109.511 -168.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.84 135.7 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 O-C-N 120.093 -1.63 . . . . 0.0 113.83 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -95.39 -56.08 2.83 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 120.098 -1.626 . . . . 0.0 109.841 173.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -156.46 130.66 8.61 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 123.972 0.909 . . . . 0.0 110.438 177.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -101.71 123.36 45.56 Favored 'General case' 0 N--CA 1.431 -1.384 0 O-C-N 120.607 -1.308 . . . . 0.0 107.965 164.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -102.52 76.9 1.57 Allowed 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.407 -1.433 . . . . 0.0 110.471 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 t -75.82 -7.5 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 123.523 1.63 . . . . 0.0 112.437 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -64.55 -30.07 71.1 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 128.814 2.846 . . . . 0.0 112.85 173.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -127.83 -46.06 1.42 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.728 -1.857 . . . . 0.0 111.444 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.45 -57.38 0.21 Allowed Glycine 0 N--CA 1.429 -1.779 0 O-C-N 119.475 -2.015 . . . . 0.0 115.929 -174.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -79.57 169.42 18.04 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.847 1.784 . . . . 0.0 114.916 -166.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.26 167.78 31.33 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 118.913 -2.367 . . . . 0.0 109.479 169.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -147.06 141.59 26.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 123.012 1.387 . . . . 0.0 111.923 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 mm -113.26 160.76 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 126.812 2.045 . . . . 0.0 108.926 -169.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -109.77 99.82 8.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.551 -1.343 . . . . 0.0 110.927 161.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.76 138.41 47.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.276 2.23 . . . . 0.0 114.93 170.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -62.48 84.95 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.607 2.447 . . . . 0.0 117.607 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -159.42 -76.12 0.07 Allowed 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.403 -2.061 . . . . 0.0 109.251 177.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.6 t -139.67 30.05 2.11 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 55.65 81.76 0.11 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.0 2.12 . . . . 0.0 114.202 -165.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -101.78 137.21 40.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.85 -1.781 . . . . 0.0 108.189 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -79.98 110.11 15.05 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 121.626 0.727 . . . . 0.0 109.925 -171.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.3 t -111.73 117.21 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -89.28 144.26 26.22 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.14 0.972 . . . . 0.0 112.957 -176.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -133.01 128.47 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 122.635 1.207 . . . . 0.0 110.847 -172.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -95.96 154.84 17.02 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.571 -1.331 . . . . 0.0 110.338 173.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -64.1 -26.1 68.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.235 -2.166 . . . . 0.0 116.443 -171.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.0 p -69.39 -27.31 65.19 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.543 -1.348 . . . . 0.0 113.755 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.83 -19.52 40.9 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.452 -1.405 . . . . 0.0 113.175 -174.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.6 mt -75.02 117.32 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 C-N-CA 126.751 2.02 . . . . 0.0 111.768 -178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.4 mttm . . . . . 0 N--CA 1.429 -1.492 0 O-C-N 120.543 -1.348 . . . . 0.0 112.423 178.779 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.736 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -76.75 117.39 18.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.171 1.462 . . . . 0.0 112.95 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.56 55.14 21.97 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 116.734 1.454 . . . . 0.0 116.734 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -73.18 150.77 41.87 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 119.184 1.492 . . . . 0.0 113.06 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 m -99.6 145.16 27.86 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.996 -1.065 . . . . 0.0 110.904 -172.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.1 m -143.08 163.14 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 125.866 1.666 . . . . 0.0 108.028 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -113.58 153.57 28.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.234 1.414 . . . . 0.0 110.461 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -164.7 172.91 12.48 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.976 0.893 . . . . 0.0 110.632 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -92.32 152.59 19.7 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.887 -2.383 . . . . 0.0 108.662 162.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.3 t -112.11 100.71 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 119.535 -1.978 . . . . 0.0 107.547 173.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 m -132.96 128.27 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 120.412 -1.43 . . . . 0.0 108.316 -168.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -96.31 150.77 20.2 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.905 -2.372 . . . . 0.0 114.4 -163.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -151.11 -68.55 0.01 OUTLIER Glycine 0 N--CA 1.432 -1.622 0 O-C-N 121.116 -0.99 . . . . 0.0 111.549 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -78.3 -145.37 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.4 1.48 . . . . 0.0 114.46 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -62.87 -22.42 66.69 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 119.841 -1.787 . . . . 0.0 115.579 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.72 -167.61 13.48 Favored Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 127.245 2.355 . . . . 0.0 108.383 175.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.11 161.31 15.15 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.09 -168.1 1.61 Allowed 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.838 -1.164 . . . . 0.0 110.626 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.06 155.68 44.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.87 1.319 . . . . 0.0 112.136 -166.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.1 166.02 24.35 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.593 1.957 . . . . 0.0 106.531 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.336 0.4 OUTLIER 34.51 63.36 0.45 Allowed 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 117.845 2.535 . . . . 0.0 117.845 -178.513 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.1 t -92.15 98.11 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 C-N-CA 125.097 1.359 . . . . 0.0 111.017 -168.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.94 155.63 22.38 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.607 1.163 . . . . 0.0 110.612 -174.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.763 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 168.93 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.1 t . . . . . 0 N--CA 1.43 -1.446 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.9 mp -86.38 -53.03 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 119.664 -1.898 . . . . 0.0 111.159 -165.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.92 160.5 24.94 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.5 p -115.5 148.4 39.53 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.575 1.55 . . . . 0.0 108.522 166.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.264 26.9 mmmt 53.38 83.01 0.07 Allowed 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.42 2.288 . . . . 0.0 115.512 -168.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.2 t -128.43 143.8 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 126.581 1.953 . . . . 0.0 107.153 -164.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.2 148.55 28.76 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.693 1.235 . . . . 0.0 109.613 174.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.12 179.79 41.59 Favored Glycine 0 N--CA 1.429 -1.788 0 O-C-N 120.796 -1.19 . . . . 0.0 111.376 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.9 m -115.26 135.3 54.3 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 124.635 1.174 . . . . 0.0 109.129 -169.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 50.2 t -84.27 124.8 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 120.387 -1.446 . . . . 0.0 109.441 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -97.41 -57.74 2.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.482 -1.386 . . . . 0.0 108.986 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.9 t-105 -144.56 96.42 2.87 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.0 0.92 . . . . 0.0 109.16 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -98.1 129.7 44.91 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.805 -1.184 . . . . 0.0 108.013 167.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -100.18 105.84 17.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.269 -1.519 . . . . 0.0 109.781 -177.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.4 t -77.23 -26.02 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 126.006 1.722 . . . . 0.0 112.144 -173.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -66.06 -45.87 79.79 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.233 -1.542 . . . . 0.0 112.815 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -78.59 -45.9 20.59 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.936 -1.728 . . . . 0.0 110.74 164.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.96 49.23 1.5 Allowed Glycine 0 N--CA 1.43 -1.723 0 CA-C-O 122.948 1.305 . . . . 0.0 110.287 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -155.71 152.6 28.78 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -162.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.32 -151.22 18.73 Favored Glycine 0 N--CA 1.43 -1.709 0 O-C-N 120.125 -1.61 . . . . 0.0 109.82 169.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -140.15 167.03 23.08 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.449 -1.03 . . . . 0.0 110.263 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.536 HG21 ' CE1' ' A' ' 61' ' ' PHE . 4.5 mm -109.63 155.81 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 170.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -92.25 104.93 17.24 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.416 -1.428 . . . . 0.0 109.305 161.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.0 ttt85 -66.22 114.75 5.55 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.548 -1.345 . . . . 0.0 109.573 153.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -64.81 -39.02 92.9 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -167.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -43.82 -52.45 6.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 128.585 2.754 . . . . 0.0 117.126 -169.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -143.22 33.89 1.34 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.862 -1.774 . . . . 0.0 106.565 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 57.38 58.51 3.8 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.57 1.548 . . . . 0.0 115.016 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -102.62 132.01 49.01 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.271 1.429 . . . . 0.0 109.025 -168.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -90.16 106.38 18.44 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 123.525 0.73 . . . . 0.0 110.135 -167.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t -105.53 109.04 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 121.027 -1.046 . . . . 0.0 110.37 -171.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -81.32 133.62 35.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.161 -1.587 . . . . 0.0 114.282 -171.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.1 p -129.7 133.3 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 120.37 -1.456 . . . . 0.0 111.92 -175.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -108.58 148.25 30.6 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.815 1.646 . . . . 0.0 108.66 173.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -58.1 -17.84 20.97 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 119.437 3.125 . . . . 0.0 119.437 -172.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.0 t -81.7 -12.06 58.79 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.386 -1.446 . . . . 0.0 113.268 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.73 -15.73 58.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.868 -2.395 . . . . 0.0 112.028 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.6 mt -82.48 124.41 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 126.062 1.745 . . . . 0.0 110.07 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -171.312 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.685 0 CA-C-O 122.089 0.827 . . . . 0.0 111.792 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -78.47 126.51 30.86 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.333 -1.686 . . . . 0.0 113.002 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.9 35.72 44.0 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 120.184 -1.573 . . . . 0.0 114.51 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.25 152.56 34.62 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.803 1.287 . . . . 0.0 113.337 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.1 p -94.11 146.09 24.22 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.726 1.611 . . . . 0.0 112.48 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.4 t -139.21 140.79 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -93.54 141.64 28.24 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.382 1.086 . . . . 0.0 111.749 165.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.536 ' CE1' HG21 ' A' ' 25' ' ' ILE . 12.6 p90 -156.06 172.73 17.91 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.873 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -99.07 156.53 16.89 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 162.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.67 89.89 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 119.876 -1.765 . . . . 0.0 107.381 172.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 m -124.85 139.34 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 120.816 -1.177 . . . . 0.0 108.026 -164.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -59.06 128.16 35.84 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.404 -2.06 . . . . 0.0 115.516 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -116.75 -112.33 2.69 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 125.319 1.437 . . . . 0.0 111.09 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -107.82 -89.57 0.45 Allowed 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 124.911 1.285 . . . . 0.0 112.561 -175.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -79.2 10.07 3.95 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 118.922 -2.361 . . . . 0.0 115.122 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.36 -167.09 38.11 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 107.057 -2.417 . . . . 0.0 107.057 -172.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.29 156.22 28.16 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.295 -1.121 . . . . 0.0 113.755 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -124.85 -172.36 2.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.557 1.543 . . . . 0.0 111.252 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.38 140.36 30.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.757 1.265 . . . . 0.0 110.24 -162.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -138.33 149.37 45.56 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.626 -172.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 52.96 50.94 16.86 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.367 2.267 . . . . 0.0 113.839 -176.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.1 t -78.26 124.04 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 120.652 -1.28 . . . . 0.0 111.603 -165.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.0 m -113.52 -122.09 0.29 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.227 -0.921 . . . . 0.0 110.713 -169.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.7 0 O-C-N 119.85 -1.781 . . . . 0.0 112.544 -170.873 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.443 HG13 HG12 ' A' ' 64' ' ' VAL . 71.7 t . . . . . 0 N--CA 1.431 -1.421 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -92.75 -54.85 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 119.875 -1.766 . . . . 0.0 110.299 -168.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -160.58 151.9 19.27 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.731 1.253 . . . . 0.0 113.603 -177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.5 p -108.06 150.02 27.69 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.282 1.833 . . . . 0.0 112.562 168.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.258 83.2 mttt 56.95 70.0 0.69 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.215 1.806 . . . . 0.0 114.872 -173.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.2 t -122.47 143.7 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 126.69 1.996 . . . . 0.0 108.732 -163.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.8 mp -128.97 168.69 15.64 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 122.318 1.056 . . . . 0.0 110.832 171.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -165.07 -147.61 5.19 Favored Glycine 0 N--CA 1.431 -1.696 0 O-C-N 120.326 -1.484 . . . . 0.0 110.168 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.3 m -118.51 133.21 56.04 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 172.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.2 t -95.65 126.15 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 120.318 -1.489 . . . . 0.0 110.437 173.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -118.25 -60.2 1.81 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.797 -1.189 . . . . 0.0 110.309 167.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -85.99 109.39 18.75 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.506 -1.371 . . . . 0.0 112.357 -175.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -151.86 129.29 11.36 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.382 -1.449 . . . . 0.0 109.018 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -97.65 107.25 19.71 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.549 1.539 . . . . 0.0 107.61 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.8 t -82.99 -45.5 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 120.319 -1.488 . . . . 0.0 113.747 -155.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -55.11 -61.2 2.47 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.225 1.41 . . . . 0.0 112.041 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -66.14 -44.89 82.88 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 172.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.2 62.15 0.92 Allowed Glycine 0 N--CA 1.429 -1.77 0 O-C-N 121.248 -0.908 . . . . 0.0 113.831 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -149.15 159.63 44.07 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 121.372 -1.075 . . . . 0.0 110.82 173.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.26 -153.71 23.45 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 120.205 -1.56 . . . . 0.0 111.349 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -147.18 151.02 36.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.841 1.305 . . . . 0.0 111.237 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 mt -105.51 159.51 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 120.206 -1.559 . . . . 0.0 108.475 -173.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -117.05 92.22 3.8 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.38 1.562 . . . . 0.0 109.721 167.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -63.48 149.35 46.33 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.427 1.891 . . . . 0.0 113.686 172.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -71.86 -19.65 61.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -76.25 -81.33 0.08 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.505 -1.997 . . . . 0.0 115.627 -163.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 t -114.17 -1.51 13.64 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.096 1.426 . . . . 0.0 108.652 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.3 mptt 77.57 62.29 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.845 3.258 . . . . 0.0 108.251 171.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -102.82 131.65 49.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 112.878 -1.965 . . . . 0.0 107.439 -165.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -85.72 109.46 18.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.967 -1.708 . . . . 0.0 110.854 -164.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.449 ' CG1' ' HB2' ' A' ' 72' ' ' ALA . 48.4 t -105.65 111.26 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.752 1.621 . . . . 0.0 107.39 -169.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -90.78 145.88 24.42 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.744 1.218 . . . . 0.0 111.606 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.34 133.85 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.566 1.65 . . . . 0.0 109.74 -174.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.419 ' CD2' ' H ' ' A' ' 38' ' ' GLN . 19.8 t-80 -119.58 162.5 18.84 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.574 1.55 . . . . 0.0 112.276 -175.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.419 ' H ' ' CD2' ' A' ' 37' ' ' HIS . 41.8 mt-30 -43.26 -55.65 3.9 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 129.301 3.04 . . . . 0.0 117.575 -173.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.6 t -80.96 -9.74 59.8 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.589 -1.319 . . . . 0.0 114.089 -172.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.38 -20.8 46.82 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.687 -1.883 . . . . 0.0 112.695 174.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.4 mt -79.03 124.15 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 126.005 1.722 . . . . 0.0 110.583 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt . . . . . 0 N--CA 1.43 -1.455 0 O-C-N 120.544 -1.347 . . . . 0.0 112.297 -176.866 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.784 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -74.04 107.1 6.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.599 -1.53 . . . . 0.0 110.522 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.08 39.75 31.6 Favored Glycine 0 N--CA 1.431 -1.684 0 O-C-N 120.582 -1.323 . . . . 0.0 114.513 -170.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.1 156.76 28.17 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 120.696 -1.473 . . . . 0.0 114.898 -175.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.43 148.1 31.7 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.705 2.002 . . . . 0.0 111.022 -175.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.8 p -155.15 145.36 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.325 1.85 . . . . 0.0 106.56 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -91.8 144.46 25.47 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 120.315 1.416 . . . . 0.0 111.88 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -151.08 169.85 20.83 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.899 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -112.94 133.17 55.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 168.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.4 t -89.32 87.12 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 120.353 -1.467 . . . . 0.0 109.585 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.443 HG12 HG13 ' A' ' 4' ' ' VAL . 2.1 m -130.06 107.35 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 120.282 -1.511 . . . . 0.0 109.396 -168.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -139.95 -111.29 0.15 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.61 -1.306 . . . . 0.0 109.456 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 137.28 -55.15 0.7 Allowed Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 114.059 0.384 . . . . 0.0 114.059 -169.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -101.75 -69.78 0.77 Allowed 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.324 -1.103 . . . . 0.0 112.624 -172.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -87.09 57.28 4.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.392 -1.443 . . . . 0.0 114.6 -170.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.43 -117.29 4.49 Favored Glycine 0 N--CA 1.43 -1.719 0 O-C-N 119.43 -2.044 . . . . 0.0 110.642 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.46 169.65 13.42 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 122.899 1.333 . . . . 0.0 112.951 169.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.497 ' HG3' ' H ' ' A' ' 72' ' ' ALA . 6.2 tt0 -145.84 178.8 7.9 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.405 2.282 . . . . 0.0 105.169 -176.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.497 ' H ' ' HG3' ' A' ' 71' ' ' GLU . . . -147.14 125.36 12.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.973 2.109 . . . . 0.0 107.061 -173.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.76 160.18 33.33 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 124.378 1.071 . . . . 0.0 108.296 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 60.1 45.76 11.45 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.936 2.094 . . . . 0.0 112.952 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.6 t -87.59 104.16 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-O 122.108 0.956 . . . . 0.0 111.806 -162.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.83 148.65 50.22 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.003 0.921 . . . . 0.0 109.51 -169.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.724 0 O-C-N 120.212 -1.555 . . . . 0.0 111.968 -176.324 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.653 HG12 ' H ' ' A' ' 65' ' ' GLU . 9.4 m . . . . . 0 N--CA 1.43 -1.436 0 CA-C-O 119.216 -0.421 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.41 HD13 HG11 ' A' ' 63' ' ' VAL . 4.2 mp -87.64 -65.34 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 119.468 -2.02 . . . . 0.0 111.082 -174.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.32 161.46 24.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.9 p -110.66 143.13 41.59 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.36 1.464 . . . . 0.0 110.22 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.27 92.2 mttt 60.95 73.15 0.49 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.225 2.21 . . . . 0.0 115.446 -170.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.7 t -126.11 159.22 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 129.557 3.143 . . . . 0.0 107.564 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.8 170.55 12.64 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.128 -1.608 . . . . 0.0 111.662 170.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.76 -170.26 34.0 Favored Glycine 0 N--CA 1.43 -1.725 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.7 m -116.98 127.89 54.64 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.821 1.296 . . . . 0.0 109.874 -166.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 t -91.85 147.32 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 127.015 2.126 . . . . 0.0 110.437 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -105.37 -86.95 0.46 Allowed 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.055 -1.653 . . . . 0.0 109.78 164.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 22.6 t-105 -155.1 140.29 17.54 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.725 -1.234 . . . . 0.0 108.317 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -97.77 155.84 16.85 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.791 -1.193 . . . . 0.0 113.614 -175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -95.22 93.39 7.28 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.53 -1.356 . . . . 0.0 109.04 174.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.9 m -73.32 -30.64 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -172.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -56.49 -65.08 0.67 Allowed 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 125.312 1.445 . . . . 0.0 112.37 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -72.01 -35.17 69.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.546 -1.971 . . . . 0.0 113.174 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.84 51.61 1.63 Allowed Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -129.93 140.43 50.94 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 121.325 -1.103 . . . . 0.0 108.405 -170.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.05 161.15 32.98 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.503 -1.373 . . . . 0.0 111.147 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -142.09 157.84 44.44 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.946 -0.738 . . . . 0.0 109.464 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.3 mm -109.24 147.34 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 124.907 1.283 . . . . 0.0 108.634 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -92.93 93.89 8.62 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.907 -1.121 . . . . 0.0 109.037 169.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.19 133.56 37.75 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 174.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -82.54 48.0 1.25 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -171.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.95 -68.45 0.7 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.692 -1.88 . . . . 0.0 109.474 163.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -150.34 35.33 0.64 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 57.87 75.99 0.35 Allowed 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 127.234 2.214 . . . . 0.0 112.856 -159.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -103.06 128.35 49.96 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.561 -1.962 . . . . 0.0 106.675 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -82.11 122.14 27.47 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.651 1.691 . . . . 0.0 110.252 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.07 108.38 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 O-C-N 120.568 -1.333 . . . . 0.0 108.407 -173.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -76.06 140.05 41.72 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.76 -1.213 . . . . 0.0 113.661 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.8 t -128.44 126.2 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.766 -1.209 . . . . 0.0 108.416 -177.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -111.92 165.6 11.95 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.01 1.324 . . . . 0.0 110.592 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.1 mm100 -59.58 -36.98 77.32 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 m -69.86 -14.63 62.84 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.727 -1.858 . . . . 0.0 113.433 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.19 -25.4 58.22 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.536 -2.602 . . . . 0.0 114.909 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 89.1 mt -79.44 126.02 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 125.741 1.616 . . . . 0.0 111.597 -175.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 83.5 mttt . . . . . 0 N--CA 1.431 -1.392 0 O-C-N 120.615 -1.303 . . . . 0.0 112.678 -179.453 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.7 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -71.04 111.39 6.37 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.977 1.311 . . . . 0.0 109.753 174.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.75 -20.5 5.15 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 121.176 -0.952 . . . . 0.0 114.361 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.71 155.16 38.0 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.107 -1.819 . . . . 0.0 115.104 -174.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.72 143.31 39.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.719 2.008 . . . . 0.0 110.734 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.06 146.86 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -92.85 144.44 25.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -158.44 170.76 21.48 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.321 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -94.78 141.6 28.44 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.834 -1.791 . . . . 0.0 107.845 168.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.41 HG11 HD13 ' A' ' 5' ' ' ILE . 42.8 t -95.51 106.38 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 O-C-N 119.197 -2.19 . . . . 0.0 108.806 171.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.65 136.72 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 120.879 -1.138 . . . . 0.0 108.06 -170.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.653 ' H ' HG12 ' A' ' 4' ' ' VAL . 23.4 tt0 -120.64 166.33 13.83 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.631 -1.918 . . . . 0.0 111.407 -166.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.54 -44.68 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.892 -1.13 . . . . 0.0 111.791 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -123.67 -145.47 0.34 Allowed 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 124.682 1.193 . . . . 0.0 113.322 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -74.37 -18.85 60.62 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.88 -1.762 . . . . 0.0 114.476 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.99 139.07 8.7 Favored Glycine 0 N--CA 1.429 -1.79 0 O-C-N 120.413 -1.429 . . . . 0.0 109.551 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.22 164.32 22.38 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -172.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -120.53 -168.04 1.57 Allowed 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.872 2.069 . . . . 0.0 111.222 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.11 155.86 43.57 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -169.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -152.51 161.91 41.93 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -174.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 56.13 51.01 12.48 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 125.138 1.375 . . . . 0.0 114.522 170.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.1 t -95.07 108.5 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 124.569 1.148 . . . . 0.0 109.14 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.7 m -83.03 -82.85 0.14 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.301 -1.499 . . . . 0.0 111.729 -176.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.733 0 C-N-CA 126.248 1.88 . . . . 0.0 112.979 -177.195 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.4 t . . . . . 0 N--CA 1.429 -1.487 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.464 HD13 HG12 ' A' ' 63' ' ' VAL . 3.4 mp -84.56 -69.6 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 119.35 -2.094 . . . . 0.0 107.505 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -149.67 153.78 37.54 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -171.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.9 p -110.59 149.31 30.59 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.29 2.236 . . . . 0.0 110.508 170.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.267 87.7 mttt 53.44 67.81 0.94 Allowed 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.567 1.692 . . . . 0.0 115.567 -172.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.8 t -120.39 142.73 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 127.742 2.417 . . . . 0.0 109.123 -163.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.19 149.43 24.67 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.678 1.228 . . . . 0.0 112.051 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.23 171.44 44.46 Favored Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.6 m -112.3 136.93 51.14 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.115 0.966 . . . . 0.0 110.876 -163.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.5 t -103.39 122.86 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 124.527 1.131 . . . . 0.0 108.53 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -154.53 99.74 2.2 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.144 -1.597 . . . . 0.0 109.195 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . 0.312 37.2 m95 77.83 154.11 0.14 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.908 2.083 . . . . 0.0 113.956 -170.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.81 -167.79 2.1 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.775 -1.203 . . . . 0.0 111.286 -165.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -127.41 64.1 1.34 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.442 -1.411 . . . . 0.0 109.781 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 m -67.57 -23.8 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 126.929 2.091 . . . . 0.0 115.704 -174.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -58.89 -48.77 80.26 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.438 -2.039 . . . . 0.0 114.393 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -93.25 -37.4 12.08 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.681 -1.262 . . . . 0.0 111.317 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.93 57.12 0.43 Allowed Glycine 0 N--CA 1.43 -1.709 0 O-C-N 120.064 -1.647 . . . . 0.0 113.162 173.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -139.43 166.89 23.36 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 124.522 1.129 . . . . 0.0 108.09 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -127.81 161.34 21.79 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 120.929 -1.107 . . . . 0.0 110.971 174.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -140.78 146.57 37.83 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 121.257 -1.143 . . . . 0.0 109.376 170.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mt -108.81 147.8 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 125.747 1.619 . . . . 0.0 108.427 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -101.73 95.2 6.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.096 0.95 . . . . 0.0 109.442 169.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -69.04 128.88 38.25 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.275 14.9 p30 -74.57 107.16 6.52 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -176.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -166.97 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.234 1.414 . . . . 0.0 108.224 173.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.0 t -139.84 43.14 1.96 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 102.725 -3.065 . . . . 0.0 102.725 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.6 mptt 51.12 73.39 0.3 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.177 2.191 . . . . 0.0 114.101 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -103.05 133.59 47.91 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.814 -1.804 . . . . 0.0 110.056 -169.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.89 114.28 26.8 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 123.761 0.824 . . . . 0.0 110.22 -164.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.5 t -114.04 113.2 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -173.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . 0.264 0.1 OUTLIER -85.81 145.26 27.3 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.054 -1.654 . . . . 0.0 112.296 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.3 p -137.45 142.82 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 122.449 1.119 . . . . 0.0 110.759 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -98.79 140.99 32.16 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.39 1.876 . . . . 0.0 108.558 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -56.42 -36.84 69.41 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -171.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 t -66.8 -18.01 65.16 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.43 -21.4 38.9 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.406 -2.059 . . . . 0.0 112.347 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.1 mt -83.75 145.48 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 125.653 1.581 . . . . 0.0 108.497 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.492 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.74 0 CA-C-O 121.427 0.459 . . . . 0.0 113.32 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -72.36 90.69 1.29 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.315 1.446 . . . . 0.0 110.261 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.04 12.84 17.11 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.189 -1.569 . . . . 0.0 113.616 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -77.51 158.32 29.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.249 -1.736 . . . . 0.0 115.397 171.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.81 148.47 24.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 121.013 -1.054 . . . . 0.0 109.407 175.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 m -138.37 157.74 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 125.573 1.549 . . . . 0.0 109.473 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -102.08 142.58 33.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.061 1.344 . . . . 0.0 111.634 171.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -161.35 -176.45 5.39 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 124.072 0.949 . . . . 0.0 110.704 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -113.67 148.17 36.82 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 120.559 -1.338 . . . . 0.0 108.106 168.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.464 HG12 HD13 ' A' ' 5' ' ' ILE . 42.8 t -100.89 85.54 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 119.361 -2.087 . . . . 0.0 109.846 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 m -136.12 85.56 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.484 -2.635 . . . . 0.0 115.406 -157.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -144.26 -77.82 0.21 Allowed 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.844 -2.41 . . . . 0.0 112.564 170.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.71 -49.19 0.87 Allowed Glycine 0 N--CA 1.431 -1.694 0 O-C-N 120.979 -1.075 . . . . 0.0 114.476 175.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -68.25 -54.82 15.02 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.457 -1.613 . . . . 0.0 113.67 -169.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -92.18 -59.17 2.16 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.451 -1.406 . . . . 0.0 109.673 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.13 -103.79 0.19 Allowed Glycine 0 N--CA 1.43 -1.715 0 O-C-N 120.527 -1.358 . . . . 0.0 110.528 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.93 149.83 50.63 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.967 -1.314 . . . . 0.0 113.275 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.9 -177.89 4.48 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 124.745 1.218 . . . . 0.0 108.994 161.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.09 154.08 44.64 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 121.947 0.879 . . . . 0.0 111.274 -168.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.37 143.8 32.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.423 1.089 . . . . 0.0 109.482 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 53.43 59.66 4.22 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.102 2.561 . . . . 0.0 115.21 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.6 t -92.17 127.81 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 120.959 -1.088 . . . . 0.0 111.752 -164.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.1 t -155.07 -179.39 8.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.412 1.101 . . . . 0.0 110.508 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.734 0 CA-C-O 117.246 -1.863 . . . . 0.0 112.02 -176.976 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.574 HG13 HG12 ' A' ' 64' ' ' VAL . 61.8 t . . . . . 0 N--CA 1.43 -1.463 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.563 HG21 HH12 ' A' ' 27' ' ' ARG . 4.2 mp -90.43 -50.55 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 119.762 -1.836 . . . . 0.0 111.051 -171.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.31 165.89 14.91 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.658 0.742 . . . . 0.0 112.492 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.1 p -107.79 159.71 16.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.203 1.801 . . . . 0.0 109.17 165.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.4 tptt 48.53 65.76 1.26 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -175.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 88.7 t -112.04 151.22 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 128.096 2.558 . . . . 0.0 108.158 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -108.78 156.88 19.11 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.862 1.792 . . . . 0.0 110.247 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.09 179.25 41.9 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 120.172 -1.58 . . . . 0.0 109.628 173.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 m -113.7 130.93 56.34 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.708 0.803 . . . . 0.0 110.335 -169.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.0 t -98.06 122.56 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 125.766 1.627 . . . . 0.0 110.986 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -110.95 -59.54 1.95 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.063 -1.648 . . . . 0.0 110.612 174.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.9 t90 -69.83 -79.29 0.06 Allowed 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.569 1.548 . . . . 0.0 114.798 -166.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.8 t80 75.1 114.69 0.06 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.718 2.407 . . . . 0.0 113.249 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.429 HD21 ' HB3' ' A' ' 20' ' ' ASN . 64.4 t-20 -110.99 124.64 52.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.064 -1.648 . . . . 0.0 109.822 -175.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.1 t -107.96 -47.58 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 120.684 -1.26 . . . . 0.0 110.769 171.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -63.77 -30.79 71.85 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -167.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.429 ' HB3' HD21 ' A' ' 17' ' ' ASN . 59.6 t30 -107.53 -25.29 11.44 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 121.345 -0.847 . . . . 0.0 111.851 166.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.56 -43.69 1.62 Allowed Glycine 0 N--CA 1.43 -1.709 0 O-C-N 118.983 -2.323 . . . . 0.0 114.236 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -75.71 105.72 6.9 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 124.792 1.237 . . . . 0.0 112.8 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.13 175.45 21.3 Favored Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 124.84 1.209 . . . . 0.0 111.325 -176.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -143.26 145.57 32.86 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 123.021 1.391 . . . . 0.0 113.433 171.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.2 mt -107.75 147.79 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 125.054 1.342 . . . . 0.0 108.964 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -93.92 87.85 5.52 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 122.674 1.226 . . . . 0.0 108.951 173.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.563 HH12 HG21 ' A' ' 5' ' ' ILE . 2.3 tmt_? -66.52 112.82 4.3 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.925 -1.734 . . . . 0.0 114.522 172.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -85.41 25.78 0.99 Allowed 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 117.43 2.382 . . . . 0.0 117.43 -160.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -73.37 -51.14 18.45 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.46 -1.4 . . . . 0.0 111.416 170.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.3 t -146.4 24.59 1.26 Allowed 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.09 76.37 0.29 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 127.516 2.327 . . . . 0.0 111.153 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -109.85 133.15 53.48 Favored 'General case' 0 N--CA 1.428 -1.525 0 O-C-N 120.555 -1.34 . . . . 0.0 109.383 -176.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -81.87 110.82 17.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.493 1.616 . . . . 0.0 110.021 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.46 112.78 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.71 -1.244 . . . . 0.0 108.224 -171.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -85.18 129.28 34.83 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -172.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.4 t -127.41 123.19 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 124.994 1.318 . . . . 0.0 110.451 -168.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -93.12 160.79 14.69 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.183 -0.948 . . . . 0.0 112.001 171.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -60.41 -29.32 68.9 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.0 m -61.89 -33.37 74.09 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 125.843 1.657 . . . . 0.0 113.475 175.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.41 -17.17 60.84 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.193 -1.567 . . . . 0.0 114.294 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 72.7 mt -88.25 112.49 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 125.24 1.416 . . . . 0.0 110.261 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt . . . . . 0 N--CA 1.43 -1.428 0 C-N-CA 124.741 1.216 . . . . 0.0 110.983 176.739 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.733 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -108.48 158.8 17.21 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 166.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.46 8.3 49.83 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 120.079 -1.638 . . . . 0.0 114.518 -177.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -75.71 166.5 23.46 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.334 1.454 . . . . 0.0 114.551 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.98 148.85 22.21 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.43 1.892 . . . . 0.0 112.776 175.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 p -147.2 153.14 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 126.995 2.118 . . . . 0.0 106.05 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -104.3 147.86 27.02 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 120.104 1.32 . . . . 0.0 110.707 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -159.78 169.67 23.13 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.256 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -97.28 147.47 24.11 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.051 -1.656 . . . . 0.0 107.202 170.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.0 t -106.86 95.71 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 O-C-N 119.204 -2.185 . . . . 0.0 109.323 175.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.574 HG12 HG13 ' A' ' 4' ' ' VAL . 0.9 OUTLIER -129.62 100.89 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 120.444 -1.41 . . . . 0.0 110.488 -162.15 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -160.25 -122.5 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.232 -1.542 . . . . 0.0 112.699 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.25 -145.48 4.14 Favored Glycine 0 N--CA 1.43 -1.723 0 C-N-CA 127.307 2.384 . . . . 0.0 110.036 -162.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -94.98 -34.87 12.2 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.72 -1.459 . . . . 0.0 114.208 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -66.08 -37.73 86.52 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.81 -1.182 . . . . 0.0 114.033 -167.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -162.81 -156.35 8.49 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 174.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.01 158.56 39.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.028 -1.278 . . . . 0.0 111.778 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -138.47 172.82 12.33 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 127.489 2.316 . . . . 0.0 106.374 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.03 154.63 42.72 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.702 -1.874 . . . . 0.0 107.762 -168.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -149.89 162.67 39.86 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 55.23 54.47 8.7 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.261 1.824 . . . . 0.0 113.563 173.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.3 t -87.69 127.49 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.796 -1.19 . . . . 0.0 110.353 -170.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.0 p -94.44 -176.28 3.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.987 1.375 . . . . 0.0 114.05 -168.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.687 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 171.667 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.43 HG13 HG12 ' A' ' 64' ' ' VAL . 78.0 t . . . . . 0 N--CA 1.431 -1.409 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.3 mp -90.91 -57.46 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 119.633 -1.917 . . . . 0.0 110.392 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.49 160.74 26.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -168.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.8 p -106.58 157.59 17.57 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.592 2.757 . . . . 0.0 112.093 163.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.8 mttp 57.79 57.76 4.03 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.128 2.171 . . . . 0.0 114.602 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 t -115.97 152.19 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 C-N-CA 128.72 2.808 . . . . 0.0 107.741 -169.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -128.11 164.79 21.67 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 123.696 1.712 . . . . 0.0 114.15 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' A' ' 27' ' ' ARG . . . -168.79 -173.86 36.92 Favored Glycine 0 N--CA 1.431 -1.685 0 O-C-N 121.018 -1.051 . . . . 0.0 110.57 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.7 m -115.98 129.55 56.43 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.463 1.601 . . . . 0.0 108.365 -172.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.3 p -87.19 147.51 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 120.567 -1.333 . . . . 0.0 112.474 -177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.8 mmtt -102.47 -99.14 0.28 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 162.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -147.29 -170.82 3.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 172.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -124.58 166.61 15.78 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 126.157 1.783 . . . . 0.0 108.305 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -87.9 91.37 8.74 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 162.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.9 m -68.12 -31.0 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 126.965 2.106 . . . . 0.0 113.794 -171.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -62.04 -43.58 98.53 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 124.622 1.169 . . . . 0.0 112.68 -175.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -92.01 -36.53 13.34 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 119.144 -2.223 . . . . 0.0 113.603 166.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.57 34.64 3.03 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 121.521 -0.737 . . . . 0.0 114.198 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -123.65 162.61 22.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.783 -1.422 . . . . 0.0 110.411 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.42 171.67 36.78 Favored Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 169.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -118.23 155.6 30.25 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 118.146 0.973 . . . . 0.0 112.077 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.8 mm -104.47 155.87 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 169.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -110.81 96.67 6.31 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 119.637 1.108 . . . . 0.0 110.589 168.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.422 ' HA ' ' HA3' ' A' ' 11' ' ' GLY . 44.0 ttt180 -36.12 147.65 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 131.158 3.783 . . . . 0.0 117.446 164.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -66.0 -7.03 14.76 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.818 2.525 . . . . 0.0 117.818 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -82.94 -78.51 0.21 Allowed 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.875 -1.765 . . . . 0.0 112.502 -171.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 t -120.55 10.52 11.12 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 121.857 2.117 . . . . 0.0 107.244 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.2 mptt 60.09 67.53 0.85 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.714 2.406 . . . . 0.0 112.049 -174.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -107.73 159.4 16.51 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.064 -1.023 . . . . 0.0 109.452 -168.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -84.71 95.11 8.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 124.44 1.096 . . . . 0.0 112.643 -172.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.8 t -109.85 110.6 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -85.16 148.7 25.98 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 120.473 -1.392 . . . . 0.0 113.574 -168.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.442 HG22 ' HB3' ' A' ' 72' ' ' ALA . 81.8 t -136.68 133.59 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 125.097 1.359 . . . . 0.0 109.138 -171.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -114.47 165.2 12.99 Favored 'General case' 0 N--CA 1.432 -1.366 0 C-N-CA 125.247 1.419 . . . . 0.0 111.057 172.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -63.51 -36.52 84.04 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -169.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.0 m -74.99 -19.81 59.93 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.958 1.303 . . . . 0.0 112.107 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.26 -26.59 60.31 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.519 -1.988 . . . . 0.0 112.79 173.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.0 mt -76.45 114.65 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.702 1.601 . . . . 0.0 109.713 170.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.4 mttt . . . . . 0 N--CA 1.431 -1.409 0 O-C-N 120.778 -1.201 . . . . 0.0 109.353 -178.413 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.657 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.0 t70 66.71 -137.98 0.14 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.825 1.25 . . . . 0.0 109.907 -169.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.79 87.17 0.47 Allowed Glycine 0 N--CA 1.43 -1.753 0 O-C-N 120.814 -1.179 . . . . 0.0 112.43 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -64.17 169.58 4.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.094 -1.827 . . . . 0.0 114.545 171.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.12 136.75 36.16 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 122.207 1.003 . . . . 0.0 110.814 172.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.3 m -123.06 151.01 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -100.14 152.61 20.06 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 121.169 -0.957 . . . . 0.0 110.254 171.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -161.21 -179.31 7.34 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.844 0.83 . . . . 0.0 110.358 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -105.06 154.48 20.09 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 164.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 64.0 t -112.61 90.3 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 119.675 -1.891 . . . . 0.0 106.632 174.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.43 HG12 HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -115.81 87.69 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 124.217 1.961 . . . . 0.0 107.174 -165.081 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -85.56 124.59 32.28 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.584 -1.322 . . . . 0.0 113.738 -171.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -124.16 -41.94 0.38 Allowed Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 125.239 1.4 . . . . 0.0 112.797 173.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -89.45 -136.23 0.11 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.322 1.449 . . . . 0.0 111.826 -172.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -85.06 -13.82 49.21 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 126.523 1.929 . . . . 0.0 112.245 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -166.46 167.61 39.58 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 105.574 -3.011 . . . . 0.0 105.574 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.67 165.41 15.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -162.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -115.84 -174.83 2.6 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.037 -1.04 . . . . 0.0 111.221 164.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.442 ' HB3' HG22 ' A' ' 36' ' ' VAL . . . -144.93 144.95 31.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.543 1.164 . . . . 0.0 108.687 -169.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.74 160.68 38.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 55.85 48.62 17.72 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.011 1.724 . . . . 0.0 114.309 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.1 t -88.05 138.79 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 124.332 1.053 . . . . 0.0 111.026 -165.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.0 p -109.14 -158.53 0.65 Allowed 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 124.18 1.943 . . . . 0.0 113.011 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.781 0 O-C-N 119.559 -1.963 . . . . 0.0 109.68 176.834 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.43 -1.458 0 CA-C-O 120.753 0.311 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.463 HD13 HG12 ' A' ' 63' ' ' VAL . 4.8 mp -97.56 -50.24 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 O-C-N 119.629 -1.92 . . . . 0.0 106.436 165.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -158.3 161.49 37.68 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 123.356 0.662 . . . . 0.0 111.408 171.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.5 p -120.87 149.42 42.62 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.586 -1.321 . . . . 0.0 110.597 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.265 54.9 mttp 59.06 73.12 0.49 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.185 2.194 . . . . 0.0 113.866 -171.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.49 149.71 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 126.892 2.077 . . . . 0.0 109.2 -163.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -109.05 159.63 16.69 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 123.787 1.756 . . . . 0.0 112.798 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.73 -178.36 44.55 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.4 m -117.14 129.51 56.01 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -172.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.6 t -72.23 135.87 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 120.796 -1.19 . . . . 0.0 111.435 -175.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -95.14 -100.69 0.16 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.347 -1.47 . . . . 0.0 110.202 173.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -130.16 157.17 43.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.871 -1.768 . . . . 0.0 111.37 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -104.03 142.09 35.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.51 1.524 . . . . 0.0 109.921 172.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -118.15 100.54 7.59 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.945 1.698 . . . . 0.0 109.058 -175.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.17 -29.81 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 120.645 -1.284 . . . . 0.0 113.409 -158.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -58.39 -59.8 4.78 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.83 -1.794 . . . . 0.0 113.34 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -78.48 -37.79 42.48 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.763 -1.211 . . . . 0.0 113.223 174.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.93 53.45 0.8 Allowed Glycine 0 N--CA 1.43 -1.735 0 CA-C-N 119.768 1.167 . . . . 0.0 114.17 175.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -125.32 175.02 7.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.723 -0.869 . . . . 0.0 110.253 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.9 176.28 35.77 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 107.64 -2.184 . . . . 0.0 107.64 163.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -149.86 153.76 37.26 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 122.699 1.238 . . . . 0.0 112.949 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.412 HD11 HG21 ' A' ' 36' ' ' VAL . 1.7 mt -124.28 147.33 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 125.634 1.574 . . . . 0.0 109.324 -172.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -99.29 93.81 6.13 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 168.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -67.03 130.51 43.37 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -82.66 68.04 8.96 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.221 1.409 . . . . 0.0 114.631 -167.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -132.42 -72.57 0.52 Allowed 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 120.427 -1.42 . . . . 0.0 109.253 170.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.0 t -131.91 38.63 3.52 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.4 mptt 57.83 69.71 0.71 Allowed 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.981 1.712 . . . . 0.0 114.227 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -103.02 141.94 34.95 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.515 -1.99 . . . . 0.0 109.623 -166.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -93.85 104.71 16.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -162.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.1 t -108.95 116.5 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.69 -1.256 . . . . 0.0 109.119 -167.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -81.12 134.47 35.65 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 125.111 1.364 . . . . 0.0 112.743 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 25' ' ' ILE . 43.1 t -126.42 123.1 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 120.438 -1.414 . . . . 0.0 111.013 -175.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -100.63 170.11 8.59 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.351 1.46 . . . . 0.0 112.305 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -68.85 -22.41 64.22 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.6 -1.938 . . . . 0.0 114.892 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.5 p -71.11 -25.15 62.47 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.74 2.016 . . . . 0.0 113.392 175.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.39 -32.33 29.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.611 -1.306 . . . . 0.0 113.195 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.83 139.82 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 C-N-CA 126.481 1.912 . . . . 0.0 113.275 -175.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.2 pttm . . . . . 0 N--CA 1.431 -1.422 0 N-CA-C 119.04 2.978 . . . . 0.0 119.04 -173.899 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.691 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -86.88 102.88 14.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.696 -1.473 . . . . 0.0 109.779 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.3 21.22 20.65 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 121.406 -0.809 . . . . 0.0 113.179 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -76.21 158.38 31.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.995 -1.297 . . . . 0.0 112.947 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 p -103.1 160.09 14.95 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.616 1.567 . . . . 0.0 113.487 -175.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -154.93 141.35 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 O-C-N 121.385 -0.822 . . . . 0.0 109.547 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -93.04 142.96 26.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.743 1.258 . . . . 0.0 112.7 165.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -155.59 172.11 18.82 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.974 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -102.88 138.28 39.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 166.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.463 HG12 HD13 ' A' ' 5' ' ' ILE . 45.7 t -96.22 91.93 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 119.676 -1.89 . . . . 0.0 109.524 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.99 90.47 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 118.607 -2.558 . . . . 0.0 111.785 -159.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -144.81 -60.3 0.36 Allowed 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 122.659 1.219 . . . . 0.0 110.931 165.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.9 -48.38 1.32 Allowed Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 115.617 1.007 . . . . 0.0 115.617 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -80.12 -85.26 0.09 Allowed 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 -172.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -86.13 -30.47 22.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.285 -1.509 . . . . 0.0 114.333 -167.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -162.92 -127.53 0.88 Allowed Glycine 0 N--CA 1.43 -1.763 0 O-C-N 119.953 -1.717 . . . . 0.0 110.56 170.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.43 ' HB1' HG13 ' A' ' 63' ' ' VAL . . . -144.48 137.37 26.88 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 122.246 1.022 . . . . 0.0 113.119 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -117.83 -166.81 1.24 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.943 -1.098 . . . . 0.0 109.725 165.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.06 153.49 42.99 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 123.018 1.39 . . . . 0.0 110.863 -170.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.44 157.76 44.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 175.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 50.72 59.32 4.68 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 36.4 t -93.97 100.26 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 120.672 -1.268 . . . . 0.0 109.073 -170.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.0 p -99.32 -103.39 0.22 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.074 1.35 . . . . 0.0 111.951 -171.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.726 0 C-N-CA 125.531 1.539 . . . . 0.0 110.194 -173.206 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.489 -1.4 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -72.03 -61.33 1.83 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.921 -1.737 . . . . 0.0 115.046 -169.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -116.64 -98.61 0.45 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.379 -1.451 . . . . 0.0 110.535 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.938 HG12 ' H ' ' A' ' 65' ' ' GLU . 4.3 m -82.94 167.02 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.407 -1.433 . . . . 0.0 112.217 -176.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.426 HD13 HG12 ' A' ' 63' ' ' VAL . 4.8 mp -91.37 -61.49 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 O-C-N 120.135 -1.603 . . . . 0.0 108.833 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -164.84 173.21 11.98 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -174.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.2 p -109.47 160.17 16.43 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.962 2.505 . . . . 0.0 109.755 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.7 mttt 59.99 49.76 7.35 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.585 2.068 . . . . 0.0 116.585 174.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.57 143.78 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.301 1.84 . . . . 0.0 109.295 -166.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -106.69 149.85 26.84 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.222 1.01 . . . . 0.0 110.323 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.35 -167.04 37.38 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.306 -1.496 . . . . 0.0 111.383 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.7 m -116.44 120.94 40.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.657 -0.908 . . . . 0.0 109.758 -164.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.2 t -87.77 130.44 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 120.89 -1.131 . . . . 0.0 110.456 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -133.04 159.71 39.27 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 120.828 -1.17 . . . . 0.0 111.461 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.4 t90 37.11 63.67 0.68 Allowed 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 118.395 2.739 . . . . 0.0 118.395 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -79.51 118.17 21.13 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.461 -1.4 . . . . 0.0 110.39 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -95.12 107.16 19.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.648 -1.283 . . . . 0.0 108.441 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.9 t -71.32 -33.98 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 126.3 1.84 . . . . 0.0 112.493 -173.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -65.38 -38.38 89.83 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.191 -1.568 . . . . 0.0 113.566 -172.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -95.13 -35.04 12.05 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.739 -1.225 . . . . 0.0 111.931 169.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.89 40.71 3.04 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.518 -1.364 . . . . 0.0 113.858 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -132.93 146.39 51.75 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.471 1.509 . . . . 0.0 109.591 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -149.88 -171.75 18.64 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 170.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -141.32 153.42 45.14 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 123.389 1.566 . . . . 0.0 111.776 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mt -112.36 141.53 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.335 1.054 . . . . 0.0 108.341 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -91.92 91.23 7.79 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 172.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.12 110.89 2.68 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 125.968 1.707 . . . . 0.0 113.753 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.331 38.7 p30 -54.14 -47.55 71.78 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 121.084 3.735 . . . . 0.0 121.084 -158.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -56.64 -49.11 75.99 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.771 2.878 . . . . 0.0 118.771 -169.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -136.25 35.73 2.76 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.19 -2.194 . . . . 0.0 106.837 173.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? 57.32 63.34 1.9 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.875 1.67 . . . . 0.0 113.278 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -107.83 151.35 25.86 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.965 -1.71 . . . . 0.0 110.531 -168.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -84.65 112.16 20.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.381 1.086 . . . . 0.0 111.943 -169.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.9 t -113.91 111.92 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -88.31 134.86 33.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.634 -1.916 . . . . 0.0 110.616 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.4 p -130.85 133.58 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.882 -1.136 . . . . 0.0 110.283 -173.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -117.43 154.73 30.87 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.011 1.724 . . . . 0.0 111.625 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -54.12 -31.05 51.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 117.794 2.516 . . . . 0.0 117.794 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.5 p -75.85 -12.14 60.11 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.516 -1.99 . . . . 0.0 114.334 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.48 -15.24 33.51 Favored 'General case' 0 CA--C 1.489 -1.37 0 O-C-N 120.766 -1.209 . . . . 0.0 112.369 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.2 mm -74.18 133.02 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 125.463 1.505 . . . . 0.0 111.116 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -72.64 168.28 19.01 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.267 -2.146 . . . . 0.0 115.09 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . 0.256 30.6 ttpt 56.75 -118.54 1.18 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.469 2.307 . . . . 0.0 116.095 171.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -151.93 142.36 22.55 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.97 1.708 . . . . 0.0 106.565 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -118.64 107.72 42.29 Favored Pre-proline 0 N--CA 1.43 -1.447 0 C-N-CA 124.723 1.209 . . . . 0.0 108.237 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.31 176.6 9.74 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 CA-C-N 123.622 2.329 . . . . 0.0 113.523 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -112.19 60.07 0.63 Allowed 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.466 1.127 . . . . 0.0 110.97 -171.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -156.79 173.09 17.5 Favored 'General case' 0 N--CA 1.432 -1.374 0 O-C-N 119.913 -1.742 . . . . 0.0 112.3 -173.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.8 t80 70.77 144.38 0.06 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.482 2.313 . . . . 0.0 115.753 175.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.6 tp -93.29 -81.3 0.36 Allowed 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 120.297 -1.502 . . . . 0.0 112.665 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -78.8 107.72 11.72 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 -163.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.7 t -117.22 -67.87 0.96 Allowed 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.563 -1.336 . . . . 0.0 109.328 172.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.2 t -128.27 -77.88 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 C-N-CA 124.858 1.263 . . . . 0.0 108.14 172.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 145.61 -144.22 12.71 Favored Glycine 0 N--CA 1.429 -1.799 0 N-CA-C 107.782 -2.127 . . . . 0.0 107.782 -174.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -80.77 146.92 30.74 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 118.895 1.347 . . . . 0.0 111.843 173.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.2 45.3 62.15 Favored Glycine 0 N--CA 1.431 -1.675 0 O-C-N 120.469 -1.394 . . . . 0.0 115.597 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -75.03 152.54 38.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.489 1.137 . . . . 0.0 113.268 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 m -97.86 138.25 35.49 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.217 1.008 . . . . 0.0 109.667 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -143.28 151.53 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -172.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -98.28 143.27 28.95 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 119.589 1.086 . . . . 0.0 110.455 171.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -157.94 160.97 38.15 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 121.79 0.805 . . . . 0.0 109.247 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -88.62 142.81 27.38 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.838 -1.789 . . . . 0.0 107.207 166.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.426 HG12 HD13 ' A' ' 5' ' ' ILE . 85.3 t -100.66 97.6 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 119.48 -2.012 . . . . 0.0 106.811 175.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.402 ' HA ' ' HB ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -123.24 144.93 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 O-C-N 120.609 -1.307 . . . . 0.0 110.101 -163.331 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.938 ' H ' HG12 ' A' ' 4' ' ' VAL . 16.7 tt0 -59.63 111.63 1.5 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.476 2.084 . . . . 0.0 113.269 -170.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.14 -128.03 3.19 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 111.747 -2.478 . . . . 0.0 112.641 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -100.35 -71.23 0.71 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 124.129 0.971 . . . . 0.0 109.326 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -83.0 -26.25 31.43 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.783 -1.198 . . . . 0.0 112.111 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.59 -88.96 0.07 OUTLIER Glycine 0 N--CA 1.429 -1.783 0 O-C-N 121.278 -0.889 . . . . 0.0 111.055 -167.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.28 149.08 35.7 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.508 1.623 . . . . 0.0 114.867 -173.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -122.37 -162.86 1.03 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.543 1.937 . . . . 0.0 110.464 168.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -146.77 133.4 19.89 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.349 -1.47 . . . . 0.0 110.161 -169.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -133.14 162.01 32.89 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.95 1.3 . . . . 0.0 108.687 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 51.04 51.63 16.66 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.731 1.613 . . . . 0.0 115.019 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.8 t -92.94 129.92 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 123.905 0.882 . . . . 0.0 112.016 -165.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.2 p -96.32 -134.27 0.22 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.417 1.087 . . . . 0.0 112.97 -175.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.46 176.77 45.79 Favored Glycine 0 N--CA 1.43 -1.716 0 O-C-N 119.709 -1.869 . . . . 0.0 108.702 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -71.13 -2.31 10.92 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 C-N-CA 123.222 2.615 . . . . 0.0 117.238 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.794 0 CA-C-N 120.742 1.61 . . . . 0.0 110.807 -175.036 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.9 ttp . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -124.4 149.68 46.43 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.717 1.607 . . . . 0.0 109.785 -176.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -95.84 -59.99 1.74 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.489 -1.382 . . . . 0.0 111.824 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.403 ' HA ' ' H ' ' A' ' 65' ' ' GLU . 12.7 m -72.66 151.19 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 120.841 -1.162 . . . . 0.0 112.966 -173.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.704 HD13 HG12 ' A' ' 63' ' ' VAL . 2.3 mp -95.61 -72.87 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.503 -1.998 . . . . 0.0 107.685 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -158.05 171.95 19.31 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -168.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -107.47 156.02 19.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.593 2.357 . . . . 0.0 111.115 168.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt 53.73 57.2 6.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 176.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.6 t -105.46 144.94 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 128.179 2.591 . . . . 0.0 107.728 -175.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -105.41 150.0 25.64 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.385 -1.447 . . . . 0.0 109.945 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -168.61 -179.84 41.1 Favored Glycine 0 N--CA 1.43 -1.712 0 O-C-N 120.529 -1.357 . . . . 0.0 110.399 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 m -115.56 133.64 55.84 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 124.221 1.009 . . . . 0.0 111.486 -167.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.7 p -109.95 142.25 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 123.901 0.881 . . . . 0.0 111.332 174.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -100.32 -87.29 0.38 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.697 -1.877 . . . . 0.0 110.027 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -112.11 128.81 56.32 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 124.873 1.269 . . . . 0.0 109.469 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -139.66 155.21 47.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.144 -0.972 . . . . 0.0 110.731 172.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -86.43 104.06 15.56 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.284 -1.51 . . . . 0.0 111.353 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.16 -34.65 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -62.66 -45.52 92.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.267 -1.521 . . . . 0.0 114.066 -173.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -83.49 -42.47 16.84 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.914 -1.116 . . . . 0.0 110.367 168.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.53 53.53 1.55 Allowed Glycine 0 N--CA 1.43 -1.745 0 O-C-N 120.255 -1.528 . . . . 0.0 110.277 -172.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -135.91 151.69 50.24 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 123.561 0.744 . . . . 0.0 109.898 -169.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.77 -158.03 26.95 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 121.236 -0.915 . . . . 0.0 111.687 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -144.86 154.04 42.22 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 123.159 1.456 . . . . 0.0 112.84 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.3 mm -109.46 162.36 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.389 1.476 . . . . 0.0 107.166 -178.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -102.3 100.61 10.79 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 120.921 -1.112 . . . . 0.0 109.442 170.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -57.92 124.96 21.05 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.049 1.74 . . . . 0.0 114.359 168.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -55.12 -47.93 74.34 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 119.273 3.064 . . . . 0.0 119.273 -168.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -68.05 -46.9 69.82 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -168.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.1 t -137.69 23.97 2.88 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 119.77 -1.831 . . . . 0.0 107.491 -170.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.61 49.77 6.22 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.941 1.696 . . . . 0.0 113.922 166.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -104.81 156.3 18.13 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 123.298 1.523 . . . . 0.0 112.807 -168.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -86.05 119.44 26.35 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.625 -171.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.4 t -108.63 103.32 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -169.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -82.73 131.83 35.19 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 122.975 1.369 . . . . 0.0 113.781 -173.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.4 t -128.88 135.39 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 124.657 1.183 . . . . 0.0 108.019 -172.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.8 176.91 6.29 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.324 1.05 . . . . 0.0 109.08 169.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -61.58 -21.64 64.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.987 2.217 . . . . 0.0 116.987 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -71.82 -26.02 62.22 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.501 1.521 . . . . 0.0 113.732 173.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.41 -22.06 26.78 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.849 -2.407 . . . . 0.0 113.011 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.8 mt -81.57 104.44 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 125.531 1.533 . . . . 0.0 109.819 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.251 50.3 mttm 65.34 -172.53 0.18 Allowed 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 125.529 1.532 . . . . 0.0 114.3 -173.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.61 119.52 6.2 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 118.708 -2.495 . . . . 0.0 109.755 177.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . 0.282 11.5 t-20 53.21 -86.98 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 127.776 2.43 . . . . 0.0 116.23 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -70.49 121.86 84.77 Favored Pre-proline 0 N--CA 1.43 -1.435 0 O-C-N 119.867 -1.771 . . . . 0.0 113.061 -177.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.53 170.91 19.03 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 CA-C-N 123.453 2.269 . . . . 0.0 114.073 -177.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -142.68 81.27 1.73 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 122.364 1.078 . . . . 0.0 109.469 176.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.257 45.6 mttp 66.74 -157.44 0.24 Allowed 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.1 2.16 . . . . 0.0 115.184 -173.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -113.02 151.65 30.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.836 -1.165 . . . . 0.0 110.484 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 tp -88.14 106.04 17.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.168 -1.582 . . . . 0.0 108.495 162.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -95.17 -58.52 2.12 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.783 -1.198 . . . . 0.0 112.545 -171.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.0 t -117.55 146.6 43.47 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 124.307 1.043 . . . . 0.0 111.572 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.3 m -120.91 156.51 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 124.618 1.167 . . . . 0.0 111.507 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -137.33 140.22 11.16 Favored Glycine 0 N--CA 1.429 -1.773 0 O-C-N 120.554 -1.341 . . . . 0.0 113.576 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.11 140.1 48.71 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.023 -1.869 . . . . 0.0 114.403 -177.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.73 11.39 79.66 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 119.741 -1.849 . . . . 0.0 113.425 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -79.69 153.29 29.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.279 1.514 . . . . 0.0 113.617 177.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 p -97.45 142.68 29.0 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 125.433 1.493 . . . . 0.0 114.678 -177.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.02 154.3 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 124.679 1.192 . . . . 0.0 109.594 -174.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.53 145.39 30.37 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.347 -1.471 . . . . 0.0 113.054 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.432 ' HB2' ' HB1' ' A' ' 72' ' ' ALA . 13.9 p90 -156.38 172.31 18.73 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.031 1.332 . . . . 0.0 110.171 -178.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -94.8 154.07 17.44 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.592 -1.942 . . . . 0.0 108.094 165.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.704 HG12 HD13 ' A' ' 5' ' ' ILE . 61.5 t -110.97 96.97 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 119.139 -2.225 . . . . 0.0 108.011 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.27 111.87 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 120.183 -1.573 . . . . 0.0 109.553 -167.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.403 ' H ' ' HA ' ' A' ' 4' ' ' VAL . 28.3 tt0 -95.44 123.66 39.08 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.756 -1.84 . . . . 0.0 113.587 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -123.82 -45.63 0.28 Allowed Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 125.156 1.36 . . . . 0.0 112.809 170.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -95.37 -136.61 0.22 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.004 1.322 . . . . 0.0 111.386 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -78.76 -32.12 46.44 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.617 -1.927 . . . . 0.0 113.19 -174.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -141.07 165.84 26.15 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 105.997 -2.841 . . . . 0.0 105.997 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.71 152.22 21.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.206 1.479 . . . . 0.0 114.676 -168.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -107.01 -166.71 1.19 Allowed 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.423 -1.423 . . . . 0.0 109.947 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' A' ' 61' ' ' PHE . . . -147.33 156.23 42.72 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -173.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.58 162.41 36.68 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 56.45 40.31 29.66 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.628 1.571 . . . . 0.0 114.414 173.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 t -76.21 109.61 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 125.948 1.699 . . . . 0.0 110.62 -172.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.7 m -125.96 -121.85 0.25 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 123.8 0.84 . . . . 0.0 110.165 -161.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 119.88 162.84 12.02 Favored Glycine 0 N--CA 1.429 -1.787 0 O-C-N 119.335 -2.103 . . . . 0.0 111.691 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.77 156.52 48.59 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 123.363 2.709 . . . . 0.0 113.009 176.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.716 0 CA-C-O 117.821 -1.544 . . . . 0.0 112.35 178.784 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 CA--C 1.49 -1.365 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -90.58 -76.52 0.43 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.436 1.095 . . . . 0.0 113.297 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -67.95 130.07 41.83 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -166.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 t 70.73 86.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 127.336 2.255 . . . . 0.0 110.87 175.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.1 mp -80.74 -72.08 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 119.952 -1.718 . . . . 0.0 113.116 -166.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.19 167.89 28.86 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -160.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.9 p -110.96 134.37 52.64 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 128.188 2.595 . . . . 0.0 109.661 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.279 25.8 ttmt 59.18 75.67 0.39 Allowed 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.683 1.993 . . . . 0.0 116.046 -172.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.6 t -121.06 149.96 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 130.311 3.444 . . . . 0.0 105.739 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.7 mp -114.84 168.06 10.23 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 123.638 1.685 . . . . 0.0 112.232 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.73 -172.78 44.17 Favored Glycine 0 N--CA 1.43 -1.751 0 O-C-N 119.333 -2.104 . . . . 0.0 113.115 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.0 m -116.68 131.42 56.95 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 123.773 0.829 . . . . 0.0 109.511 -168.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.84 135.7 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 O-C-N 120.093 -1.63 . . . . 0.0 113.83 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -95.39 -56.08 2.83 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 120.098 -1.626 . . . . 0.0 109.841 173.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -156.46 130.66 8.61 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 123.972 0.909 . . . . 0.0 110.438 177.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -101.71 123.36 45.56 Favored 'General case' 0 N--CA 1.431 -1.384 0 O-C-N 120.607 -1.308 . . . . 0.0 107.965 164.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -102.52 76.9 1.57 Allowed 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.407 -1.433 . . . . 0.0 110.471 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 t -75.82 -7.5 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 123.523 1.63 . . . . 0.0 112.437 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -64.55 -30.07 71.1 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 128.814 2.846 . . . . 0.0 112.85 173.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -127.83 -46.06 1.42 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.728 -1.857 . . . . 0.0 111.444 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.45 -57.38 0.21 Allowed Glycine 0 N--CA 1.429 -1.779 0 O-C-N 119.475 -2.015 . . . . 0.0 115.929 -174.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -79.57 169.42 18.04 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.847 1.784 . . . . 0.0 114.916 -166.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.26 167.78 31.33 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 118.913 -2.367 . . . . 0.0 109.479 169.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -147.06 141.59 26.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 123.012 1.387 . . . . 0.0 111.923 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 mm -113.26 160.76 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 126.812 2.045 . . . . 0.0 108.926 -169.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -109.77 99.82 8.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.551 -1.343 . . . . 0.0 110.927 161.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.76 138.41 47.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.276 2.23 . . . . 0.0 114.93 170.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -62.48 84.95 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.607 2.447 . . . . 0.0 117.607 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -159.42 -76.12 0.07 Allowed 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.403 -2.061 . . . . 0.0 109.251 177.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.6 t -139.67 30.05 2.11 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 55.65 81.76 0.11 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.0 2.12 . . . . 0.0 114.202 -165.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -101.78 137.21 40.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.85 -1.781 . . . . 0.0 108.189 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -79.98 110.11 15.05 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 121.626 0.727 . . . . 0.0 109.925 -171.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.3 t -111.73 117.21 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -89.28 144.26 26.22 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.14 0.972 . . . . 0.0 112.957 -176.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -133.01 128.47 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 122.635 1.207 . . . . 0.0 110.847 -172.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -95.96 154.84 17.02 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.571 -1.331 . . . . 0.0 110.338 173.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -64.1 -26.1 68.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.235 -2.166 . . . . 0.0 116.443 -171.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.0 p -69.39 -27.31 65.19 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.543 -1.348 . . . . 0.0 113.755 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.83 -19.52 40.9 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.452 -1.405 . . . . 0.0 113.175 -174.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.6 mt -75.02 117.32 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 C-N-CA 126.751 2.02 . . . . 0.0 111.768 -178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -81.37 92.56 6.43 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.543 -1.348 . . . . 0.0 112.423 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -83.25 128.54 34.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.507 -1.371 . . . . 0.0 109.169 168.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -128.75 -39.91 1.59 Allowed 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 121.116 -0.99 . . . . 0.0 112.526 -173.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -107.58 138.26 19.93 Favored Pre-proline 0 N--CA 1.429 -1.48 0 O-C-N 121.189 -0.944 . . . . 0.0 111.11 -165.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.8 -15.96 14.83 Favored 'Trans proline' 0 N--CA 1.434 -1.979 0 C-N-CA 122.795 2.33 . . . . 0.0 113.605 177.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -100.3 162.9 12.66 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 119.624 1.102 . . . . 0.0 111.635 -171.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.281 31.9 mtmm 59.32 -156.52 0.34 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.44 1.896 . . . . 0.0 115.336 -173.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.2 t80 51.31 65.92 1.34 Allowed 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 127.505 2.322 . . . . 0.0 114.947 -172.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.3 mt -88.32 -143.21 0.13 Allowed 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.748 -1.22 . . . . 0.0 112.444 -171.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -75.87 -63.54 1.28 Allowed 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.654 -1.904 . . . . 0.0 112.486 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 65.4 m -77.04 145.81 37.73 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 124.945 1.298 . . . . 0.0 112.12 -177.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 m -106.52 157.8 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 120.486 -1.383 . . . . 0.0 112.842 -172.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.11 143.65 21.33 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 120.504 -1.373 . . . . 0.0 109.938 172.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -76.75 117.39 18.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.171 1.462 . . . . 0.0 112.95 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.56 55.14 21.97 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 116.734 1.454 . . . . 0.0 116.734 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -73.18 150.77 41.87 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 119.184 1.492 . . . . 0.0 113.06 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 m -99.6 145.16 27.86 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.996 -1.065 . . . . 0.0 110.904 -172.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.1 m -143.08 163.14 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 125.866 1.666 . . . . 0.0 108.028 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -113.58 153.57 28.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.234 1.414 . . . . 0.0 110.461 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -164.7 172.91 12.48 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.976 0.893 . . . . 0.0 110.632 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -92.32 152.59 19.7 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.887 -2.383 . . . . 0.0 108.662 162.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.3 t -112.11 100.71 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 119.535 -1.978 . . . . 0.0 107.547 173.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 m -132.96 128.27 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 120.412 -1.43 . . . . 0.0 108.316 -168.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -96.31 150.77 20.2 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.905 -2.372 . . . . 0.0 114.4 -163.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -151.11 -68.55 0.01 OUTLIER Glycine 0 N--CA 1.432 -1.622 0 O-C-N 121.116 -0.99 . . . . 0.0 111.549 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -78.3 -145.37 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.4 1.48 . . . . 0.0 114.46 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -62.87 -22.42 66.69 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 119.841 -1.787 . . . . 0.0 115.579 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.72 -167.61 13.48 Favored Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 127.245 2.355 . . . . 0.0 108.383 175.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.11 161.31 15.15 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.09 -168.1 1.61 Allowed 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.838 -1.164 . . . . 0.0 110.626 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.06 155.68 44.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.87 1.319 . . . . 0.0 112.136 -166.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.1 166.02 24.35 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.593 1.957 . . . . 0.0 106.531 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.336 0.4 OUTLIER 34.51 63.36 0.45 Allowed 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 117.845 2.535 . . . . 0.0 117.845 -178.513 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.1 t -92.15 98.11 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 C-N-CA 125.097 1.359 . . . . 0.0 111.017 -168.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.94 155.63 22.38 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.607 1.163 . . . . 0.0 110.612 -174.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -136.13 155.23 22.31 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 168.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -79.74 178.61 7.11 Favored 'Trans proline' 0 N--CA 1.434 -1.997 0 C-N-CA 123.273 2.649 . . . . 0.0 111.702 170.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.735 0 CA-C-O 118.704 -1.053 . . . . 0.0 111.046 171.913 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ttt . . . . . 0 CA--C 1.49 -1.34 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -80.89 -54.03 5.95 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.003 -1.685 . . . . 0.0 111.896 175.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -69.63 -67.99 0.44 Allowed 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -167.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.1 t -97.16 104.57 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 120.66 -1.275 . . . . 0.0 107.845 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.9 mp -86.38 -53.03 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 119.664 -1.898 . . . . 0.0 111.159 -165.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.92 160.5 24.94 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.5 p -115.5 148.4 39.53 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.575 1.55 . . . . 0.0 108.522 166.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.264 26.9 mmmt 53.38 83.01 0.07 Allowed 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.42 2.288 . . . . 0.0 115.512 -168.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.2 t -128.43 143.8 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 126.581 1.953 . . . . 0.0 107.153 -164.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.2 148.55 28.76 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.693 1.235 . . . . 0.0 109.613 174.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.12 179.79 41.59 Favored Glycine 0 N--CA 1.429 -1.788 0 O-C-N 120.796 -1.19 . . . . 0.0 111.376 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.9 m -115.26 135.3 54.3 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 124.635 1.174 . . . . 0.0 109.129 -169.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 50.2 t -84.27 124.8 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 120.387 -1.446 . . . . 0.0 109.441 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -97.41 -57.74 2.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.482 -1.386 . . . . 0.0 108.986 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.9 t-105 -144.56 96.42 2.87 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.0 0.92 . . . . 0.0 109.16 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -98.1 129.7 44.91 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.805 -1.184 . . . . 0.0 108.013 167.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -100.18 105.84 17.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.269 -1.519 . . . . 0.0 109.781 -177.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.4 t -77.23 -26.02 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 126.006 1.722 . . . . 0.0 112.144 -173.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -66.06 -45.87 79.79 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.233 -1.542 . . . . 0.0 112.815 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -78.59 -45.9 20.59 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.936 -1.728 . . . . 0.0 110.74 164.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.96 49.23 1.5 Allowed Glycine 0 N--CA 1.43 -1.723 0 CA-C-O 122.948 1.305 . . . . 0.0 110.287 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -155.71 152.6 28.78 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -162.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.32 -151.22 18.73 Favored Glycine 0 N--CA 1.43 -1.709 0 O-C-N 120.125 -1.61 . . . . 0.0 109.82 169.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -140.15 167.03 23.08 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.449 -1.03 . . . . 0.0 110.263 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.536 HG21 ' CE1' ' A' ' 61' ' ' PHE . 4.5 mm -109.63 155.81 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 170.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -92.25 104.93 17.24 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.416 -1.428 . . . . 0.0 109.305 161.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.0 ttt85 -66.22 114.75 5.55 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.548 -1.345 . . . . 0.0 109.573 153.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -64.81 -39.02 92.9 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -167.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -43.82 -52.45 6.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 128.585 2.754 . . . . 0.0 117.126 -169.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -143.22 33.89 1.34 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.862 -1.774 . . . . 0.0 106.565 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 57.38 58.51 3.8 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.57 1.548 . . . . 0.0 115.016 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -102.62 132.01 49.01 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.271 1.429 . . . . 0.0 109.025 -168.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -90.16 106.38 18.44 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 123.525 0.73 . . . . 0.0 110.135 -167.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t -105.53 109.04 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 121.027 -1.046 . . . . 0.0 110.37 -171.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -81.32 133.62 35.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.161 -1.587 . . . . 0.0 114.282 -171.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.1 p -129.7 133.3 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 120.37 -1.456 . . . . 0.0 111.92 -175.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -108.58 148.25 30.6 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.815 1.646 . . . . 0.0 108.66 173.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -58.1 -17.84 20.97 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 119.437 3.125 . . . . 0.0 119.437 -172.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.0 t -81.7 -12.06 58.79 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.386 -1.446 . . . . 0.0 113.268 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.73 -15.73 58.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.868 -2.395 . . . . 0.0 112.028 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.6 mt -82.48 124.41 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 126.062 1.745 . . . . 0.0 110.07 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -74.06 168.48 19.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -171.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -94.46 -50.66 5.11 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.351 -2.093 . . . . 0.0 112.766 -169.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -74.89 148.24 40.31 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 120.528 -1.358 . . . . 0.0 112.892 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -152.87 155.58 32.34 Favored Pre-proline 0 N--CA 1.43 -1.457 0 O-C-N 120.461 -1.4 . . . . 0.0 108.656 174.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.9 -34.81 1.62 Allowed 'Trans proline' 0 N--CA 1.434 -1.99 0 CA-C-N 122.905 2.073 . . . . 0.0 111.592 169.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -163.61 160.52 23.02 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 126.016 1.726 . . . . 0.0 108.642 173.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -155.81 173.08 17.26 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.449 ' HB3' ' H ' ' A' ' 50' ' ' LEU . 38.6 m-85 -86.81 -147.64 0.13 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.458 -1.401 . . . . 0.0 111.454 170.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.449 ' H ' ' HB3' ' A' ' 49' ' ' TYR . 1.2 tm? -75.61 -55.74 5.36 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.93 -1.731 . . . . 0.0 108.278 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 -139.71 -83.21 0.26 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 121.326 -0.859 . . . . 0.0 109.499 160.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.6 p -90.22 174.44 7.6 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -167.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.4 t -106.07 -49.73 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 C-N-CA 126.13 1.772 . . . . 0.0 108.808 -175.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 162.68 -148.22 14.93 Favored Glycine 0 N--CA 1.431 -1.685 0 O-C-N 120.295 -1.503 . . . . 0.0 111.792 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -78.47 126.51 30.86 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.333 -1.686 . . . . 0.0 113.002 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.9 35.72 44.0 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 120.184 -1.573 . . . . 0.0 114.51 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.25 152.56 34.62 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.803 1.287 . . . . 0.0 113.337 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.1 p -94.11 146.09 24.22 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.726 1.611 . . . . 0.0 112.48 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.4 t -139.21 140.79 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -93.54 141.64 28.24 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.382 1.086 . . . . 0.0 111.749 165.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.536 ' CE1' HG21 ' A' ' 25' ' ' ILE . 12.6 p90 -156.06 172.73 17.91 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.873 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -99.07 156.53 16.89 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 162.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.67 89.89 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 119.876 -1.765 . . . . 0.0 107.381 172.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 m -124.85 139.34 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 120.816 -1.177 . . . . 0.0 108.026 -164.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -59.06 128.16 35.84 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.404 -2.06 . . . . 0.0 115.516 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -116.75 -112.33 2.69 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 125.319 1.437 . . . . 0.0 111.09 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -107.82 -89.57 0.45 Allowed 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 124.911 1.285 . . . . 0.0 112.561 -175.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -79.2 10.07 3.95 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 118.922 -2.361 . . . . 0.0 115.122 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.36 -167.09 38.11 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 107.057 -2.417 . . . . 0.0 107.057 -172.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.29 156.22 28.16 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.295 -1.121 . . . . 0.0 113.755 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -124.85 -172.36 2.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.557 1.543 . . . . 0.0 111.252 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.38 140.36 30.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.757 1.265 . . . . 0.0 110.24 -162.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -138.33 149.37 45.56 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.626 -172.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 52.96 50.94 16.86 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.367 2.267 . . . . 0.0 113.839 -176.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.1 t -78.26 124.04 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 120.652 -1.28 . . . . 0.0 111.603 -165.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.0 m -113.52 -122.09 0.29 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.227 -0.921 . . . . 0.0 110.713 -169.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.0 -84.12 0.37 Allowed Glycine 0 N--CA 1.43 -1.7 0 O-C-N 119.85 -1.781 . . . . 0.0 112.544 -170.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.41 161.6 39.85 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 121.804 2.802 . . . . 0.0 113.153 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.823 0 CA-C-O 118.93 -0.928 . . . . 0.0 111.839 -173.478 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 CA--C 1.489 -1.368 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -132.11 -168.3 2.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.275 -1.515 . . . . 0.0 109.027 171.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.264 57.8 mtpt 75.38 -98.9 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.245 1.818 . . . . 0.0 115.494 169.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.443 HG13 HG12 ' A' ' 64' ' ' VAL . 71.7 t -99.72 105.51 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 120.047 -1.658 . . . . 0.0 106.799 167.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -92.75 -54.85 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 119.875 -1.766 . . . . 0.0 110.299 -168.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -160.58 151.9 19.27 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.731 1.253 . . . . 0.0 113.603 -177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.5 p -108.06 150.02 27.69 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.282 1.833 . . . . 0.0 112.562 168.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.258 83.2 mttt 56.95 70.0 0.69 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.215 1.806 . . . . 0.0 114.872 -173.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.2 t -122.47 143.7 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 126.69 1.996 . . . . 0.0 108.732 -163.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.8 mp -128.97 168.69 15.64 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 122.318 1.056 . . . . 0.0 110.832 171.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -165.07 -147.61 5.19 Favored Glycine 0 N--CA 1.431 -1.696 0 O-C-N 120.326 -1.484 . . . . 0.0 110.168 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.3 m -118.51 133.21 56.04 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 172.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.2 t -95.65 126.15 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 120.318 -1.489 . . . . 0.0 110.437 173.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -118.25 -60.2 1.81 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.797 -1.189 . . . . 0.0 110.309 167.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -85.99 109.39 18.75 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.506 -1.371 . . . . 0.0 112.357 -175.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -151.86 129.29 11.36 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.382 -1.449 . . . . 0.0 109.018 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -97.65 107.25 19.71 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.549 1.539 . . . . 0.0 107.61 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.8 t -82.99 -45.5 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 120.319 -1.488 . . . . 0.0 113.747 -155.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -55.11 -61.2 2.47 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.225 1.41 . . . . 0.0 112.041 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -66.14 -44.89 82.88 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 172.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.2 62.15 0.92 Allowed Glycine 0 N--CA 1.429 -1.77 0 O-C-N 121.248 -0.908 . . . . 0.0 113.831 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -149.15 159.63 44.07 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 121.372 -1.075 . . . . 0.0 110.82 173.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.26 -153.71 23.45 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 120.205 -1.56 . . . . 0.0 111.349 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -147.18 151.02 36.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.841 1.305 . . . . 0.0 111.237 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 mt -105.51 159.51 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 120.206 -1.559 . . . . 0.0 108.475 -173.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -117.05 92.22 3.8 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.38 1.562 . . . . 0.0 109.721 167.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -63.48 149.35 46.33 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.427 1.891 . . . . 0.0 113.686 172.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -71.86 -19.65 61.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -76.25 -81.33 0.08 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.505 -1.997 . . . . 0.0 115.627 -163.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 t -114.17 -1.51 13.64 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.096 1.426 . . . . 0.0 108.652 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.3 mptt 77.57 62.29 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.845 3.258 . . . . 0.0 108.251 171.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -102.82 131.65 49.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 112.878 -1.965 . . . . 0.0 107.439 -165.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -85.72 109.46 18.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.967 -1.708 . . . . 0.0 110.854 -164.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.449 ' CG1' ' HB2' ' A' ' 72' ' ' ALA . 48.4 t -105.65 111.26 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.752 1.621 . . . . 0.0 107.39 -169.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -90.78 145.88 24.42 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.744 1.218 . . . . 0.0 111.606 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.34 133.85 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.566 1.65 . . . . 0.0 109.74 -174.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.419 ' CD2' ' H ' ' A' ' 38' ' ' GLN . 19.8 t-80 -119.58 162.5 18.84 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.574 1.55 . . . . 0.0 112.276 -175.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.419 ' H ' ' CD2' ' A' ' 37' ' ' HIS . 41.8 mt-30 -43.26 -55.65 3.9 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 129.301 3.04 . . . . 0.0 117.575 -173.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.6 t -80.96 -9.74 59.8 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.589 -1.319 . . . . 0.0 114.089 -172.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.38 -20.8 46.82 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.687 -1.883 . . . . 0.0 112.695 174.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.4 mt -79.03 124.15 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 126.005 1.722 . . . . 0.0 110.583 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -94.71 133.09 38.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.544 -1.347 . . . . 0.0 112.297 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -145.96 132.88 20.18 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.454 1.102 . . . . 0.0 110.05 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -76.73 -80.39 0.1 Allowed 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.442 1.497 . . . . 0.0 109.575 169.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -106.35 117.96 55.92 Favored Pre-proline 0 N--CA 1.431 -1.419 0 O-C-N 120.727 -1.233 . . . . 0.0 108.046 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.59 89.05 1.31 Allowed 'Trans proline' 0 C--N 1.3 -2.019 0 C-N-CA 123.065 2.51 . . . . 0.0 112.524 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -107.77 174.15 6.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 124.348 1.059 . . . . 0.0 109.927 175.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -61.83 -53.35 57.03 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.544 1.537 . . . . 0.0 115.074 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 66.32 159.74 0.13 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.239 2.616 . . . . 0.0 114.34 -171.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.3 tp -88.84 147.46 24.39 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.706 -1.871 . . . . 0.0 108.881 168.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -85.16 107.53 17.27 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.151 -1.593 . . . . 0.0 110.665 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.6 t -96.26 -55.77 2.84 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.928 1.291 . . . . 0.0 108.73 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.5 m -108.54 154.09 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 122.533 1.158 . . . . 0.0 109.295 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.1 -70.23 0.03 OUTLIER Glycine 0 N--CA 1.429 -1.784 0 O-C-N 119.887 -1.758 . . . . 0.0 111.351 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -74.04 107.1 6.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.599 -1.53 . . . . 0.0 110.522 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.08 39.75 31.6 Favored Glycine 0 N--CA 1.431 -1.684 0 O-C-N 120.582 -1.323 . . . . 0.0 114.513 -170.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.1 156.76 28.17 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 120.696 -1.473 . . . . 0.0 114.898 -175.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.43 148.1 31.7 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.705 2.002 . . . . 0.0 111.022 -175.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.8 p -155.15 145.36 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.325 1.85 . . . . 0.0 106.56 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -91.8 144.46 25.47 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 120.315 1.416 . . . . 0.0 111.88 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -151.08 169.85 20.83 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.899 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -112.94 133.17 55.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 168.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.4 t -89.32 87.12 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 120.353 -1.467 . . . . 0.0 109.585 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.443 HG12 HG13 ' A' ' 4' ' ' VAL . 2.1 m -130.06 107.35 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 120.282 -1.511 . . . . 0.0 109.396 -168.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -139.95 -111.29 0.15 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.61 -1.306 . . . . 0.0 109.456 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 137.28 -55.15 0.7 Allowed Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 114.059 0.384 . . . . 0.0 114.059 -169.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -101.75 -69.78 0.77 Allowed 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.324 -1.103 . . . . 0.0 112.624 -172.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -87.09 57.28 4.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.392 -1.443 . . . . 0.0 114.6 -170.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.43 -117.29 4.49 Favored Glycine 0 N--CA 1.43 -1.719 0 O-C-N 119.43 -2.044 . . . . 0.0 110.642 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.46 169.65 13.42 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 122.899 1.333 . . . . 0.0 112.951 169.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.497 ' HG3' ' H ' ' A' ' 72' ' ' ALA . 6.2 tt0 -145.84 178.8 7.9 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.405 2.282 . . . . 0.0 105.169 -176.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.497 ' H ' ' HG3' ' A' ' 71' ' ' GLU . . . -147.14 125.36 12.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.973 2.109 . . . . 0.0 107.061 -173.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.76 160.18 33.33 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 124.378 1.071 . . . . 0.0 108.296 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 60.1 45.76 11.45 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.936 2.094 . . . . 0.0 112.952 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.6 t -87.59 104.16 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-O 122.108 0.956 . . . . 0.0 111.806 -162.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.83 148.65 50.22 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.003 0.921 . . . . 0.0 109.51 -169.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -136.87 -172.81 12.66 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 120.212 -1.555 . . . . 0.0 111.968 -176.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.36 160.01 29.23 Favored 'Trans proline' 0 N--CA 1.434 -1.99 0 C-N-CA 123.081 2.521 . . . . 0.0 113.522 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.795 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 178.655 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ttt . . . . . 0 CA--C 1.489 -1.371 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.7 ptmm? -78.08 -29.24 49.01 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.223 -1.548 . . . . 0.0 112.549 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -78.25 150.12 33.48 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.334 -1.479 . . . . 0.0 111.934 169.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.653 HG12 ' H ' ' A' ' 65' ' ' GLU . 9.4 m -123.28 165.8 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 121.048 -1.032 . . . . 0.0 110.179 -176.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.41 HD13 HG11 ' A' ' 63' ' ' VAL . 4.2 mp -87.64 -65.34 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 119.468 -2.02 . . . . 0.0 111.082 -174.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.32 161.46 24.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.9 p -110.66 143.13 41.59 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.36 1.464 . . . . 0.0 110.22 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.27 92.2 mttt 60.95 73.15 0.49 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.225 2.21 . . . . 0.0 115.446 -170.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.7 t -126.11 159.22 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 129.557 3.143 . . . . 0.0 107.564 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.8 170.55 12.64 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.128 -1.608 . . . . 0.0 111.662 170.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.76 -170.26 34.0 Favored Glycine 0 N--CA 1.43 -1.725 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.7 m -116.98 127.89 54.64 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.821 1.296 . . . . 0.0 109.874 -166.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 t -91.85 147.32 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 127.015 2.126 . . . . 0.0 110.437 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -105.37 -86.95 0.46 Allowed 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.055 -1.653 . . . . 0.0 109.78 164.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 22.6 t-105 -155.1 140.29 17.54 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.725 -1.234 . . . . 0.0 108.317 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -97.77 155.84 16.85 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.791 -1.193 . . . . 0.0 113.614 -175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -95.22 93.39 7.28 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.53 -1.356 . . . . 0.0 109.04 174.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.9 m -73.32 -30.64 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -172.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -56.49 -65.08 0.67 Allowed 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 125.312 1.445 . . . . 0.0 112.37 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -72.01 -35.17 69.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.546 -1.971 . . . . 0.0 113.174 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.84 51.61 1.63 Allowed Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -129.93 140.43 50.94 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 121.325 -1.103 . . . . 0.0 108.405 -170.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.05 161.15 32.98 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.503 -1.373 . . . . 0.0 111.147 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -142.09 157.84 44.44 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.946 -0.738 . . . . 0.0 109.464 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.3 mm -109.24 147.34 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 124.907 1.283 . . . . 0.0 108.634 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -92.93 93.89 8.62 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.907 -1.121 . . . . 0.0 109.037 169.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.19 133.56 37.75 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 174.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -82.54 48.0 1.25 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -171.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.95 -68.45 0.7 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.692 -1.88 . . . . 0.0 109.474 163.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -150.34 35.33 0.64 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 57.87 75.99 0.35 Allowed 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 127.234 2.214 . . . . 0.0 112.856 -159.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -103.06 128.35 49.96 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.561 -1.962 . . . . 0.0 106.675 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -82.11 122.14 27.47 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.651 1.691 . . . . 0.0 110.252 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.07 108.38 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 O-C-N 120.568 -1.333 . . . . 0.0 108.407 -173.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -76.06 140.05 41.72 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.76 -1.213 . . . . 0.0 113.661 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.8 t -128.44 126.2 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.766 -1.209 . . . . 0.0 108.416 -177.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -111.92 165.6 11.95 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.01 1.324 . . . . 0.0 110.592 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.1 mm100 -59.58 -36.98 77.32 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 m -69.86 -14.63 62.84 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.727 -1.858 . . . . 0.0 113.433 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.19 -25.4 58.22 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.536 -2.602 . . . . 0.0 114.909 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 89.1 mt -79.44 126.02 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 125.741 1.616 . . . . 0.0 111.597 -175.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -73.43 -74.91 0.16 Allowed 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 120.615 -1.303 . . . . 0.0 112.678 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -91.59 128.47 37.43 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 121.059 -1.025 . . . . 0.0 110.813 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -90.13 138.2 31.71 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.598 -1.314 . . . . 0.0 112.277 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -108.9 158.33 34.48 Favored Pre-proline 0 N--CA 1.431 -1.397 0 C-N-CA 125.625 1.57 . . . . 0.0 114.076 -163.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -83.18 -170.88 0.98 Allowed 'Trans proline' 0 C--N 1.3 -2.026 0 C-N-CA 122.59 2.193 . . . . 0.0 112.616 170.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -106.99 134.16 50.56 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 161.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -123.4 136.34 54.58 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -97.93 56.82 1.26 Allowed 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.505 -1.372 . . . . 0.0 110.899 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.4 tp -105.34 149.61 25.92 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.321 -1.487 . . . . 0.0 109.517 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -101.49 79.79 2.0 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.882 -1.762 . . . . 0.0 110.359 173.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.3 p -107.02 -85.57 0.51 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.82 1.248 . . . . 0.0 110.399 -172.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 m -108.42 -106.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 126.434 1.894 . . . . 0.0 111.983 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.58 -114.59 4.29 Favored Glycine 0 N--CA 1.43 -1.7 0 C-N-CA 124.926 1.25 . . . . 0.0 110.76 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -71.04 111.39 6.37 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.977 1.311 . . . . 0.0 109.753 174.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.75 -20.5 5.15 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 121.176 -0.952 . . . . 0.0 114.361 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.71 155.16 38.0 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.107 -1.819 . . . . 0.0 115.104 -174.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.72 143.31 39.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.719 2.008 . . . . 0.0 110.734 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.06 146.86 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -92.85 144.44 25.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -158.44 170.76 21.48 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.321 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -94.78 141.6 28.44 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.834 -1.791 . . . . 0.0 107.845 168.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.41 HG11 HD13 ' A' ' 5' ' ' ILE . 42.8 t -95.51 106.38 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 O-C-N 119.197 -2.19 . . . . 0.0 108.806 171.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.65 136.72 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 120.879 -1.138 . . . . 0.0 108.06 -170.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.653 ' H ' HG12 ' A' ' 4' ' ' VAL . 23.4 tt0 -120.64 166.33 13.83 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.631 -1.918 . . . . 0.0 111.407 -166.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.54 -44.68 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.892 -1.13 . . . . 0.0 111.791 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -123.67 -145.47 0.34 Allowed 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 124.682 1.193 . . . . 0.0 113.322 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -74.37 -18.85 60.62 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.88 -1.762 . . . . 0.0 114.476 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.99 139.07 8.7 Favored Glycine 0 N--CA 1.429 -1.79 0 O-C-N 120.413 -1.429 . . . . 0.0 109.551 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.22 164.32 22.38 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -172.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -120.53 -168.04 1.57 Allowed 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.872 2.069 . . . . 0.0 111.222 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.11 155.86 43.57 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -169.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -152.51 161.91 41.93 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -174.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 56.13 51.01 12.48 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 125.138 1.375 . . . . 0.0 114.522 170.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.1 t -95.07 108.5 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 124.569 1.148 . . . . 0.0 109.14 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.7 m -83.03 -82.85 0.14 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.301 -1.499 . . . . 0.0 111.729 -176.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.43 101.39 0.45 Allowed Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 126.248 1.88 . . . . 0.0 112.979 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.87 158.89 45.93 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 CA-C-N 123.985 3.893 . . . . 0.0 113.55 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.802 0 C-N-CA 124.37 0.986 . . . . 0.0 112.406 -179.513 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptm . . . . . 0 CA--C 1.489 -1.386 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.251 20.1 tptm 60.83 -72.2 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 118.129 2.64 . . . . 0.0 118.129 175.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.531 ' HA ' HG12 ' A' ' 64' ' ' VAL 0.269 90.9 mttt 76.79 88.27 0.08 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.979 2.112 . . . . 0.0 114.642 174.52 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.4 t -113.97 -72.54 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 121.02 -1.05 . . . . 0.0 113.574 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.464 HD13 HG12 ' A' ' 63' ' ' VAL . 3.4 mp -84.56 -69.6 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 119.35 -2.094 . . . . 0.0 107.505 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -149.67 153.78 37.54 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -171.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.9 p -110.59 149.31 30.59 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.29 2.236 . . . . 0.0 110.508 170.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.267 87.7 mttt 53.44 67.81 0.94 Allowed 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.567 1.692 . . . . 0.0 115.567 -172.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.8 t -120.39 142.73 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 127.742 2.417 . . . . 0.0 109.123 -163.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.19 149.43 24.67 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.678 1.228 . . . . 0.0 112.051 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.23 171.44 44.46 Favored Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.6 m -112.3 136.93 51.14 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.115 0.966 . . . . 0.0 110.876 -163.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.5 t -103.39 122.86 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 124.527 1.131 . . . . 0.0 108.53 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -154.53 99.74 2.2 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.144 -1.597 . . . . 0.0 109.195 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . 0.312 37.2 m95 77.83 154.11 0.14 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.908 2.083 . . . . 0.0 113.956 -170.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.81 -167.79 2.1 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.775 -1.203 . . . . 0.0 111.286 -165.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -127.41 64.1 1.34 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.442 -1.411 . . . . 0.0 109.781 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 m -67.57 -23.8 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 126.929 2.091 . . . . 0.0 115.704 -174.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -58.89 -48.77 80.26 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.438 -2.039 . . . . 0.0 114.393 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -93.25 -37.4 12.08 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.681 -1.262 . . . . 0.0 111.317 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.93 57.12 0.43 Allowed Glycine 0 N--CA 1.43 -1.709 0 O-C-N 120.064 -1.647 . . . . 0.0 113.162 173.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -139.43 166.89 23.36 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 124.522 1.129 . . . . 0.0 108.09 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -127.81 161.34 21.79 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 120.929 -1.107 . . . . 0.0 110.971 174.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -140.78 146.57 37.83 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 121.257 -1.143 . . . . 0.0 109.376 170.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mt -108.81 147.8 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 125.747 1.619 . . . . 0.0 108.427 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -101.73 95.2 6.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.096 0.95 . . . . 0.0 109.442 169.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -69.04 128.88 38.25 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.275 14.9 p30 -74.57 107.16 6.52 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -176.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -166.97 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.234 1.414 . . . . 0.0 108.224 173.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.0 t -139.84 43.14 1.96 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 102.725 -3.065 . . . . 0.0 102.725 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.6 mptt 51.12 73.39 0.3 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.177 2.191 . . . . 0.0 114.101 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -103.05 133.59 47.91 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.814 -1.804 . . . . 0.0 110.056 -169.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.89 114.28 26.8 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 123.761 0.824 . . . . 0.0 110.22 -164.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.5 t -114.04 113.2 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -173.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . 0.264 0.1 OUTLIER -85.81 145.26 27.3 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.054 -1.654 . . . . 0.0 112.296 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.3 p -137.45 142.82 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 122.449 1.119 . . . . 0.0 110.759 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -98.79 140.99 32.16 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.39 1.876 . . . . 0.0 108.558 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -56.42 -36.84 69.41 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -171.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 t -66.8 -18.01 65.16 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.43 -21.4 38.9 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.406 -2.059 . . . . 0.0 112.347 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.1 mt -83.75 145.48 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 125.653 1.581 . . . . 0.0 108.497 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.68 143.95 4.76 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -157.27 168.19 28.11 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.596 -1.315 . . . . 0.0 110.833 -165.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.4 m120 69.53 -49.13 0.61 Allowed 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 127.696 2.399 . . . . 0.0 116.025 175.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -75.68 109.71 8.71 Favored Pre-proline 0 N--CA 1.431 -1.41 0 O-C-N 120.427 -1.42 . . . . 0.0 110.858 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.37 164.8 26.14 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-N 122.65 1.982 . . . . 0.0 111.884 -171.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -121.52 93.33 3.97 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.149 0.976 . . . . 0.0 108.896 173.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -92.85 70.49 4.72 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.192 1.397 . . . . 0.0 113.793 -162.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -108.49 -171.62 1.89 Allowed 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 120.055 -1.653 . . . . 0.0 108.056 169.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.4 mt -82.16 -86.83 0.1 Allowed 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.97 -1.706 . . . . 0.0 109.068 167.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -91.12 136.44 33.08 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.06 -1.65 . . . . 0.0 113.513 -176.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.4 t -133.22 -169.38 2.26 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 124.692 1.197 . . . . 0.0 109.706 168.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.8 m -119.12 169.99 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 127.118 2.167 . . . . 0.0 110.41 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.26 -58.63 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.74 0 O-C-N 119.757 -1.839 . . . . 0.0 113.32 177.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -72.36 90.69 1.29 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.315 1.446 . . . . 0.0 110.261 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.04 12.84 17.11 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.189 -1.569 . . . . 0.0 113.616 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -77.51 158.32 29.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.249 -1.736 . . . . 0.0 115.397 171.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.81 148.47 24.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 121.013 -1.054 . . . . 0.0 109.407 175.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 m -138.37 157.74 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 125.573 1.549 . . . . 0.0 109.473 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -102.08 142.58 33.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.061 1.344 . . . . 0.0 111.634 171.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -161.35 -176.45 5.39 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 124.072 0.949 . . . . 0.0 110.704 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -113.67 148.17 36.82 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 120.559 -1.338 . . . . 0.0 108.106 168.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.464 HG12 HD13 ' A' ' 5' ' ' ILE . 42.8 t -100.89 85.54 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 119.361 -2.087 . . . . 0.0 109.846 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' A' ' 3' ' ' LYS . 3.7 m -136.12 85.56 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.484 -2.635 . . . . 0.0 115.406 -157.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -144.26 -77.82 0.21 Allowed 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.844 -2.41 . . . . 0.0 112.564 170.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.71 -49.19 0.87 Allowed Glycine 0 N--CA 1.431 -1.694 0 O-C-N 120.979 -1.075 . . . . 0.0 114.476 175.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -68.25 -54.82 15.02 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.457 -1.613 . . . . 0.0 113.67 -169.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -92.18 -59.17 2.16 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.451 -1.406 . . . . 0.0 109.673 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.13 -103.79 0.19 Allowed Glycine 0 N--CA 1.43 -1.715 0 O-C-N 120.527 -1.358 . . . . 0.0 110.528 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.93 149.83 50.63 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.967 -1.314 . . . . 0.0 113.275 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.9 -177.89 4.48 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 124.745 1.218 . . . . 0.0 108.994 161.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.09 154.08 44.64 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 121.947 0.879 . . . . 0.0 111.274 -168.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.37 143.8 32.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.423 1.089 . . . . 0.0 109.482 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 53.43 59.66 4.22 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.102 2.561 . . . . 0.0 115.21 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.6 t -92.17 127.81 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 120.959 -1.088 . . . . 0.0 111.752 -164.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.1 t -155.07 -179.39 8.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.412 1.101 . . . . 0.0 110.508 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -86.63 147.93 21.57 Favored Glycine 0 N--CA 1.43 -1.734 0 CA-C-O 117.246 -1.863 . . . . 0.0 112.02 -176.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -66.87 148.22 81.96 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 CA-C-N 123.328 3.564 . . . . 0.0 116.094 -172.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.801 0 CA-C-O 118.635 -1.092 . . . . 0.0 110.701 179.007 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.1 ttm . . . . . 0 CA--C 1.489 -1.371 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -107.77 168.74 9.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.345 -1.472 . . . . 0.0 110.032 158.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -48.45 103.29 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 129.494 3.117 . . . . 0.0 117.705 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.574 HG13 HG12 ' A' ' 64' ' ' VAL . 61.8 t 61.9 103.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 127.373 2.269 . . . . 0.0 113.784 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.563 HG21 HH12 ' A' ' 27' ' ' ARG . 4.2 mp -90.43 -50.55 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 119.762 -1.836 . . . . 0.0 111.051 -171.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.31 165.89 14.91 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.658 0.742 . . . . 0.0 112.492 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.1 p -107.79 159.71 16.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.203 1.801 . . . . 0.0 109.17 165.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.4 tptt 48.53 65.76 1.26 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -175.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 88.7 t -112.04 151.22 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 128.096 2.558 . . . . 0.0 108.158 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -108.78 156.88 19.11 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.862 1.792 . . . . 0.0 110.247 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.09 179.25 41.9 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 120.172 -1.58 . . . . 0.0 109.628 173.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 m -113.7 130.93 56.34 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.708 0.803 . . . . 0.0 110.335 -169.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.0 t -98.06 122.56 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 125.766 1.627 . . . . 0.0 110.986 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -110.95 -59.54 1.95 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.063 -1.648 . . . . 0.0 110.612 174.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.9 t90 -69.83 -79.29 0.06 Allowed 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.569 1.548 . . . . 0.0 114.798 -166.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.8 t80 75.1 114.69 0.06 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.718 2.407 . . . . 0.0 113.249 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.429 HD21 ' HB3' ' A' ' 20' ' ' ASN . 64.4 t-20 -110.99 124.64 52.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.064 -1.648 . . . . 0.0 109.822 -175.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.1 t -107.96 -47.58 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 120.684 -1.26 . . . . 0.0 110.769 171.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -63.77 -30.79 71.85 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -167.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.429 ' HB3' HD21 ' A' ' 17' ' ' ASN . 59.6 t30 -107.53 -25.29 11.44 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 121.345 -0.847 . . . . 0.0 111.851 166.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.56 -43.69 1.62 Allowed Glycine 0 N--CA 1.43 -1.709 0 O-C-N 118.983 -2.323 . . . . 0.0 114.236 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -75.71 105.72 6.9 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 124.792 1.237 . . . . 0.0 112.8 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.13 175.45 21.3 Favored Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 124.84 1.209 . . . . 0.0 111.325 -176.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -143.26 145.57 32.86 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 123.021 1.391 . . . . 0.0 113.433 171.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.2 mt -107.75 147.79 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 125.054 1.342 . . . . 0.0 108.964 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -93.92 87.85 5.52 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 122.674 1.226 . . . . 0.0 108.951 173.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.563 HH12 HG21 ' A' ' 5' ' ' ILE . 2.3 tmt_? -66.52 112.82 4.3 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.925 -1.734 . . . . 0.0 114.522 172.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -85.41 25.78 0.99 Allowed 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 117.43 2.382 . . . . 0.0 117.43 -160.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -73.37 -51.14 18.45 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.46 -1.4 . . . . 0.0 111.416 170.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.3 t -146.4 24.59 1.26 Allowed 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.09 76.37 0.29 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 127.516 2.327 . . . . 0.0 111.153 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -109.85 133.15 53.48 Favored 'General case' 0 N--CA 1.428 -1.525 0 O-C-N 120.555 -1.34 . . . . 0.0 109.383 -176.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -81.87 110.82 17.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.493 1.616 . . . . 0.0 110.021 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.46 112.78 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.71 -1.244 . . . . 0.0 108.224 -171.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -85.18 129.28 34.83 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -172.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.4 t -127.41 123.19 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 124.994 1.318 . . . . 0.0 110.451 -168.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -93.12 160.79 14.69 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.183 -0.948 . . . . 0.0 112.001 171.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -60.41 -29.32 68.9 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.0 m -61.89 -33.37 74.09 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 125.843 1.657 . . . . 0.0 113.475 175.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.41 -17.17 60.84 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.193 -1.567 . . . . 0.0 114.294 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 72.7 mt -88.25 112.49 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 125.24 1.416 . . . . 0.0 110.261 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -126.16 142.97 51.31 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 124.741 1.216 . . . . 0.0 110.983 176.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -144.9 127.72 16.33 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.55 -1.344 . . . . 0.0 110.817 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -89.76 -44.84 9.71 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 121.095 -1.003 . . . . 0.0 112.96 176.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -100.56 108.77 54.92 Favored Pre-proline 0 N--CA 1.43 -1.426 0 O-C-N 120.421 -1.424 . . . . 0.0 112.783 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.16 127.31 14.88 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 CA-C-N 124.051 2.483 . . . . 0.0 111.198 159.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -100.54 156.11 17.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.855 1.662 . . . . 0.0 110.962 -165.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -72.16 123.01 21.99 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.366 -2.084 . . . . 0.0 116.192 -167.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . 0.27 4.8 t80 75.85 166.81 0.27 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.751 2.82 . . . . 0.0 113.81 174.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.11 139.94 30.06 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 119.68 -1.887 . . . . 0.0 111.097 177.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.268 41.7 mtm105 71.4 112.76 0.06 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.257 1.823 . . . . 0.0 114.614 -174.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.4 t -81.23 -70.37 0.54 Allowed 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.35 -1.469 . . . . 0.0 110.792 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 83.5 t -110.63 -53.01 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 O-C-N 120.457 -1.402 . . . . 0.0 108.303 168.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 166.81 -124.65 1.24 Allowed Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -108.48 158.8 17.21 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 166.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.46 8.3 49.83 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 120.079 -1.638 . . . . 0.0 114.518 -177.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -75.71 166.5 23.46 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.334 1.454 . . . . 0.0 114.551 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.98 148.85 22.21 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.43 1.892 . . . . 0.0 112.776 175.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 p -147.2 153.14 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 126.995 2.118 . . . . 0.0 106.05 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -104.3 147.86 27.02 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 120.104 1.32 . . . . 0.0 110.707 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -159.78 169.67 23.13 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.256 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -97.28 147.47 24.11 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.051 -1.656 . . . . 0.0 107.202 170.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.0 t -106.86 95.71 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 O-C-N 119.204 -2.185 . . . . 0.0 109.323 175.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.574 HG12 HG13 ' A' ' 4' ' ' VAL . 0.9 OUTLIER -129.62 100.89 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 120.444 -1.41 . . . . 0.0 110.488 -162.15 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -160.25 -122.5 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.232 -1.542 . . . . 0.0 112.699 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.25 -145.48 4.14 Favored Glycine 0 N--CA 1.43 -1.723 0 C-N-CA 127.307 2.384 . . . . 0.0 110.036 -162.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -94.98 -34.87 12.2 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.72 -1.459 . . . . 0.0 114.208 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -66.08 -37.73 86.52 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.81 -1.182 . . . . 0.0 114.033 -167.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -162.81 -156.35 8.49 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 174.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.01 158.56 39.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.028 -1.278 . . . . 0.0 111.778 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -138.47 172.82 12.33 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 127.489 2.316 . . . . 0.0 106.374 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.03 154.63 42.72 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.702 -1.874 . . . . 0.0 107.762 -168.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -149.89 162.67 39.86 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 55.23 54.47 8.7 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.261 1.824 . . . . 0.0 113.563 173.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.3 t -87.69 127.49 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.796 -1.19 . . . . 0.0 110.353 -170.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.0 p -94.44 -176.28 3.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.987 1.375 . . . . 0.0 114.05 -168.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -150.72 75.33 0.25 Allowed Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 171.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.08 162.58 31.63 Favored 'Trans proline' 0 N--CA 1.433 -2.075 0 C-N-CA 122.52 2.147 . . . . 0.0 112.861 -170.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.796 0 CA-C-O 117.951 -1.472 . . . . 0.0 110.635 179.358 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptm . . . . . 0 CA--C 1.489 -1.385 0 N-CA-C 120.188 3.403 . . . . 0.0 120.188 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -72.36 -51.18 21.73 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.312 -2.118 . . . . 0.0 114.288 -168.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -79.14 -97.16 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.435 -1.416 . . . . 0.0 112.087 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.43 HG13 HG12 ' A' ' 64' ' ' VAL . 78.0 t 65.61 117.15 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 126.364 1.866 . . . . 0.0 115.498 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.3 mp -90.91 -57.46 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 119.633 -1.917 . . . . 0.0 110.392 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.49 160.74 26.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -168.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.8 p -106.58 157.59 17.57 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.592 2.757 . . . . 0.0 112.093 163.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.8 mttp 57.79 57.76 4.03 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.128 2.171 . . . . 0.0 114.602 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 t -115.97 152.19 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 C-N-CA 128.72 2.808 . . . . 0.0 107.741 -169.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -128.11 164.79 21.67 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 123.696 1.712 . . . . 0.0 114.15 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' A' ' 27' ' ' ARG . . . -168.79 -173.86 36.92 Favored Glycine 0 N--CA 1.431 -1.685 0 O-C-N 121.018 -1.051 . . . . 0.0 110.57 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.7 m -115.98 129.55 56.43 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.463 1.601 . . . . 0.0 108.365 -172.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.3 p -87.19 147.51 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 120.567 -1.333 . . . . 0.0 112.474 -177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.8 mmtt -102.47 -99.14 0.28 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 162.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -147.29 -170.82 3.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 172.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -124.58 166.61 15.78 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 126.157 1.783 . . . . 0.0 108.305 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -87.9 91.37 8.74 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 162.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.9 m -68.12 -31.0 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 126.965 2.106 . . . . 0.0 113.794 -171.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -62.04 -43.58 98.53 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 124.622 1.169 . . . . 0.0 112.68 -175.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -92.01 -36.53 13.34 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 119.144 -2.223 . . . . 0.0 113.603 166.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.57 34.64 3.03 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 121.521 -0.737 . . . . 0.0 114.198 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -123.65 162.61 22.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.783 -1.422 . . . . 0.0 110.411 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.42 171.67 36.78 Favored Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 169.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -118.23 155.6 30.25 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 118.146 0.973 . . . . 0.0 112.077 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.8 mm -104.47 155.87 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 169.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -110.81 96.67 6.31 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 119.637 1.108 . . . . 0.0 110.589 168.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.422 ' HA ' ' HA3' ' A' ' 11' ' ' GLY . 44.0 ttt180 -36.12 147.65 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 131.158 3.783 . . . . 0.0 117.446 164.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -66.0 -7.03 14.76 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.818 2.525 . . . . 0.0 117.818 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -82.94 -78.51 0.21 Allowed 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.875 -1.765 . . . . 0.0 112.502 -171.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 t -120.55 10.52 11.12 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 121.857 2.117 . . . . 0.0 107.244 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.2 mptt 60.09 67.53 0.85 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.714 2.406 . . . . 0.0 112.049 -174.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -107.73 159.4 16.51 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.064 -1.023 . . . . 0.0 109.452 -168.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -84.71 95.11 8.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 124.44 1.096 . . . . 0.0 112.643 -172.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.8 t -109.85 110.6 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -85.16 148.7 25.98 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 120.473 -1.392 . . . . 0.0 113.574 -168.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.442 HG22 ' HB3' ' A' ' 72' ' ' ALA . 81.8 t -136.68 133.59 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 125.097 1.359 . . . . 0.0 109.138 -171.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -114.47 165.2 12.99 Favored 'General case' 0 N--CA 1.432 -1.366 0 C-N-CA 125.247 1.419 . . . . 0.0 111.057 172.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -63.51 -36.52 84.04 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -169.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.0 m -74.99 -19.81 59.93 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.958 1.303 . . . . 0.0 112.107 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.26 -26.59 60.31 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.519 -1.988 . . . . 0.0 112.79 173.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.0 mt -76.45 114.65 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.702 1.601 . . . . 0.0 109.713 170.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -108.34 132.91 53.24 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.778 -1.201 . . . . 0.0 109.353 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -85.59 90.26 7.94 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.797 -1.189 . . . . 0.0 110.894 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -88.01 -60.85 1.85 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.915 -1.116 . . . . 0.0 108.824 177.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -118.53 68.58 7.92 Favored Pre-proline 0 N--CA 1.43 -1.445 0 C-N-CA 124.656 1.182 . . . . 0.0 112.956 -177.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.0 104.32 1.88 Allowed 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 123.869 2.418 . . . . 0.0 113.427 -177.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.8 mmm-85 -107.72 154.0 22.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.554 1.169 . . . . 0.0 112.897 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -92.5 -93.38 0.15 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 124.984 1.314 . . . . 0.0 111.078 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.1 t80 60.04 52.34 5.22 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.647 2.379 . . . . 0.0 115.369 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.5 tp 74.2 -60.51 0.52 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.46 2.304 . . . . 0.0 114.477 177.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -134.72 146.95 49.92 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.358 1.463 . . . . 0.0 108.924 175.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.3 m -88.76 -63.53 1.28 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.077 1.751 . . . . 0.0 107.473 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.4 m -105.85 -177.74 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 C-N-CA 124.889 1.275 . . . . 0.0 111.646 -170.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 148.59 124.61 1.4 Allowed Glycine 0 N--CA 1.431 -1.657 0 O-C-N 120.64 -1.287 . . . . 0.0 109.953 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.0 t70 66.71 -137.98 0.14 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.825 1.25 . . . . 0.0 109.907 -169.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.79 87.17 0.47 Allowed Glycine 0 N--CA 1.43 -1.753 0 O-C-N 120.814 -1.179 . . . . 0.0 112.43 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -64.17 169.58 4.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.094 -1.827 . . . . 0.0 114.545 171.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.12 136.75 36.16 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 122.207 1.003 . . . . 0.0 110.814 172.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.3 m -123.06 151.01 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -100.14 152.61 20.06 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 121.169 -0.957 . . . . 0.0 110.254 171.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -161.21 -179.31 7.34 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.844 0.83 . . . . 0.0 110.358 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -105.06 154.48 20.09 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 164.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 64.0 t -112.61 90.3 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 119.675 -1.891 . . . . 0.0 106.632 174.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.43 HG12 HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -115.81 87.69 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 124.217 1.961 . . . . 0.0 107.174 -165.081 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -85.56 124.59 32.28 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.584 -1.322 . . . . 0.0 113.738 -171.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -124.16 -41.94 0.38 Allowed Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 125.239 1.4 . . . . 0.0 112.797 173.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -89.45 -136.23 0.11 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.322 1.449 . . . . 0.0 111.826 -172.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -85.06 -13.82 49.21 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 126.523 1.929 . . . . 0.0 112.245 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -166.46 167.61 39.58 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 105.574 -3.011 . . . . 0.0 105.574 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.67 165.41 15.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -162.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -115.84 -174.83 2.6 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.037 -1.04 . . . . 0.0 111.221 164.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.442 ' HB3' HG22 ' A' ' 36' ' ' VAL . . . -144.93 144.95 31.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.543 1.164 . . . . 0.0 108.687 -169.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.74 160.68 38.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 55.85 48.62 17.72 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.011 1.724 . . . . 0.0 114.309 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.1 t -88.05 138.79 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 124.332 1.053 . . . . 0.0 111.026 -165.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.0 p -109.14 -158.53 0.65 Allowed 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 124.18 1.943 . . . . 0.0 113.011 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 168.62 -173.99 43.28 Favored Glycine 0 N--CA 1.429 -1.781 0 O-C-N 119.559 -1.963 . . . . 0.0 109.68 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.76 -32.14 6.04 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 123.402 2.735 . . . . 0.0 111.857 168.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.748 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.002 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.9 mtp . . . . . 0 CA--C 1.489 -1.368 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 58.7 mttm 62.82 46.05 5.31 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -145.78 -28.65 0.43 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.988 -1.07 . . . . 0.0 113.693 -175.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.26 141.22 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.824 -1.798 . . . . 0.0 110.986 -160.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.463 HD13 HG12 ' A' ' 63' ' ' VAL . 4.8 mp -97.56 -50.24 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 O-C-N 119.629 -1.92 . . . . 0.0 106.436 165.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -158.3 161.49 37.68 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 123.356 0.662 . . . . 0.0 111.408 171.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.5 p -120.87 149.42 42.62 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.586 -1.321 . . . . 0.0 110.597 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.265 54.9 mttp 59.06 73.12 0.49 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.185 2.194 . . . . 0.0 113.866 -171.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.49 149.71 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 126.892 2.077 . . . . 0.0 109.2 -163.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -109.05 159.63 16.69 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 123.787 1.756 . . . . 0.0 112.798 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.73 -178.36 44.55 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.4 m -117.14 129.51 56.01 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -172.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.6 t -72.23 135.87 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 120.796 -1.19 . . . . 0.0 111.435 -175.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -95.14 -100.69 0.16 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.347 -1.47 . . . . 0.0 110.202 173.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -130.16 157.17 43.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.871 -1.768 . . . . 0.0 111.37 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -104.03 142.09 35.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.51 1.524 . . . . 0.0 109.921 172.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -118.15 100.54 7.59 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.945 1.698 . . . . 0.0 109.058 -175.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.17 -29.81 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 120.645 -1.284 . . . . 0.0 113.409 -158.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -58.39 -59.8 4.78 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.83 -1.794 . . . . 0.0 113.34 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -78.48 -37.79 42.48 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.763 -1.211 . . . . 0.0 113.223 174.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.93 53.45 0.8 Allowed Glycine 0 N--CA 1.43 -1.735 0 CA-C-N 119.768 1.167 . . . . 0.0 114.17 175.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -125.32 175.02 7.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.723 -0.869 . . . . 0.0 110.253 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.9 176.28 35.77 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 107.64 -2.184 . . . . 0.0 107.64 163.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -149.86 153.76 37.26 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 122.699 1.238 . . . . 0.0 112.949 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.412 HD11 HG21 ' A' ' 36' ' ' VAL . 1.7 mt -124.28 147.33 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 125.634 1.574 . . . . 0.0 109.324 -172.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -99.29 93.81 6.13 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 168.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -67.03 130.51 43.37 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -82.66 68.04 8.96 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.221 1.409 . . . . 0.0 114.631 -167.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -132.42 -72.57 0.52 Allowed 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 120.427 -1.42 . . . . 0.0 109.253 170.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.0 t -131.91 38.63 3.52 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.4 mptt 57.83 69.71 0.71 Allowed 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.981 1.712 . . . . 0.0 114.227 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -103.02 141.94 34.95 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.515 -1.99 . . . . 0.0 109.623 -166.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -93.85 104.71 16.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -162.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.1 t -108.95 116.5 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.69 -1.256 . . . . 0.0 109.119 -167.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -81.12 134.47 35.65 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 125.111 1.364 . . . . 0.0 112.743 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 25' ' ' ILE . 43.1 t -126.42 123.1 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 120.438 -1.414 . . . . 0.0 111.013 -175.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -100.63 170.11 8.59 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.351 1.46 . . . . 0.0 112.305 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -68.85 -22.41 64.22 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.6 -1.938 . . . . 0.0 114.892 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.5 p -71.11 -25.15 62.47 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.74 2.016 . . . . 0.0 113.392 175.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.39 -32.33 29.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.611 -1.306 . . . . 0.0 113.195 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.83 139.82 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 C-N-CA 126.481 1.912 . . . . 0.0 113.275 -175.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -49.85 -51.86 37.03 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 119.04 2.978 . . . . 0.0 119.04 -173.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -139.12 141.07 38.1 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.275 -1.516 . . . . 0.0 108.652 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -124.82 143.13 50.98 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 121.292 -0.88 . . . . 0.0 110.724 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -107.28 115.43 59.75 Favored Pre-proline 0 N--CA 1.431 -1.404 0 C-N-CA 124.98 1.312 . . . . 0.0 110.357 -173.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -66.9 -41.37 10.4 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 C-N-CA 123.451 2.768 . . . . 0.0 114.289 171.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -107.54 -81.25 0.56 Allowed 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 118.763 0.71 . . . . 0.0 112.176 -173.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 173.9 10.67 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -165.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -69.38 164.27 23.33 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 -170.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.8 tp -89.09 166.2 14.02 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 125.1 1.36 . . . . 0.0 112.947 -175.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -72.2 160.57 32.2 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.308 -1.495 . . . . 0.0 112.078 170.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.8 m -72.27 147.06 46.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.411 -1.43 . . . . 0.0 113.699 -175.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.9 m -110.32 160.59 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 120.632 -1.292 . . . . 0.0 110.087 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.24 149.63 17.29 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 125.031 1.3 . . . . 0.0 111.396 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -86.88 102.88 14.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.696 -1.473 . . . . 0.0 109.779 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.3 21.22 20.65 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 121.406 -0.809 . . . . 0.0 113.179 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -76.21 158.38 31.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.995 -1.297 . . . . 0.0 112.947 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 p -103.1 160.09 14.95 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.616 1.567 . . . . 0.0 113.487 -175.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -154.93 141.35 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 O-C-N 121.385 -0.822 . . . . 0.0 109.547 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -93.04 142.96 26.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.743 1.258 . . . . 0.0 112.7 165.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -155.59 172.11 18.82 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.974 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -102.88 138.28 39.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 166.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.463 HG12 HD13 ' A' ' 5' ' ' ILE . 45.7 t -96.22 91.93 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 119.676 -1.89 . . . . 0.0 109.524 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.99 90.47 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 118.607 -2.558 . . . . 0.0 111.785 -159.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -144.81 -60.3 0.36 Allowed 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 122.659 1.219 . . . . 0.0 110.931 165.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.9 -48.38 1.32 Allowed Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 115.617 1.007 . . . . 0.0 115.617 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -80.12 -85.26 0.09 Allowed 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 -172.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -86.13 -30.47 22.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.285 -1.509 . . . . 0.0 114.333 -167.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -162.92 -127.53 0.88 Allowed Glycine 0 N--CA 1.43 -1.763 0 O-C-N 119.953 -1.717 . . . . 0.0 110.56 170.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.43 ' HB1' HG13 ' A' ' 63' ' ' VAL . . . -144.48 137.37 26.88 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 122.246 1.022 . . . . 0.0 113.119 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -117.83 -166.81 1.24 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.943 -1.098 . . . . 0.0 109.725 165.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.06 153.49 42.99 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 123.018 1.39 . . . . 0.0 110.863 -170.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.44 157.76 44.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 175.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 50.72 59.32 4.68 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 36.4 t -93.97 100.26 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 120.672 -1.268 . . . . 0.0 109.073 -170.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.0 p -99.32 -103.39 0.22 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.074 1.35 . . . . 0.0 111.951 -171.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.07 -168.95 31.83 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 125.531 1.539 . . . . 0.0 110.194 -173.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -71.28 168.88 22.15 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 C-N-CA 123.096 2.531 . . . . 0.0 112.619 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.731 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.337 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.938 HG12 ' H ' ' A' ' 65' ' ' GLU . 4.3 m . . . . . 0 N--CA 1.43 -1.432 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.426 HD13 HG12 ' A' ' 63' ' ' VAL . 4.8 mp -91.37 -61.49 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 O-C-N 120.135 -1.603 . . . . 0.0 108.833 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -164.84 173.21 11.98 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -174.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.2 p -109.47 160.17 16.43 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.962 2.505 . . . . 0.0 109.755 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.7 mttt 59.99 49.76 7.35 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.585 2.068 . . . . 0.0 116.585 174.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.57 143.78 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.301 1.84 . . . . 0.0 109.295 -166.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -106.69 149.85 26.84 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.222 1.01 . . . . 0.0 110.323 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.35 -167.04 37.38 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.306 -1.496 . . . . 0.0 111.383 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.7 m -116.44 120.94 40.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.657 -0.908 . . . . 0.0 109.758 -164.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.2 t -87.77 130.44 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 120.89 -1.131 . . . . 0.0 110.456 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -133.04 159.71 39.27 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 120.828 -1.17 . . . . 0.0 111.461 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.4 t90 37.11 63.67 0.68 Allowed 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 118.395 2.739 . . . . 0.0 118.395 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -79.51 118.17 21.13 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.461 -1.4 . . . . 0.0 110.39 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -95.12 107.16 19.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.648 -1.283 . . . . 0.0 108.441 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.9 t -71.32 -33.98 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 126.3 1.84 . . . . 0.0 112.493 -173.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -65.38 -38.38 89.83 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.191 -1.568 . . . . 0.0 113.566 -172.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -95.13 -35.04 12.05 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.739 -1.225 . . . . 0.0 111.931 169.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.89 40.71 3.04 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.518 -1.364 . . . . 0.0 113.858 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -132.93 146.39 51.75 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.471 1.509 . . . . 0.0 109.591 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -149.88 -171.75 18.64 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 170.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -141.32 153.42 45.14 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 123.389 1.566 . . . . 0.0 111.776 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mt -112.36 141.53 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.335 1.054 . . . . 0.0 108.341 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -91.92 91.23 7.79 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 172.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.12 110.89 2.68 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 125.968 1.707 . . . . 0.0 113.753 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.331 38.7 p30 -54.14 -47.55 71.78 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 121.084 3.735 . . . . 0.0 121.084 -158.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -56.64 -49.11 75.99 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.771 2.878 . . . . 0.0 118.771 -169.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -136.25 35.73 2.76 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.19 -2.194 . . . . 0.0 106.837 173.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? 57.32 63.34 1.9 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.875 1.67 . . . . 0.0 113.278 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -107.83 151.35 25.86 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.965 -1.71 . . . . 0.0 110.531 -168.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -84.65 112.16 20.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.381 1.086 . . . . 0.0 111.943 -169.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.9 t -113.91 111.92 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -88.31 134.86 33.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.634 -1.916 . . . . 0.0 110.616 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.4 p -130.85 133.58 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.882 -1.136 . . . . 0.0 110.283 -173.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -117.43 154.73 30.87 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.011 1.724 . . . . 0.0 111.625 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -54.12 -31.05 51.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 117.794 2.516 . . . . 0.0 117.794 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.5 p -75.85 -12.14 60.11 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.516 -1.99 . . . . 0.0 114.334 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.48 -15.24 33.51 Favored 'General case' 0 CA--C 1.489 -1.37 0 O-C-N 120.766 -1.209 . . . . 0.0 112.369 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.2 mm -74.18 133.02 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 125.463 1.505 . . . . 0.0 111.116 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp . . . . . 0 N--CA 1.43 -1.441 0 O-C-N 119.267 -2.146 . . . . 0.0 115.09 -179.283 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.799 0 N-CA-C 107.782 -2.127 . . . . 0.0 107.782 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -80.77 146.92 30.74 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 118.895 1.347 . . . . 0.0 111.843 173.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.2 45.3 62.15 Favored Glycine 0 N--CA 1.431 -1.675 0 O-C-N 120.469 -1.394 . . . . 0.0 115.597 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -75.03 152.54 38.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.489 1.137 . . . . 0.0 113.268 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 m -97.86 138.25 35.49 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.217 1.008 . . . . 0.0 109.667 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -143.28 151.53 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -172.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -98.28 143.27 28.95 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 119.589 1.086 . . . . 0.0 110.455 171.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -157.94 160.97 38.15 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 121.79 0.805 . . . . 0.0 109.247 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -88.62 142.81 27.38 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.838 -1.789 . . . . 0.0 107.207 166.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.426 HG12 HD13 ' A' ' 5' ' ' ILE . 85.3 t -100.66 97.6 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 119.48 -2.012 . . . . 0.0 106.811 175.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.402 ' HA ' ' HB ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -123.24 144.93 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 O-C-N 120.609 -1.307 . . . . 0.0 110.101 -163.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.938 ' H ' HG12 ' A' ' 4' ' ' VAL . 16.7 tt0 -59.63 111.63 1.5 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.476 2.084 . . . . 0.0 113.269 -170.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.14 -128.03 3.19 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 111.747 -2.478 . . . . 0.0 112.641 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -100.35 -71.23 0.71 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 124.129 0.971 . . . . 0.0 109.326 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -83.0 -26.25 31.43 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.783 -1.198 . . . . 0.0 112.111 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.59 -88.96 0.07 OUTLIER Glycine 0 N--CA 1.429 -1.783 0 O-C-N 121.278 -0.889 . . . . 0.0 111.055 -167.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.28 149.08 35.7 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.508 1.623 . . . . 0.0 114.867 -173.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -122.37 -162.86 1.03 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.543 1.937 . . . . 0.0 110.464 168.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -146.77 133.4 19.89 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.349 -1.47 . . . . 0.0 110.161 -169.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -133.14 162.01 32.89 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.95 1.3 . . . . 0.0 108.687 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 51.04 51.63 16.66 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.731 1.613 . . . . 0.0 115.019 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.8 t -92.94 129.92 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 123.905 0.882 . . . . 0.0 112.016 -165.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.2 p -96.32 -134.27 0.22 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.417 1.087 . . . . 0.0 112.97 -175.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.716 0 O-C-N 119.709 -1.869 . . . . 0.0 108.702 178.419 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.403 ' HA ' ' H ' ' A' ' 65' ' ' GLU . 12.7 m . . . . . 0 N--CA 1.43 -1.435 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.704 HD13 HG12 ' A' ' 63' ' ' VAL . 2.3 mp -95.61 -72.87 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.503 -1.998 . . . . 0.0 107.685 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -158.05 171.95 19.31 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -168.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -107.47 156.02 19.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.593 2.357 . . . . 0.0 111.115 168.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt 53.73 57.2 6.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 176.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.6 t -105.46 144.94 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 128.179 2.591 . . . . 0.0 107.728 -175.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -105.41 150.0 25.64 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.385 -1.447 . . . . 0.0 109.945 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -168.61 -179.84 41.1 Favored Glycine 0 N--CA 1.43 -1.712 0 O-C-N 120.529 -1.357 . . . . 0.0 110.399 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 m -115.56 133.64 55.84 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 124.221 1.009 . . . . 0.0 111.486 -167.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.7 p -109.95 142.25 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 123.901 0.881 . . . . 0.0 111.332 174.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -100.32 -87.29 0.38 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.697 -1.877 . . . . 0.0 110.027 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -112.11 128.81 56.32 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 124.873 1.269 . . . . 0.0 109.469 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -139.66 155.21 47.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.144 -0.972 . . . . 0.0 110.731 172.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -86.43 104.06 15.56 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.284 -1.51 . . . . 0.0 111.353 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.16 -34.65 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -62.66 -45.52 92.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.267 -1.521 . . . . 0.0 114.066 -173.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -83.49 -42.47 16.84 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.914 -1.116 . . . . 0.0 110.367 168.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.53 53.53 1.55 Allowed Glycine 0 N--CA 1.43 -1.745 0 O-C-N 120.255 -1.528 . . . . 0.0 110.277 -172.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -135.91 151.69 50.24 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 123.561 0.744 . . . . 0.0 109.898 -169.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.77 -158.03 26.95 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 121.236 -0.915 . . . . 0.0 111.687 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -144.86 154.04 42.22 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 123.159 1.456 . . . . 0.0 112.84 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.3 mm -109.46 162.36 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.389 1.476 . . . . 0.0 107.166 -178.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -102.3 100.61 10.79 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 120.921 -1.112 . . . . 0.0 109.442 170.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -57.92 124.96 21.05 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.049 1.74 . . . . 0.0 114.359 168.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -55.12 -47.93 74.34 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 119.273 3.064 . . . . 0.0 119.273 -168.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -68.05 -46.9 69.82 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -168.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.1 t -137.69 23.97 2.88 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 119.77 -1.831 . . . . 0.0 107.491 -170.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.61 49.77 6.22 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.941 1.696 . . . . 0.0 113.922 166.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -104.81 156.3 18.13 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 123.298 1.523 . . . . 0.0 112.807 -168.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -86.05 119.44 26.35 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.625 -171.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.4 t -108.63 103.32 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -169.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -82.73 131.83 35.19 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 122.975 1.369 . . . . 0.0 113.781 -173.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.4 t -128.88 135.39 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 124.657 1.183 . . . . 0.0 108.019 -172.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.8 176.91 6.29 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.324 1.05 . . . . 0.0 109.08 169.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -61.58 -21.64 64.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.987 2.217 . . . . 0.0 116.987 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -71.82 -26.02 62.22 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.501 1.521 . . . . 0.0 113.732 173.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.41 -22.06 26.78 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.849 -2.407 . . . . 0.0 113.011 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.8 mt -81.57 104.44 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 125.531 1.533 . . . . 0.0 109.819 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.251 50.3 mttm . . . . . 0 N--CA 1.431 -1.402 0 C-N-CA 125.529 1.532 . . . . 0.0 114.3 -173.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.773 0 CA-C-O 122.223 0.902 . . . . 0.0 113.576 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.11 140.1 48.71 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.023 -1.869 . . . . 0.0 114.403 -177.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.73 11.39 79.66 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 119.741 -1.849 . . . . 0.0 113.425 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -79.69 153.29 29.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.279 1.514 . . . . 0.0 113.617 177.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 p -97.45 142.68 29.0 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 125.433 1.493 . . . . 0.0 114.678 -177.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.02 154.3 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 124.679 1.192 . . . . 0.0 109.594 -174.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.53 145.39 30.37 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.347 -1.471 . . . . 0.0 113.054 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.432 ' HB2' ' HB1' ' A' ' 72' ' ' ALA . 13.9 p90 -156.38 172.31 18.73 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.031 1.332 . . . . 0.0 110.171 -178.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -94.8 154.07 17.44 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.592 -1.942 . . . . 0.0 108.094 165.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.704 HG12 HD13 ' A' ' 5' ' ' ILE . 61.5 t -110.97 96.97 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 119.139 -2.225 . . . . 0.0 108.011 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.27 111.87 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 120.183 -1.573 . . . . 0.0 109.553 -167.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.403 ' H ' ' HA ' ' A' ' 4' ' ' VAL . 28.3 tt0 -95.44 123.66 39.08 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.756 -1.84 . . . . 0.0 113.587 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -123.82 -45.63 0.28 Allowed Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 125.156 1.36 . . . . 0.0 112.809 170.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -95.37 -136.61 0.22 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.004 1.322 . . . . 0.0 111.386 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -78.76 -32.12 46.44 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.617 -1.927 . . . . 0.0 113.19 -174.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -141.07 165.84 26.15 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 105.997 -2.841 . . . . 0.0 105.997 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.71 152.22 21.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.206 1.479 . . . . 0.0 114.676 -168.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -107.01 -166.71 1.19 Allowed 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.423 -1.423 . . . . 0.0 109.947 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' A' ' 61' ' ' PHE . . . -147.33 156.23 42.72 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -173.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.58 162.41 36.68 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 56.45 40.31 29.66 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.628 1.571 . . . . 0.0 114.414 173.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 t -76.21 109.61 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 125.948 1.699 . . . . 0.0 110.62 -172.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.7 m -125.96 -121.85 0.25 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 123.8 0.84 . . . . 0.0 110.165 -161.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.787 0 O-C-N 119.335 -2.103 . . . . 0.0 111.691 -178.238 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.429 -1.509 0 CA-C-O 121.14 0.495 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.1 mp -80.74 -72.08 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 119.952 -1.718 . . . . 0.0 113.116 -166.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.19 167.89 28.86 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -160.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.9 p -110.96 134.37 52.64 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 128.188 2.595 . . . . 0.0 109.661 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.279 25.8 ttmt 59.18 75.67 0.39 Allowed 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.683 1.993 . . . . 0.0 116.046 -172.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.6 t -121.06 149.96 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 130.311 3.444 . . . . 0.0 105.739 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.7 mp -114.84 168.06 10.23 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 123.638 1.685 . . . . 0.0 112.232 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.73 -172.78 44.17 Favored Glycine 0 N--CA 1.43 -1.751 0 O-C-N 119.333 -2.104 . . . . 0.0 113.115 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.0 m -116.68 131.42 56.95 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 123.773 0.829 . . . . 0.0 109.511 -168.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.84 135.7 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 O-C-N 120.093 -1.63 . . . . 0.0 113.83 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -95.39 -56.08 2.83 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 120.098 -1.626 . . . . 0.0 109.841 173.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -156.46 130.66 8.61 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 123.972 0.909 . . . . 0.0 110.438 177.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -101.71 123.36 45.56 Favored 'General case' 0 N--CA 1.431 -1.384 0 O-C-N 120.607 -1.308 . . . . 0.0 107.965 164.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -102.52 76.9 1.57 Allowed 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.407 -1.433 . . . . 0.0 110.471 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 t -75.82 -7.5 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 123.523 1.63 . . . . 0.0 112.437 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -64.55 -30.07 71.1 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 128.814 2.846 . . . . 0.0 112.85 173.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -127.83 -46.06 1.42 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.728 -1.857 . . . . 0.0 111.444 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.45 -57.38 0.21 Allowed Glycine 0 N--CA 1.429 -1.779 0 O-C-N 119.475 -2.015 . . . . 0.0 115.929 -174.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -79.57 169.42 18.04 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.847 1.784 . . . . 0.0 114.916 -166.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.26 167.78 31.33 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 118.913 -2.367 . . . . 0.0 109.479 169.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -147.06 141.59 26.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 123.012 1.387 . . . . 0.0 111.923 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 mm -113.26 160.76 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 126.812 2.045 . . . . 0.0 108.926 -169.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -109.77 99.82 8.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.551 -1.343 . . . . 0.0 110.927 161.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.76 138.41 47.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.276 2.23 . . . . 0.0 114.93 170.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -62.48 84.95 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.607 2.447 . . . . 0.0 117.607 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -159.42 -76.12 0.07 Allowed 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.403 -2.061 . . . . 0.0 109.251 177.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.6 t -139.67 30.05 2.11 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 55.65 81.76 0.11 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.0 2.12 . . . . 0.0 114.202 -165.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -101.78 137.21 40.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.85 -1.781 . . . . 0.0 108.189 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -79.98 110.11 15.05 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 121.626 0.727 . . . . 0.0 109.925 -171.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.3 t -111.73 117.21 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -89.28 144.26 26.22 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.14 0.972 . . . . 0.0 112.957 -176.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -133.01 128.47 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 122.635 1.207 . . . . 0.0 110.847 -172.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -95.96 154.84 17.02 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.571 -1.331 . . . . 0.0 110.338 173.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -64.1 -26.1 68.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.235 -2.166 . . . . 0.0 116.443 -171.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.0 p -69.39 -27.31 65.19 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.543 -1.348 . . . . 0.0 113.755 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.83 -19.52 40.9 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.452 -1.405 . . . . 0.0 113.175 -174.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.6 mt -75.02 117.32 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 C-N-CA 126.751 2.02 . . . . 0.0 111.768 -178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.4 mttm . . . . . 0 N--CA 1.429 -1.492 0 O-C-N 120.543 -1.348 . . . . 0.0 112.423 178.779 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.736 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -76.75 117.39 18.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.171 1.462 . . . . 0.0 112.95 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.56 55.14 21.97 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 116.734 1.454 . . . . 0.0 116.734 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -73.18 150.77 41.87 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 119.184 1.492 . . . . 0.0 113.06 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 m -99.6 145.16 27.86 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.996 -1.065 . . . . 0.0 110.904 -172.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.1 m -143.08 163.14 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 125.866 1.666 . . . . 0.0 108.028 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -113.58 153.57 28.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.234 1.414 . . . . 0.0 110.461 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -164.7 172.91 12.48 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.976 0.893 . . . . 0.0 110.632 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -92.32 152.59 19.7 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.887 -2.383 . . . . 0.0 108.662 162.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.3 t -112.11 100.71 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 119.535 -1.978 . . . . 0.0 107.547 173.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 m -132.96 128.27 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 120.412 -1.43 . . . . 0.0 108.316 -168.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -96.31 150.77 20.2 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.905 -2.372 . . . . 0.0 114.4 -163.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -151.11 -68.55 0.01 OUTLIER Glycine 0 N--CA 1.432 -1.622 0 O-C-N 121.116 -0.99 . . . . 0.0 111.549 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -78.3 -145.37 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.4 1.48 . . . . 0.0 114.46 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -62.87 -22.42 66.69 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 119.841 -1.787 . . . . 0.0 115.579 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.72 -167.61 13.48 Favored Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 127.245 2.355 . . . . 0.0 108.383 175.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.11 161.31 15.15 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.09 -168.1 1.61 Allowed 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.838 -1.164 . . . . 0.0 110.626 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.06 155.68 44.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.87 1.319 . . . . 0.0 112.136 -166.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.1 166.02 24.35 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.593 1.957 . . . . 0.0 106.531 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.336 0.4 OUTLIER 34.51 63.36 0.45 Allowed 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 117.845 2.535 . . . . 0.0 117.845 -178.513 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.1 t -92.15 98.11 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 C-N-CA 125.097 1.359 . . . . 0.0 111.017 -168.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.94 155.63 22.38 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.607 1.163 . . . . 0.0 110.612 -174.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.763 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 168.93 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.1 t . . . . . 0 N--CA 1.43 -1.446 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.9 mp -86.38 -53.03 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 119.664 -1.898 . . . . 0.0 111.159 -165.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.92 160.5 24.94 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.5 p -115.5 148.4 39.53 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.575 1.55 . . . . 0.0 108.522 166.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.264 26.9 mmmt 53.38 83.01 0.07 Allowed 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.42 2.288 . . . . 0.0 115.512 -168.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.2 t -128.43 143.8 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 126.581 1.953 . . . . 0.0 107.153 -164.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.2 148.55 28.76 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.693 1.235 . . . . 0.0 109.613 174.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.12 179.79 41.59 Favored Glycine 0 N--CA 1.429 -1.788 0 O-C-N 120.796 -1.19 . . . . 0.0 111.376 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.9 m -115.26 135.3 54.3 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 124.635 1.174 . . . . 0.0 109.129 -169.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 50.2 t -84.27 124.8 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 120.387 -1.446 . . . . 0.0 109.441 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -97.41 -57.74 2.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.482 -1.386 . . . . 0.0 108.986 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.9 t-105 -144.56 96.42 2.87 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.0 0.92 . . . . 0.0 109.16 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -98.1 129.7 44.91 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.805 -1.184 . . . . 0.0 108.013 167.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -100.18 105.84 17.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.269 -1.519 . . . . 0.0 109.781 -177.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.4 t -77.23 -26.02 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 126.006 1.722 . . . . 0.0 112.144 -173.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -66.06 -45.87 79.79 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.233 -1.542 . . . . 0.0 112.815 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -78.59 -45.9 20.59 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.936 -1.728 . . . . 0.0 110.74 164.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.96 49.23 1.5 Allowed Glycine 0 N--CA 1.43 -1.723 0 CA-C-O 122.948 1.305 . . . . 0.0 110.287 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -155.71 152.6 28.78 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -162.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.32 -151.22 18.73 Favored Glycine 0 N--CA 1.43 -1.709 0 O-C-N 120.125 -1.61 . . . . 0.0 109.82 169.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -140.15 167.03 23.08 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.449 -1.03 . . . . 0.0 110.263 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.536 HG21 ' CE1' ' A' ' 61' ' ' PHE . 4.5 mm -109.63 155.81 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 170.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -92.25 104.93 17.24 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.416 -1.428 . . . . 0.0 109.305 161.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.0 ttt85 -66.22 114.75 5.55 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.548 -1.345 . . . . 0.0 109.573 153.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -64.81 -39.02 92.9 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -167.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -43.82 -52.45 6.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 128.585 2.754 . . . . 0.0 117.126 -169.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -143.22 33.89 1.34 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.862 -1.774 . . . . 0.0 106.565 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 57.38 58.51 3.8 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.57 1.548 . . . . 0.0 115.016 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -102.62 132.01 49.01 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.271 1.429 . . . . 0.0 109.025 -168.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -90.16 106.38 18.44 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 123.525 0.73 . . . . 0.0 110.135 -167.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t -105.53 109.04 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 121.027 -1.046 . . . . 0.0 110.37 -171.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -81.32 133.62 35.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.161 -1.587 . . . . 0.0 114.282 -171.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.1 p -129.7 133.3 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 120.37 -1.456 . . . . 0.0 111.92 -175.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -108.58 148.25 30.6 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.815 1.646 . . . . 0.0 108.66 173.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -58.1 -17.84 20.97 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 119.437 3.125 . . . . 0.0 119.437 -172.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.0 t -81.7 -12.06 58.79 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.386 -1.446 . . . . 0.0 113.268 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.73 -15.73 58.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.868 -2.395 . . . . 0.0 112.028 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.6 mt -82.48 124.41 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 126.062 1.745 . . . . 0.0 110.07 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -171.312 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.685 0 CA-C-O 122.089 0.827 . . . . 0.0 111.792 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -78.47 126.51 30.86 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.333 -1.686 . . . . 0.0 113.002 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.9 35.72 44.0 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 120.184 -1.573 . . . . 0.0 114.51 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.25 152.56 34.62 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.803 1.287 . . . . 0.0 113.337 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.1 p -94.11 146.09 24.22 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.726 1.611 . . . . 0.0 112.48 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.4 t -139.21 140.79 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -93.54 141.64 28.24 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.382 1.086 . . . . 0.0 111.749 165.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.536 ' CE1' HG21 ' A' ' 25' ' ' ILE . 12.6 p90 -156.06 172.73 17.91 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.873 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -99.07 156.53 16.89 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 162.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.67 89.89 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 119.876 -1.765 . . . . 0.0 107.381 172.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 m -124.85 139.34 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 120.816 -1.177 . . . . 0.0 108.026 -164.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -59.06 128.16 35.84 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.404 -2.06 . . . . 0.0 115.516 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -116.75 -112.33 2.69 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 125.319 1.437 . . . . 0.0 111.09 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -107.82 -89.57 0.45 Allowed 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 124.911 1.285 . . . . 0.0 112.561 -175.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -79.2 10.07 3.95 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 118.922 -2.361 . . . . 0.0 115.122 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.36 -167.09 38.11 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 107.057 -2.417 . . . . 0.0 107.057 -172.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.29 156.22 28.16 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.295 -1.121 . . . . 0.0 113.755 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -124.85 -172.36 2.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.557 1.543 . . . . 0.0 111.252 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.38 140.36 30.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.757 1.265 . . . . 0.0 110.24 -162.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -138.33 149.37 45.56 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.626 -172.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 52.96 50.94 16.86 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.367 2.267 . . . . 0.0 113.839 -176.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.1 t -78.26 124.04 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 120.652 -1.28 . . . . 0.0 111.603 -165.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.0 m -113.52 -122.09 0.29 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.227 -0.921 . . . . 0.0 110.713 -169.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.7 0 O-C-N 119.85 -1.781 . . . . 0.0 112.544 -170.873 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.443 HG13 HG12 ' A' ' 64' ' ' VAL . 71.7 t . . . . . 0 N--CA 1.431 -1.421 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -92.75 -54.85 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 119.875 -1.766 . . . . 0.0 110.299 -168.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -160.58 151.9 19.27 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.731 1.253 . . . . 0.0 113.603 -177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.5 p -108.06 150.02 27.69 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.282 1.833 . . . . 0.0 112.562 168.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.258 83.2 mttt 56.95 70.0 0.69 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.215 1.806 . . . . 0.0 114.872 -173.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.2 t -122.47 143.7 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 126.69 1.996 . . . . 0.0 108.732 -163.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.8 mp -128.97 168.69 15.64 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 122.318 1.056 . . . . 0.0 110.832 171.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -165.07 -147.61 5.19 Favored Glycine 0 N--CA 1.431 -1.696 0 O-C-N 120.326 -1.484 . . . . 0.0 110.168 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.3 m -118.51 133.21 56.04 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 172.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.2 t -95.65 126.15 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 120.318 -1.489 . . . . 0.0 110.437 173.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -118.25 -60.2 1.81 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.797 -1.189 . . . . 0.0 110.309 167.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -85.99 109.39 18.75 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.506 -1.371 . . . . 0.0 112.357 -175.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -151.86 129.29 11.36 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.382 -1.449 . . . . 0.0 109.018 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -97.65 107.25 19.71 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.549 1.539 . . . . 0.0 107.61 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.8 t -82.99 -45.5 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 120.319 -1.488 . . . . 0.0 113.747 -155.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -55.11 -61.2 2.47 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.225 1.41 . . . . 0.0 112.041 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -66.14 -44.89 82.88 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 172.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.2 62.15 0.92 Allowed Glycine 0 N--CA 1.429 -1.77 0 O-C-N 121.248 -0.908 . . . . 0.0 113.831 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -149.15 159.63 44.07 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 121.372 -1.075 . . . . 0.0 110.82 173.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.26 -153.71 23.45 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 120.205 -1.56 . . . . 0.0 111.349 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -147.18 151.02 36.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.841 1.305 . . . . 0.0 111.237 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 mt -105.51 159.51 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 120.206 -1.559 . . . . 0.0 108.475 -173.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -117.05 92.22 3.8 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.38 1.562 . . . . 0.0 109.721 167.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -63.48 149.35 46.33 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.427 1.891 . . . . 0.0 113.686 172.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -71.86 -19.65 61.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -76.25 -81.33 0.08 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.505 -1.997 . . . . 0.0 115.627 -163.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 t -114.17 -1.51 13.64 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.096 1.426 . . . . 0.0 108.652 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.3 mptt 77.57 62.29 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.845 3.258 . . . . 0.0 108.251 171.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -102.82 131.65 49.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 112.878 -1.965 . . . . 0.0 107.439 -165.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -85.72 109.46 18.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.967 -1.708 . . . . 0.0 110.854 -164.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.449 ' CG1' ' HB2' ' A' ' 72' ' ' ALA . 48.4 t -105.65 111.26 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.752 1.621 . . . . 0.0 107.39 -169.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -90.78 145.88 24.42 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.744 1.218 . . . . 0.0 111.606 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.34 133.85 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.566 1.65 . . . . 0.0 109.74 -174.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.419 ' CD2' ' H ' ' A' ' 38' ' ' GLN . 19.8 t-80 -119.58 162.5 18.84 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.574 1.55 . . . . 0.0 112.276 -175.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.419 ' H ' ' CD2' ' A' ' 37' ' ' HIS . 41.8 mt-30 -43.26 -55.65 3.9 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 129.301 3.04 . . . . 0.0 117.575 -173.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.6 t -80.96 -9.74 59.8 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.589 -1.319 . . . . 0.0 114.089 -172.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.38 -20.8 46.82 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.687 -1.883 . . . . 0.0 112.695 174.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.4 mt -79.03 124.15 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 126.005 1.722 . . . . 0.0 110.583 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt . . . . . 0 N--CA 1.43 -1.455 0 O-C-N 120.544 -1.347 . . . . 0.0 112.297 -176.866 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.784 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -74.04 107.1 6.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.599 -1.53 . . . . 0.0 110.522 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.08 39.75 31.6 Favored Glycine 0 N--CA 1.431 -1.684 0 O-C-N 120.582 -1.323 . . . . 0.0 114.513 -170.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.1 156.76 28.17 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 120.696 -1.473 . . . . 0.0 114.898 -175.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.43 148.1 31.7 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.705 2.002 . . . . 0.0 111.022 -175.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.8 p -155.15 145.36 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.325 1.85 . . . . 0.0 106.56 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -91.8 144.46 25.47 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 120.315 1.416 . . . . 0.0 111.88 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -151.08 169.85 20.83 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.899 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -112.94 133.17 55.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 168.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.4 t -89.32 87.12 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 120.353 -1.467 . . . . 0.0 109.585 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.443 HG12 HG13 ' A' ' 4' ' ' VAL . 2.1 m -130.06 107.35 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 120.282 -1.511 . . . . 0.0 109.396 -168.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -139.95 -111.29 0.15 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.61 -1.306 . . . . 0.0 109.456 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 137.28 -55.15 0.7 Allowed Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 114.059 0.384 . . . . 0.0 114.059 -169.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -101.75 -69.78 0.77 Allowed 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.324 -1.103 . . . . 0.0 112.624 -172.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -87.09 57.28 4.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.392 -1.443 . . . . 0.0 114.6 -170.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.43 -117.29 4.49 Favored Glycine 0 N--CA 1.43 -1.719 0 O-C-N 119.43 -2.044 . . . . 0.0 110.642 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.46 169.65 13.42 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 122.899 1.333 . . . . 0.0 112.951 169.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.497 ' HG3' ' H ' ' A' ' 72' ' ' ALA . 6.2 tt0 -145.84 178.8 7.9 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.405 2.282 . . . . 0.0 105.169 -176.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.497 ' H ' ' HG3' ' A' ' 71' ' ' GLU . . . -147.14 125.36 12.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.973 2.109 . . . . 0.0 107.061 -173.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.76 160.18 33.33 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 124.378 1.071 . . . . 0.0 108.296 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 60.1 45.76 11.45 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.936 2.094 . . . . 0.0 112.952 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.6 t -87.59 104.16 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-O 122.108 0.956 . . . . 0.0 111.806 -162.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.83 148.65 50.22 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.003 0.921 . . . . 0.0 109.51 -169.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.724 0 O-C-N 120.212 -1.555 . . . . 0.0 111.968 -176.324 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.653 HG12 ' H ' ' A' ' 65' ' ' GLU . 9.4 m . . . . . 0 N--CA 1.43 -1.436 0 CA-C-O 119.216 -0.421 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.41 HD13 HG11 ' A' ' 63' ' ' VAL . 4.2 mp -87.64 -65.34 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 119.468 -2.02 . . . . 0.0 111.082 -174.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.32 161.46 24.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.9 p -110.66 143.13 41.59 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.36 1.464 . . . . 0.0 110.22 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.27 92.2 mttt 60.95 73.15 0.49 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.225 2.21 . . . . 0.0 115.446 -170.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.7 t -126.11 159.22 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 129.557 3.143 . . . . 0.0 107.564 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.8 170.55 12.64 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.128 -1.608 . . . . 0.0 111.662 170.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.76 -170.26 34.0 Favored Glycine 0 N--CA 1.43 -1.725 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.7 m -116.98 127.89 54.64 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.821 1.296 . . . . 0.0 109.874 -166.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 t -91.85 147.32 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 127.015 2.126 . . . . 0.0 110.437 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -105.37 -86.95 0.46 Allowed 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.055 -1.653 . . . . 0.0 109.78 164.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 22.6 t-105 -155.1 140.29 17.54 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.725 -1.234 . . . . 0.0 108.317 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -97.77 155.84 16.85 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.791 -1.193 . . . . 0.0 113.614 -175.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -95.22 93.39 7.28 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.53 -1.356 . . . . 0.0 109.04 174.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.9 m -73.32 -30.64 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -172.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -56.49 -65.08 0.67 Allowed 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 125.312 1.445 . . . . 0.0 112.37 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -72.01 -35.17 69.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.546 -1.971 . . . . 0.0 113.174 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.84 51.61 1.63 Allowed Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -129.93 140.43 50.94 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 121.325 -1.103 . . . . 0.0 108.405 -170.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.05 161.15 32.98 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.503 -1.373 . . . . 0.0 111.147 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -142.09 157.84 44.44 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.946 -0.738 . . . . 0.0 109.464 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.3 mm -109.24 147.34 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 124.907 1.283 . . . . 0.0 108.634 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -92.93 93.89 8.62 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.907 -1.121 . . . . 0.0 109.037 169.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.19 133.56 37.75 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 174.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -82.54 48.0 1.25 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -171.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.95 -68.45 0.7 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.692 -1.88 . . . . 0.0 109.474 163.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -150.34 35.33 0.64 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 57.87 75.99 0.35 Allowed 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 127.234 2.214 . . . . 0.0 112.856 -159.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -103.06 128.35 49.96 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.561 -1.962 . . . . 0.0 106.675 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -82.11 122.14 27.47 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.651 1.691 . . . . 0.0 110.252 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.07 108.38 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 O-C-N 120.568 -1.333 . . . . 0.0 108.407 -173.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -76.06 140.05 41.72 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.76 -1.213 . . . . 0.0 113.661 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.8 t -128.44 126.2 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.766 -1.209 . . . . 0.0 108.416 -177.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -111.92 165.6 11.95 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.01 1.324 . . . . 0.0 110.592 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.1 mm100 -59.58 -36.98 77.32 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 m -69.86 -14.63 62.84 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.727 -1.858 . . . . 0.0 113.433 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.19 -25.4 58.22 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.536 -2.602 . . . . 0.0 114.909 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 89.1 mt -79.44 126.02 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 125.741 1.616 . . . . 0.0 111.597 -175.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 83.5 mttt . . . . . 0 N--CA 1.431 -1.392 0 O-C-N 120.615 -1.303 . . . . 0.0 112.678 -179.453 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.7 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -71.04 111.39 6.37 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.977 1.311 . . . . 0.0 109.753 174.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.75 -20.5 5.15 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 121.176 -0.952 . . . . 0.0 114.361 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.71 155.16 38.0 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.107 -1.819 . . . . 0.0 115.104 -174.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.72 143.31 39.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.719 2.008 . . . . 0.0 110.734 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.06 146.86 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -92.85 144.44 25.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -158.44 170.76 21.48 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.321 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -94.78 141.6 28.44 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.834 -1.791 . . . . 0.0 107.845 168.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.41 HG11 HD13 ' A' ' 5' ' ' ILE . 42.8 t -95.51 106.38 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 O-C-N 119.197 -2.19 . . . . 0.0 108.806 171.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.65 136.72 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 120.879 -1.138 . . . . 0.0 108.06 -170.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.653 ' H ' HG12 ' A' ' 4' ' ' VAL . 23.4 tt0 -120.64 166.33 13.83 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.631 -1.918 . . . . 0.0 111.407 -166.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.54 -44.68 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.892 -1.13 . . . . 0.0 111.791 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -123.67 -145.47 0.34 Allowed 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 124.682 1.193 . . . . 0.0 113.322 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -74.37 -18.85 60.62 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.88 -1.762 . . . . 0.0 114.476 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.99 139.07 8.7 Favored Glycine 0 N--CA 1.429 -1.79 0 O-C-N 120.413 -1.429 . . . . 0.0 109.551 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.22 164.32 22.38 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -172.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -120.53 -168.04 1.57 Allowed 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.872 2.069 . . . . 0.0 111.222 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.11 155.86 43.57 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -169.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -152.51 161.91 41.93 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -174.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 56.13 51.01 12.48 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 125.138 1.375 . . . . 0.0 114.522 170.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.1 t -95.07 108.5 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 124.569 1.148 . . . . 0.0 109.14 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.7 m -83.03 -82.85 0.14 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.301 -1.499 . . . . 0.0 111.729 -176.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.733 0 C-N-CA 126.248 1.88 . . . . 0.0 112.979 -177.195 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.4 t . . . . . 0 N--CA 1.429 -1.487 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.464 HD13 HG12 ' A' ' 63' ' ' VAL . 3.4 mp -84.56 -69.6 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 119.35 -2.094 . . . . 0.0 107.505 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -149.67 153.78 37.54 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -171.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.9 p -110.59 149.31 30.59 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.29 2.236 . . . . 0.0 110.508 170.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.267 87.7 mttt 53.44 67.81 0.94 Allowed 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.567 1.692 . . . . 0.0 115.567 -172.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.8 t -120.39 142.73 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 127.742 2.417 . . . . 0.0 109.123 -163.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.19 149.43 24.67 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.678 1.228 . . . . 0.0 112.051 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.23 171.44 44.46 Favored Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.6 m -112.3 136.93 51.14 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.115 0.966 . . . . 0.0 110.876 -163.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.5 t -103.39 122.86 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 124.527 1.131 . . . . 0.0 108.53 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -154.53 99.74 2.2 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.144 -1.597 . . . . 0.0 109.195 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . 0.312 37.2 m95 77.83 154.11 0.14 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.908 2.083 . . . . 0.0 113.956 -170.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.81 -167.79 2.1 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.775 -1.203 . . . . 0.0 111.286 -165.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -127.41 64.1 1.34 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.442 -1.411 . . . . 0.0 109.781 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 m -67.57 -23.8 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 126.929 2.091 . . . . 0.0 115.704 -174.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -58.89 -48.77 80.26 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.438 -2.039 . . . . 0.0 114.393 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -93.25 -37.4 12.08 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.681 -1.262 . . . . 0.0 111.317 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.93 57.12 0.43 Allowed Glycine 0 N--CA 1.43 -1.709 0 O-C-N 120.064 -1.647 . . . . 0.0 113.162 173.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -139.43 166.89 23.36 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 124.522 1.129 . . . . 0.0 108.09 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -127.81 161.34 21.79 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 120.929 -1.107 . . . . 0.0 110.971 174.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -140.78 146.57 37.83 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 121.257 -1.143 . . . . 0.0 109.376 170.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mt -108.81 147.8 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 125.747 1.619 . . . . 0.0 108.427 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -101.73 95.2 6.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.096 0.95 . . . . 0.0 109.442 169.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -69.04 128.88 38.25 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.275 14.9 p30 -74.57 107.16 6.52 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -176.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -166.97 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.234 1.414 . . . . 0.0 108.224 173.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.0 t -139.84 43.14 1.96 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 102.725 -3.065 . . . . 0.0 102.725 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.6 mptt 51.12 73.39 0.3 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.177 2.191 . . . . 0.0 114.101 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -103.05 133.59 47.91 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.814 -1.804 . . . . 0.0 110.056 -169.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.89 114.28 26.8 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 123.761 0.824 . . . . 0.0 110.22 -164.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.5 t -114.04 113.2 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -173.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . 0.264 0.1 OUTLIER -85.81 145.26 27.3 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.054 -1.654 . . . . 0.0 112.296 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.3 p -137.45 142.82 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 122.449 1.119 . . . . 0.0 110.759 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -98.79 140.99 32.16 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.39 1.876 . . . . 0.0 108.558 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -56.42 -36.84 69.41 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -171.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 t -66.8 -18.01 65.16 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.43 -21.4 38.9 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.406 -2.059 . . . . 0.0 112.347 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.1 mt -83.75 145.48 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 125.653 1.581 . . . . 0.0 108.497 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.492 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.74 0 CA-C-O 121.427 0.459 . . . . 0.0 113.32 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -72.36 90.69 1.29 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.315 1.446 . . . . 0.0 110.261 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.04 12.84 17.11 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.189 -1.569 . . . . 0.0 113.616 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -77.51 158.32 29.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.249 -1.736 . . . . 0.0 115.397 171.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.81 148.47 24.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 121.013 -1.054 . . . . 0.0 109.407 175.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 m -138.37 157.74 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 125.573 1.549 . . . . 0.0 109.473 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -102.08 142.58 33.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.061 1.344 . . . . 0.0 111.634 171.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -161.35 -176.45 5.39 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 124.072 0.949 . . . . 0.0 110.704 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -113.67 148.17 36.82 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 120.559 -1.338 . . . . 0.0 108.106 168.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.464 HG12 HD13 ' A' ' 5' ' ' ILE . 42.8 t -100.89 85.54 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 119.361 -2.087 . . . . 0.0 109.846 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 m -136.12 85.56 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.484 -2.635 . . . . 0.0 115.406 -157.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -144.26 -77.82 0.21 Allowed 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.844 -2.41 . . . . 0.0 112.564 170.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.71 -49.19 0.87 Allowed Glycine 0 N--CA 1.431 -1.694 0 O-C-N 120.979 -1.075 . . . . 0.0 114.476 175.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -68.25 -54.82 15.02 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.457 -1.613 . . . . 0.0 113.67 -169.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -92.18 -59.17 2.16 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.451 -1.406 . . . . 0.0 109.673 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.13 -103.79 0.19 Allowed Glycine 0 N--CA 1.43 -1.715 0 O-C-N 120.527 -1.358 . . . . 0.0 110.528 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.93 149.83 50.63 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.967 -1.314 . . . . 0.0 113.275 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.9 -177.89 4.48 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 124.745 1.218 . . . . 0.0 108.994 161.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.09 154.08 44.64 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 121.947 0.879 . . . . 0.0 111.274 -168.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.37 143.8 32.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.423 1.089 . . . . 0.0 109.482 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 53.43 59.66 4.22 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.102 2.561 . . . . 0.0 115.21 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.6 t -92.17 127.81 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 120.959 -1.088 . . . . 0.0 111.752 -164.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.1 t -155.07 -179.39 8.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.412 1.101 . . . . 0.0 110.508 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.734 0 CA-C-O 117.246 -1.863 . . . . 0.0 112.02 -176.976 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.574 HG13 HG12 ' A' ' 64' ' ' VAL . 61.8 t . . . . . 0 N--CA 1.43 -1.463 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.563 HG21 HH12 ' A' ' 27' ' ' ARG . 4.2 mp -90.43 -50.55 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 119.762 -1.836 . . . . 0.0 111.051 -171.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.31 165.89 14.91 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.658 0.742 . . . . 0.0 112.492 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.1 p -107.79 159.71 16.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.203 1.801 . . . . 0.0 109.17 165.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.4 tptt 48.53 65.76 1.26 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -175.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 88.7 t -112.04 151.22 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 128.096 2.558 . . . . 0.0 108.158 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -108.78 156.88 19.11 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.862 1.792 . . . . 0.0 110.247 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.09 179.25 41.9 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 120.172 -1.58 . . . . 0.0 109.628 173.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 m -113.7 130.93 56.34 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.708 0.803 . . . . 0.0 110.335 -169.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.0 t -98.06 122.56 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 125.766 1.627 . . . . 0.0 110.986 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -110.95 -59.54 1.95 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.063 -1.648 . . . . 0.0 110.612 174.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.9 t90 -69.83 -79.29 0.06 Allowed 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.569 1.548 . . . . 0.0 114.798 -166.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.8 t80 75.1 114.69 0.06 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.718 2.407 . . . . 0.0 113.249 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.429 HD21 ' HB3' ' A' ' 20' ' ' ASN . 64.4 t-20 -110.99 124.64 52.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.064 -1.648 . . . . 0.0 109.822 -175.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.1 t -107.96 -47.58 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 120.684 -1.26 . . . . 0.0 110.769 171.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -63.77 -30.79 71.85 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -167.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.429 ' HB3' HD21 ' A' ' 17' ' ' ASN . 59.6 t30 -107.53 -25.29 11.44 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 121.345 -0.847 . . . . 0.0 111.851 166.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.56 -43.69 1.62 Allowed Glycine 0 N--CA 1.43 -1.709 0 O-C-N 118.983 -2.323 . . . . 0.0 114.236 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -75.71 105.72 6.9 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 124.792 1.237 . . . . 0.0 112.8 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.13 175.45 21.3 Favored Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 124.84 1.209 . . . . 0.0 111.325 -176.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -143.26 145.57 32.86 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 123.021 1.391 . . . . 0.0 113.433 171.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.2 mt -107.75 147.79 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 125.054 1.342 . . . . 0.0 108.964 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -93.92 87.85 5.52 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 122.674 1.226 . . . . 0.0 108.951 173.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.563 HH12 HG21 ' A' ' 5' ' ' ILE . 2.3 tmt_? -66.52 112.82 4.3 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.925 -1.734 . . . . 0.0 114.522 172.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -85.41 25.78 0.99 Allowed 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 117.43 2.382 . . . . 0.0 117.43 -160.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -73.37 -51.14 18.45 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.46 -1.4 . . . . 0.0 111.416 170.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.3 t -146.4 24.59 1.26 Allowed 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.09 76.37 0.29 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 127.516 2.327 . . . . 0.0 111.153 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -109.85 133.15 53.48 Favored 'General case' 0 N--CA 1.428 -1.525 0 O-C-N 120.555 -1.34 . . . . 0.0 109.383 -176.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -81.87 110.82 17.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.493 1.616 . . . . 0.0 110.021 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.46 112.78 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.71 -1.244 . . . . 0.0 108.224 -171.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -85.18 129.28 34.83 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -172.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.4 t -127.41 123.19 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 124.994 1.318 . . . . 0.0 110.451 -168.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -93.12 160.79 14.69 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.183 -0.948 . . . . 0.0 112.001 171.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -60.41 -29.32 68.9 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.0 m -61.89 -33.37 74.09 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 125.843 1.657 . . . . 0.0 113.475 175.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.41 -17.17 60.84 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.193 -1.567 . . . . 0.0 114.294 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 72.7 mt -88.25 112.49 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 125.24 1.416 . . . . 0.0 110.261 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt . . . . . 0 N--CA 1.43 -1.428 0 C-N-CA 124.741 1.216 . . . . 0.0 110.983 176.739 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.733 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -108.48 158.8 17.21 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 166.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.46 8.3 49.83 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 120.079 -1.638 . . . . 0.0 114.518 -177.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -75.71 166.5 23.46 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.334 1.454 . . . . 0.0 114.551 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.98 148.85 22.21 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.43 1.892 . . . . 0.0 112.776 175.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 p -147.2 153.14 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 126.995 2.118 . . . . 0.0 106.05 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -104.3 147.86 27.02 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 120.104 1.32 . . . . 0.0 110.707 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -159.78 169.67 23.13 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.256 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -97.28 147.47 24.11 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.051 -1.656 . . . . 0.0 107.202 170.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.0 t -106.86 95.71 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 O-C-N 119.204 -2.185 . . . . 0.0 109.323 175.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.574 HG12 HG13 ' A' ' 4' ' ' VAL . 0.9 OUTLIER -129.62 100.89 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 120.444 -1.41 . . . . 0.0 110.488 -162.15 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -160.25 -122.5 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.232 -1.542 . . . . 0.0 112.699 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.25 -145.48 4.14 Favored Glycine 0 N--CA 1.43 -1.723 0 C-N-CA 127.307 2.384 . . . . 0.0 110.036 -162.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -94.98 -34.87 12.2 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.72 -1.459 . . . . 0.0 114.208 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -66.08 -37.73 86.52 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.81 -1.182 . . . . 0.0 114.033 -167.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -162.81 -156.35 8.49 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 174.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.01 158.56 39.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.028 -1.278 . . . . 0.0 111.778 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -138.47 172.82 12.33 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 127.489 2.316 . . . . 0.0 106.374 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.03 154.63 42.72 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.702 -1.874 . . . . 0.0 107.762 -168.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -149.89 162.67 39.86 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 55.23 54.47 8.7 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.261 1.824 . . . . 0.0 113.563 173.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.3 t -87.69 127.49 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.796 -1.19 . . . . 0.0 110.353 -170.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.0 p -94.44 -176.28 3.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.987 1.375 . . . . 0.0 114.05 -168.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.687 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 171.667 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.43 HG13 HG12 ' A' ' 64' ' ' VAL . 78.0 t . . . . . 0 N--CA 1.431 -1.409 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.3 mp -90.91 -57.46 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 119.633 -1.917 . . . . 0.0 110.392 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.49 160.74 26.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -168.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.8 p -106.58 157.59 17.57 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.592 2.757 . . . . 0.0 112.093 163.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.8 mttp 57.79 57.76 4.03 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.128 2.171 . . . . 0.0 114.602 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 t -115.97 152.19 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 C-N-CA 128.72 2.808 . . . . 0.0 107.741 -169.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -128.11 164.79 21.67 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 123.696 1.712 . . . . 0.0 114.15 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' A' ' 27' ' ' ARG . . . -168.79 -173.86 36.92 Favored Glycine 0 N--CA 1.431 -1.685 0 O-C-N 121.018 -1.051 . . . . 0.0 110.57 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.7 m -115.98 129.55 56.43 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.463 1.601 . . . . 0.0 108.365 -172.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.3 p -87.19 147.51 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 120.567 -1.333 . . . . 0.0 112.474 -177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.8 mmtt -102.47 -99.14 0.28 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 162.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -147.29 -170.82 3.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 172.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -124.58 166.61 15.78 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 126.157 1.783 . . . . 0.0 108.305 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -87.9 91.37 8.74 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 162.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.9 m -68.12 -31.0 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 126.965 2.106 . . . . 0.0 113.794 -171.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -62.04 -43.58 98.53 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 124.622 1.169 . . . . 0.0 112.68 -175.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -92.01 -36.53 13.34 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 119.144 -2.223 . . . . 0.0 113.603 166.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.57 34.64 3.03 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 121.521 -0.737 . . . . 0.0 114.198 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -123.65 162.61 22.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.783 -1.422 . . . . 0.0 110.411 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.42 171.67 36.78 Favored Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 169.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -118.23 155.6 30.25 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 118.146 0.973 . . . . 0.0 112.077 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.8 mm -104.47 155.87 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 169.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -110.81 96.67 6.31 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 119.637 1.108 . . . . 0.0 110.589 168.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.422 ' HA ' ' HA3' ' A' ' 11' ' ' GLY . 44.0 ttt180 -36.12 147.65 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 131.158 3.783 . . . . 0.0 117.446 164.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -66.0 -7.03 14.76 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.818 2.525 . . . . 0.0 117.818 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -82.94 -78.51 0.21 Allowed 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.875 -1.765 . . . . 0.0 112.502 -171.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 t -120.55 10.52 11.12 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 121.857 2.117 . . . . 0.0 107.244 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.2 mptt 60.09 67.53 0.85 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.714 2.406 . . . . 0.0 112.049 -174.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -107.73 159.4 16.51 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.064 -1.023 . . . . 0.0 109.452 -168.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -84.71 95.11 8.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 124.44 1.096 . . . . 0.0 112.643 -172.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.8 t -109.85 110.6 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -85.16 148.7 25.98 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 120.473 -1.392 . . . . 0.0 113.574 -168.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.442 HG22 ' HB3' ' A' ' 72' ' ' ALA . 81.8 t -136.68 133.59 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 125.097 1.359 . . . . 0.0 109.138 -171.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -114.47 165.2 12.99 Favored 'General case' 0 N--CA 1.432 -1.366 0 C-N-CA 125.247 1.419 . . . . 0.0 111.057 172.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -63.51 -36.52 84.04 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -169.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.0 m -74.99 -19.81 59.93 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.958 1.303 . . . . 0.0 112.107 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.26 -26.59 60.31 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.519 -1.988 . . . . 0.0 112.79 173.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.0 mt -76.45 114.65 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.702 1.601 . . . . 0.0 109.713 170.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.4 mttt . . . . . 0 N--CA 1.431 -1.409 0 O-C-N 120.778 -1.201 . . . . 0.0 109.353 -178.413 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.657 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.0 t70 66.71 -137.98 0.14 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.825 1.25 . . . . 0.0 109.907 -169.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.79 87.17 0.47 Allowed Glycine 0 N--CA 1.43 -1.753 0 O-C-N 120.814 -1.179 . . . . 0.0 112.43 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -64.17 169.58 4.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.094 -1.827 . . . . 0.0 114.545 171.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.12 136.75 36.16 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 122.207 1.003 . . . . 0.0 110.814 172.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.3 m -123.06 151.01 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -100.14 152.61 20.06 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 121.169 -0.957 . . . . 0.0 110.254 171.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -161.21 -179.31 7.34 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.844 0.83 . . . . 0.0 110.358 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -105.06 154.48 20.09 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 164.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 64.0 t -112.61 90.3 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 119.675 -1.891 . . . . 0.0 106.632 174.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.43 HG12 HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -115.81 87.69 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 124.217 1.961 . . . . 0.0 107.174 -165.081 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -85.56 124.59 32.28 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.584 -1.322 . . . . 0.0 113.738 -171.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -124.16 -41.94 0.38 Allowed Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 125.239 1.4 . . . . 0.0 112.797 173.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -89.45 -136.23 0.11 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.322 1.449 . . . . 0.0 111.826 -172.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -85.06 -13.82 49.21 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 126.523 1.929 . . . . 0.0 112.245 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -166.46 167.61 39.58 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 105.574 -3.011 . . . . 0.0 105.574 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.67 165.41 15.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -162.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -115.84 -174.83 2.6 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.037 -1.04 . . . . 0.0 111.221 164.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.442 ' HB3' HG22 ' A' ' 36' ' ' VAL . . . -144.93 144.95 31.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.543 1.164 . . . . 0.0 108.687 -169.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.74 160.68 38.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 55.85 48.62 17.72 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.011 1.724 . . . . 0.0 114.309 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.1 t -88.05 138.79 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 124.332 1.053 . . . . 0.0 111.026 -165.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.0 p -109.14 -158.53 0.65 Allowed 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 124.18 1.943 . . . . 0.0 113.011 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.781 0 O-C-N 119.559 -1.963 . . . . 0.0 109.68 176.834 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.43 -1.458 0 CA-C-O 120.753 0.311 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.463 HD13 HG12 ' A' ' 63' ' ' VAL . 4.8 mp -97.56 -50.24 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 O-C-N 119.629 -1.92 . . . . 0.0 106.436 165.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -158.3 161.49 37.68 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 123.356 0.662 . . . . 0.0 111.408 171.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.5 p -120.87 149.42 42.62 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.586 -1.321 . . . . 0.0 110.597 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.265 54.9 mttp 59.06 73.12 0.49 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.185 2.194 . . . . 0.0 113.866 -171.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.49 149.71 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 126.892 2.077 . . . . 0.0 109.2 -163.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -109.05 159.63 16.69 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 123.787 1.756 . . . . 0.0 112.798 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.73 -178.36 44.55 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.4 m -117.14 129.51 56.01 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -172.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.6 t -72.23 135.87 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 120.796 -1.19 . . . . 0.0 111.435 -175.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -95.14 -100.69 0.16 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.347 -1.47 . . . . 0.0 110.202 173.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -130.16 157.17 43.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.871 -1.768 . . . . 0.0 111.37 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -104.03 142.09 35.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.51 1.524 . . . . 0.0 109.921 172.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -118.15 100.54 7.59 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.945 1.698 . . . . 0.0 109.058 -175.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.17 -29.81 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 120.645 -1.284 . . . . 0.0 113.409 -158.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -58.39 -59.8 4.78 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.83 -1.794 . . . . 0.0 113.34 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -78.48 -37.79 42.48 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.763 -1.211 . . . . 0.0 113.223 174.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.93 53.45 0.8 Allowed Glycine 0 N--CA 1.43 -1.735 0 CA-C-N 119.768 1.167 . . . . 0.0 114.17 175.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -125.32 175.02 7.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.723 -0.869 . . . . 0.0 110.253 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.9 176.28 35.77 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 107.64 -2.184 . . . . 0.0 107.64 163.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -149.86 153.76 37.26 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 122.699 1.238 . . . . 0.0 112.949 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.412 HD11 HG21 ' A' ' 36' ' ' VAL . 1.7 mt -124.28 147.33 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 125.634 1.574 . . . . 0.0 109.324 -172.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -99.29 93.81 6.13 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 168.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -67.03 130.51 43.37 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -82.66 68.04 8.96 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.221 1.409 . . . . 0.0 114.631 -167.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -132.42 -72.57 0.52 Allowed 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 120.427 -1.42 . . . . 0.0 109.253 170.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.0 t -131.91 38.63 3.52 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.4 mptt 57.83 69.71 0.71 Allowed 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.981 1.712 . . . . 0.0 114.227 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -103.02 141.94 34.95 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.515 -1.99 . . . . 0.0 109.623 -166.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -93.85 104.71 16.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -162.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.1 t -108.95 116.5 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.69 -1.256 . . . . 0.0 109.119 -167.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -81.12 134.47 35.65 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 125.111 1.364 . . . . 0.0 112.743 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 25' ' ' ILE . 43.1 t -126.42 123.1 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 120.438 -1.414 . . . . 0.0 111.013 -175.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -100.63 170.11 8.59 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.351 1.46 . . . . 0.0 112.305 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -68.85 -22.41 64.22 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.6 -1.938 . . . . 0.0 114.892 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.5 p -71.11 -25.15 62.47 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.74 2.016 . . . . 0.0 113.392 175.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.39 -32.33 29.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.611 -1.306 . . . . 0.0 113.195 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.83 139.82 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 C-N-CA 126.481 1.912 . . . . 0.0 113.275 -175.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.2 pttm . . . . . 0 N--CA 1.431 -1.422 0 N-CA-C 119.04 2.978 . . . . 0.0 119.04 -173.899 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.691 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -86.88 102.88 14.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.696 -1.473 . . . . 0.0 109.779 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.3 21.22 20.65 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 121.406 -0.809 . . . . 0.0 113.179 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -76.21 158.38 31.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.995 -1.297 . . . . 0.0 112.947 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 p -103.1 160.09 14.95 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.616 1.567 . . . . 0.0 113.487 -175.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -154.93 141.35 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 O-C-N 121.385 -0.822 . . . . 0.0 109.547 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -93.04 142.96 26.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.743 1.258 . . . . 0.0 112.7 165.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -155.59 172.11 18.82 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.974 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -102.88 138.28 39.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 166.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.463 HG12 HD13 ' A' ' 5' ' ' ILE . 45.7 t -96.22 91.93 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 119.676 -1.89 . . . . 0.0 109.524 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.99 90.47 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 118.607 -2.558 . . . . 0.0 111.785 -159.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -144.81 -60.3 0.36 Allowed 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 122.659 1.219 . . . . 0.0 110.931 165.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.9 -48.38 1.32 Allowed Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 115.617 1.007 . . . . 0.0 115.617 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -80.12 -85.26 0.09 Allowed 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 -172.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -86.13 -30.47 22.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.285 -1.509 . . . . 0.0 114.333 -167.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -162.92 -127.53 0.88 Allowed Glycine 0 N--CA 1.43 -1.763 0 O-C-N 119.953 -1.717 . . . . 0.0 110.56 170.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.43 ' HB1' HG13 ' A' ' 63' ' ' VAL . . . -144.48 137.37 26.88 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 122.246 1.022 . . . . 0.0 113.119 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -117.83 -166.81 1.24 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.943 -1.098 . . . . 0.0 109.725 165.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.06 153.49 42.99 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 123.018 1.39 . . . . 0.0 110.863 -170.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.44 157.76 44.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 175.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 50.72 59.32 4.68 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 36.4 t -93.97 100.26 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 120.672 -1.268 . . . . 0.0 109.073 -170.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.0 p -99.32 -103.39 0.22 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.074 1.35 . . . . 0.0 111.951 -171.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.726 0 C-N-CA 125.531 1.539 . . . . 0.0 110.194 -173.206 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.489 -1.4 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -72.03 -61.33 1.83 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.921 -1.737 . . . . 0.0 115.046 -169.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -116.64 -98.61 0.45 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.379 -1.451 . . . . 0.0 110.535 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.938 HG12 ' H ' ' A' ' 65' ' ' GLU . 4.3 m -82.94 167.02 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.407 -1.433 . . . . 0.0 112.217 -176.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.426 HD13 HG12 ' A' ' 63' ' ' VAL . 4.8 mp -91.37 -61.49 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 O-C-N 120.135 -1.603 . . . . 0.0 108.833 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -164.84 173.21 11.98 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -174.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.2 p -109.47 160.17 16.43 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.962 2.505 . . . . 0.0 109.755 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.7 mttt 59.99 49.76 7.35 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.585 2.068 . . . . 0.0 116.585 174.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.57 143.78 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.301 1.84 . . . . 0.0 109.295 -166.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -106.69 149.85 26.84 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.222 1.01 . . . . 0.0 110.323 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.35 -167.04 37.38 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.306 -1.496 . . . . 0.0 111.383 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.7 m -116.44 120.94 40.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.657 -0.908 . . . . 0.0 109.758 -164.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.2 t -87.77 130.44 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 120.89 -1.131 . . . . 0.0 110.456 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -133.04 159.71 39.27 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 120.828 -1.17 . . . . 0.0 111.461 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.4 t90 37.11 63.67 0.68 Allowed 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 118.395 2.739 . . . . 0.0 118.395 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -79.51 118.17 21.13 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.461 -1.4 . . . . 0.0 110.39 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -95.12 107.16 19.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.648 -1.283 . . . . 0.0 108.441 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.9 t -71.32 -33.98 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 126.3 1.84 . . . . 0.0 112.493 -173.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -65.38 -38.38 89.83 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.191 -1.568 . . . . 0.0 113.566 -172.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -95.13 -35.04 12.05 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.739 -1.225 . . . . 0.0 111.931 169.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.89 40.71 3.04 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.518 -1.364 . . . . 0.0 113.858 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -132.93 146.39 51.75 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.471 1.509 . . . . 0.0 109.591 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -149.88 -171.75 18.64 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 170.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -141.32 153.42 45.14 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 123.389 1.566 . . . . 0.0 111.776 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mt -112.36 141.53 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.335 1.054 . . . . 0.0 108.341 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -91.92 91.23 7.79 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 172.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.12 110.89 2.68 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 125.968 1.707 . . . . 0.0 113.753 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.331 38.7 p30 -54.14 -47.55 71.78 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 121.084 3.735 . . . . 0.0 121.084 -158.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -56.64 -49.11 75.99 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.771 2.878 . . . . 0.0 118.771 -169.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -136.25 35.73 2.76 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.19 -2.194 . . . . 0.0 106.837 173.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? 57.32 63.34 1.9 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.875 1.67 . . . . 0.0 113.278 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -107.83 151.35 25.86 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.965 -1.71 . . . . 0.0 110.531 -168.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -84.65 112.16 20.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.381 1.086 . . . . 0.0 111.943 -169.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.9 t -113.91 111.92 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -88.31 134.86 33.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.634 -1.916 . . . . 0.0 110.616 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.4 p -130.85 133.58 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.882 -1.136 . . . . 0.0 110.283 -173.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -117.43 154.73 30.87 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.011 1.724 . . . . 0.0 111.625 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -54.12 -31.05 51.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 117.794 2.516 . . . . 0.0 117.794 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.5 p -75.85 -12.14 60.11 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.516 -1.99 . . . . 0.0 114.334 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.48 -15.24 33.51 Favored 'General case' 0 CA--C 1.489 -1.37 0 O-C-N 120.766 -1.209 . . . . 0.0 112.369 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.2 mm -74.18 133.02 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 125.463 1.505 . . . . 0.0 111.116 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -72.64 168.28 19.01 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.267 -2.146 . . . . 0.0 115.09 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . 0.256 30.6 ttpt 56.75 -118.54 1.18 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.469 2.307 . . . . 0.0 116.095 171.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -151.93 142.36 22.55 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.97 1.708 . . . . 0.0 106.565 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -118.64 107.72 42.29 Favored Pre-proline 0 N--CA 1.43 -1.447 0 C-N-CA 124.723 1.209 . . . . 0.0 108.237 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.31 176.6 9.74 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 CA-C-N 123.622 2.329 . . . . 0.0 113.523 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -112.19 60.07 0.63 Allowed 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.466 1.127 . . . . 0.0 110.97 -171.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -156.79 173.09 17.5 Favored 'General case' 0 N--CA 1.432 -1.374 0 O-C-N 119.913 -1.742 . . . . 0.0 112.3 -173.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.8 t80 70.77 144.38 0.06 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.482 2.313 . . . . 0.0 115.753 175.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.6 tp -93.29 -81.3 0.36 Allowed 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 120.297 -1.502 . . . . 0.0 112.665 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -78.8 107.72 11.72 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 -163.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.7 t -117.22 -67.87 0.96 Allowed 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.563 -1.336 . . . . 0.0 109.328 172.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.2 t -128.27 -77.88 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 C-N-CA 124.858 1.263 . . . . 0.0 108.14 172.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 145.61 -144.22 12.71 Favored Glycine 0 N--CA 1.429 -1.799 0 N-CA-C 107.782 -2.127 . . . . 0.0 107.782 -174.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -80.77 146.92 30.74 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 118.895 1.347 . . . . 0.0 111.843 173.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.2 45.3 62.15 Favored Glycine 0 N--CA 1.431 -1.675 0 O-C-N 120.469 -1.394 . . . . 0.0 115.597 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -75.03 152.54 38.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.489 1.137 . . . . 0.0 113.268 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 m -97.86 138.25 35.49 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.217 1.008 . . . . 0.0 109.667 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -143.28 151.53 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -172.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -98.28 143.27 28.95 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 119.589 1.086 . . . . 0.0 110.455 171.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -157.94 160.97 38.15 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 121.79 0.805 . . . . 0.0 109.247 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -88.62 142.81 27.38 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.838 -1.789 . . . . 0.0 107.207 166.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.426 HG12 HD13 ' A' ' 5' ' ' ILE . 85.3 t -100.66 97.6 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 119.48 -2.012 . . . . 0.0 106.811 175.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.402 ' HA ' ' HB ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -123.24 144.93 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 O-C-N 120.609 -1.307 . . . . 0.0 110.101 -163.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.938 ' H ' HG12 ' A' ' 4' ' ' VAL . 16.7 tt0 -59.63 111.63 1.5 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.476 2.084 . . . . 0.0 113.269 -170.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.14 -128.03 3.19 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 111.747 -2.478 . . . . 0.0 112.641 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -100.35 -71.23 0.71 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 124.129 0.971 . . . . 0.0 109.326 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -83.0 -26.25 31.43 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.783 -1.198 . . . . 0.0 112.111 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.59 -88.96 0.07 OUTLIER Glycine 0 N--CA 1.429 -1.783 0 O-C-N 121.278 -0.889 . . . . 0.0 111.055 -167.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.28 149.08 35.7 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.508 1.623 . . . . 0.0 114.867 -173.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -122.37 -162.86 1.03 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.543 1.937 . . . . 0.0 110.464 168.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -146.77 133.4 19.89 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.349 -1.47 . . . . 0.0 110.161 -169.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -133.14 162.01 32.89 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.95 1.3 . . . . 0.0 108.687 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 51.04 51.63 16.66 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.731 1.613 . . . . 0.0 115.019 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.8 t -92.94 129.92 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 123.905 0.882 . . . . 0.0 112.016 -165.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.2 p -96.32 -134.27 0.22 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.417 1.087 . . . . 0.0 112.97 -175.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.46 176.77 45.79 Favored Glycine 0 N--CA 1.43 -1.716 0 O-C-N 119.709 -1.869 . . . . 0.0 108.702 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -71.13 -2.31 10.92 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 C-N-CA 123.222 2.615 . . . . 0.0 117.238 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.794 0 CA-C-N 120.742 1.61 . . . . 0.0 110.807 -175.036 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.9 ttp . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -124.4 149.68 46.43 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.717 1.607 . . . . 0.0 109.785 -176.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -95.84 -59.99 1.74 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.489 -1.382 . . . . 0.0 111.824 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.403 ' HA ' ' H ' ' A' ' 65' ' ' GLU . 12.7 m -72.66 151.19 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 120.841 -1.162 . . . . 0.0 112.966 -173.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.704 HD13 HG12 ' A' ' 63' ' ' VAL . 2.3 mp -95.61 -72.87 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.503 -1.998 . . . . 0.0 107.685 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -158.05 171.95 19.31 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -168.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -107.47 156.02 19.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.593 2.357 . . . . 0.0 111.115 168.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt 53.73 57.2 6.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 176.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.6 t -105.46 144.94 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 128.179 2.591 . . . . 0.0 107.728 -175.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -105.41 150.0 25.64 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.385 -1.447 . . . . 0.0 109.945 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -168.61 -179.84 41.1 Favored Glycine 0 N--CA 1.43 -1.712 0 O-C-N 120.529 -1.357 . . . . 0.0 110.399 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 m -115.56 133.64 55.84 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 124.221 1.009 . . . . 0.0 111.486 -167.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.7 p -109.95 142.25 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 123.901 0.881 . . . . 0.0 111.332 174.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -100.32 -87.29 0.38 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.697 -1.877 . . . . 0.0 110.027 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -112.11 128.81 56.32 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 124.873 1.269 . . . . 0.0 109.469 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -139.66 155.21 47.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.144 -0.972 . . . . 0.0 110.731 172.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -86.43 104.06 15.56 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.284 -1.51 . . . . 0.0 111.353 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.16 -34.65 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -62.66 -45.52 92.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.267 -1.521 . . . . 0.0 114.066 -173.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -83.49 -42.47 16.84 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.914 -1.116 . . . . 0.0 110.367 168.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.53 53.53 1.55 Allowed Glycine 0 N--CA 1.43 -1.745 0 O-C-N 120.255 -1.528 . . . . 0.0 110.277 -172.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -135.91 151.69 50.24 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 123.561 0.744 . . . . 0.0 109.898 -169.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.77 -158.03 26.95 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 121.236 -0.915 . . . . 0.0 111.687 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -144.86 154.04 42.22 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 123.159 1.456 . . . . 0.0 112.84 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.3 mm -109.46 162.36 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.389 1.476 . . . . 0.0 107.166 -178.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -102.3 100.61 10.79 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 120.921 -1.112 . . . . 0.0 109.442 170.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -57.92 124.96 21.05 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.049 1.74 . . . . 0.0 114.359 168.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -55.12 -47.93 74.34 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 119.273 3.064 . . . . 0.0 119.273 -168.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -68.05 -46.9 69.82 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -168.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.1 t -137.69 23.97 2.88 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 119.77 -1.831 . . . . 0.0 107.491 -170.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.61 49.77 6.22 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.941 1.696 . . . . 0.0 113.922 166.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -104.81 156.3 18.13 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 123.298 1.523 . . . . 0.0 112.807 -168.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -86.05 119.44 26.35 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.625 -171.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.4 t -108.63 103.32 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -169.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -82.73 131.83 35.19 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 122.975 1.369 . . . . 0.0 113.781 -173.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.4 t -128.88 135.39 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 124.657 1.183 . . . . 0.0 108.019 -172.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.8 176.91 6.29 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.324 1.05 . . . . 0.0 109.08 169.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -61.58 -21.64 64.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.987 2.217 . . . . 0.0 116.987 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -71.82 -26.02 62.22 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.501 1.521 . . . . 0.0 113.732 173.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.41 -22.06 26.78 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.849 -2.407 . . . . 0.0 113.011 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.8 mt -81.57 104.44 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 125.531 1.533 . . . . 0.0 109.819 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.251 50.3 mttm 65.34 -172.53 0.18 Allowed 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 125.529 1.532 . . . . 0.0 114.3 -173.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.61 119.52 6.2 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 118.708 -2.495 . . . . 0.0 109.755 177.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . 0.282 11.5 t-20 53.21 -86.98 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 127.776 2.43 . . . . 0.0 116.23 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -70.49 121.86 84.77 Favored Pre-proline 0 N--CA 1.43 -1.435 0 O-C-N 119.867 -1.771 . . . . 0.0 113.061 -177.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.53 170.91 19.03 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 CA-C-N 123.453 2.269 . . . . 0.0 114.073 -177.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -142.68 81.27 1.73 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 122.364 1.078 . . . . 0.0 109.469 176.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.257 45.6 mttp 66.74 -157.44 0.24 Allowed 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.1 2.16 . . . . 0.0 115.184 -173.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -113.02 151.65 30.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.836 -1.165 . . . . 0.0 110.484 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 tp -88.14 106.04 17.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.168 -1.582 . . . . 0.0 108.495 162.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -95.17 -58.52 2.12 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.783 -1.198 . . . . 0.0 112.545 -171.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.0 t -117.55 146.6 43.47 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 124.307 1.043 . . . . 0.0 111.572 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.3 m -120.91 156.51 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 124.618 1.167 . . . . 0.0 111.507 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -137.33 140.22 11.16 Favored Glycine 0 N--CA 1.429 -1.773 0 O-C-N 120.554 -1.341 . . . . 0.0 113.576 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.11 140.1 48.71 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.023 -1.869 . . . . 0.0 114.403 -177.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.73 11.39 79.66 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 119.741 -1.849 . . . . 0.0 113.425 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -79.69 153.29 29.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.279 1.514 . . . . 0.0 113.617 177.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 p -97.45 142.68 29.0 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 125.433 1.493 . . . . 0.0 114.678 -177.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.02 154.3 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 124.679 1.192 . . . . 0.0 109.594 -174.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.53 145.39 30.37 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.347 -1.471 . . . . 0.0 113.054 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.432 ' HB2' ' HB1' ' A' ' 72' ' ' ALA . 13.9 p90 -156.38 172.31 18.73 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.031 1.332 . . . . 0.0 110.171 -178.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -94.8 154.07 17.44 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.592 -1.942 . . . . 0.0 108.094 165.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.704 HG12 HD13 ' A' ' 5' ' ' ILE . 61.5 t -110.97 96.97 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 119.139 -2.225 . . . . 0.0 108.011 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.27 111.87 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 120.183 -1.573 . . . . 0.0 109.553 -167.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.403 ' H ' ' HA ' ' A' ' 4' ' ' VAL . 28.3 tt0 -95.44 123.66 39.08 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.756 -1.84 . . . . 0.0 113.587 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -123.82 -45.63 0.28 Allowed Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 125.156 1.36 . . . . 0.0 112.809 170.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -95.37 -136.61 0.22 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.004 1.322 . . . . 0.0 111.386 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -78.76 -32.12 46.44 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.617 -1.927 . . . . 0.0 113.19 -174.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -141.07 165.84 26.15 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 105.997 -2.841 . . . . 0.0 105.997 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.71 152.22 21.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.206 1.479 . . . . 0.0 114.676 -168.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -107.01 -166.71 1.19 Allowed 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.423 -1.423 . . . . 0.0 109.947 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' A' ' 61' ' ' PHE . . . -147.33 156.23 42.72 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -173.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.58 162.41 36.68 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 56.45 40.31 29.66 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.628 1.571 . . . . 0.0 114.414 173.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 t -76.21 109.61 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 125.948 1.699 . . . . 0.0 110.62 -172.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.7 m -125.96 -121.85 0.25 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 123.8 0.84 . . . . 0.0 110.165 -161.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 119.88 162.84 12.02 Favored Glycine 0 N--CA 1.429 -1.787 0 O-C-N 119.335 -2.103 . . . . 0.0 111.691 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.77 156.52 48.59 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 123.363 2.709 . . . . 0.0 113.009 176.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.716 0 CA-C-O 117.821 -1.544 . . . . 0.0 112.35 178.784 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 CA--C 1.49 -1.365 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -90.58 -76.52 0.43 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.436 1.095 . . . . 0.0 113.297 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -67.95 130.07 41.83 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -166.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 t 70.73 86.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 127.336 2.255 . . . . 0.0 110.87 175.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.1 mp -80.74 -72.08 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 119.952 -1.718 . . . . 0.0 113.116 -166.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.19 167.89 28.86 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -160.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.9 p -110.96 134.37 52.64 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 128.188 2.595 . . . . 0.0 109.661 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.279 25.8 ttmt 59.18 75.67 0.39 Allowed 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.683 1.993 . . . . 0.0 116.046 -172.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.6 t -121.06 149.96 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 130.311 3.444 . . . . 0.0 105.739 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.7 mp -114.84 168.06 10.23 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 123.638 1.685 . . . . 0.0 112.232 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.73 -172.78 44.17 Favored Glycine 0 N--CA 1.43 -1.751 0 O-C-N 119.333 -2.104 . . . . 0.0 113.115 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.0 m -116.68 131.42 56.95 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 123.773 0.829 . . . . 0.0 109.511 -168.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.84 135.7 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 O-C-N 120.093 -1.63 . . . . 0.0 113.83 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -95.39 -56.08 2.83 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 120.098 -1.626 . . . . 0.0 109.841 173.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -156.46 130.66 8.61 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 123.972 0.909 . . . . 0.0 110.438 177.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -101.71 123.36 45.56 Favored 'General case' 0 N--CA 1.431 -1.384 0 O-C-N 120.607 -1.308 . . . . 0.0 107.965 164.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -102.52 76.9 1.57 Allowed 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.407 -1.433 . . . . 0.0 110.471 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 t -75.82 -7.5 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 123.523 1.63 . . . . 0.0 112.437 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -64.55 -30.07 71.1 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 128.814 2.846 . . . . 0.0 112.85 173.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -127.83 -46.06 1.42 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.728 -1.857 . . . . 0.0 111.444 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.45 -57.38 0.21 Allowed Glycine 0 N--CA 1.429 -1.779 0 O-C-N 119.475 -2.015 . . . . 0.0 115.929 -174.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -79.57 169.42 18.04 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.847 1.784 . . . . 0.0 114.916 -166.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.26 167.78 31.33 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 118.913 -2.367 . . . . 0.0 109.479 169.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -147.06 141.59 26.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 123.012 1.387 . . . . 0.0 111.923 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 mm -113.26 160.76 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 126.812 2.045 . . . . 0.0 108.926 -169.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -109.77 99.82 8.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.551 -1.343 . . . . 0.0 110.927 161.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.76 138.41 47.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.276 2.23 . . . . 0.0 114.93 170.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -62.48 84.95 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.607 2.447 . . . . 0.0 117.607 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -159.42 -76.12 0.07 Allowed 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.403 -2.061 . . . . 0.0 109.251 177.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.6 t -139.67 30.05 2.11 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 55.65 81.76 0.11 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.0 2.12 . . . . 0.0 114.202 -165.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -101.78 137.21 40.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.85 -1.781 . . . . 0.0 108.189 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -79.98 110.11 15.05 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 121.626 0.727 . . . . 0.0 109.925 -171.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.3 t -111.73 117.21 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -89.28 144.26 26.22 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.14 0.972 . . . . 0.0 112.957 -176.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -133.01 128.47 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 122.635 1.207 . . . . 0.0 110.847 -172.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -95.96 154.84 17.02 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.571 -1.331 . . . . 0.0 110.338 173.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -64.1 -26.1 68.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.235 -2.166 . . . . 0.0 116.443 -171.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.0 p -69.39 -27.31 65.19 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.543 -1.348 . . . . 0.0 113.755 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.83 -19.52 40.9 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.452 -1.405 . . . . 0.0 113.175 -174.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.6 mt -75.02 117.32 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 C-N-CA 126.751 2.02 . . . . 0.0 111.768 -178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -81.37 92.56 6.43 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.543 -1.348 . . . . 0.0 112.423 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -83.25 128.54 34.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.507 -1.371 . . . . 0.0 109.169 168.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -128.75 -39.91 1.59 Allowed 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 121.116 -0.99 . . . . 0.0 112.526 -173.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -107.58 138.26 19.93 Favored Pre-proline 0 N--CA 1.429 -1.48 0 O-C-N 121.189 -0.944 . . . . 0.0 111.11 -165.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.8 -15.96 14.83 Favored 'Trans proline' 0 N--CA 1.434 -1.979 0 C-N-CA 122.795 2.33 . . . . 0.0 113.605 177.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -100.3 162.9 12.66 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 119.624 1.102 . . . . 0.0 111.635 -171.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.281 31.9 mtmm 59.32 -156.52 0.34 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.44 1.896 . . . . 0.0 115.336 -173.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.2 t80 51.31 65.92 1.34 Allowed 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 127.505 2.322 . . . . 0.0 114.947 -172.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.3 mt -88.32 -143.21 0.13 Allowed 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.748 -1.22 . . . . 0.0 112.444 -171.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -75.87 -63.54 1.28 Allowed 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.654 -1.904 . . . . 0.0 112.486 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 65.4 m -77.04 145.81 37.73 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 124.945 1.298 . . . . 0.0 112.12 -177.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 m -106.52 157.8 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 120.486 -1.383 . . . . 0.0 112.842 -172.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.11 143.65 21.33 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 120.504 -1.373 . . . . 0.0 109.938 172.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -76.75 117.39 18.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.171 1.462 . . . . 0.0 112.95 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.56 55.14 21.97 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 116.734 1.454 . . . . 0.0 116.734 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -73.18 150.77 41.87 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 119.184 1.492 . . . . 0.0 113.06 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 m -99.6 145.16 27.86 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.996 -1.065 . . . . 0.0 110.904 -172.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.1 m -143.08 163.14 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 125.866 1.666 . . . . 0.0 108.028 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -113.58 153.57 28.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.234 1.414 . . . . 0.0 110.461 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -164.7 172.91 12.48 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.976 0.893 . . . . 0.0 110.632 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -92.32 152.59 19.7 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.887 -2.383 . . . . 0.0 108.662 162.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.3 t -112.11 100.71 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 119.535 -1.978 . . . . 0.0 107.547 173.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 m -132.96 128.27 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 120.412 -1.43 . . . . 0.0 108.316 -168.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -96.31 150.77 20.2 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.905 -2.372 . . . . 0.0 114.4 -163.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -151.11 -68.55 0.01 OUTLIER Glycine 0 N--CA 1.432 -1.622 0 O-C-N 121.116 -0.99 . . . . 0.0 111.549 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -78.3 -145.37 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.4 1.48 . . . . 0.0 114.46 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -62.87 -22.42 66.69 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 119.841 -1.787 . . . . 0.0 115.579 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.72 -167.61 13.48 Favored Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 127.245 2.355 . . . . 0.0 108.383 175.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.11 161.31 15.15 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.09 -168.1 1.61 Allowed 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.838 -1.164 . . . . 0.0 110.626 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.06 155.68 44.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.87 1.319 . . . . 0.0 112.136 -166.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.1 166.02 24.35 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.593 1.957 . . . . 0.0 106.531 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.336 0.4 OUTLIER 34.51 63.36 0.45 Allowed 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 117.845 2.535 . . . . 0.0 117.845 -178.513 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.1 t -92.15 98.11 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 C-N-CA 125.097 1.359 . . . . 0.0 111.017 -168.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.94 155.63 22.38 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.607 1.163 . . . . 0.0 110.612 -174.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -136.13 155.23 22.31 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 168.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -79.74 178.61 7.11 Favored 'Trans proline' 0 N--CA 1.434 -1.997 0 C-N-CA 123.273 2.649 . . . . 0.0 111.702 170.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.735 0 CA-C-O 118.704 -1.053 . . . . 0.0 111.046 171.913 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ttt . . . . . 0 CA--C 1.49 -1.34 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -80.89 -54.03 5.95 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.003 -1.685 . . . . 0.0 111.896 175.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -69.63 -67.99 0.44 Allowed 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -167.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.1 t -97.16 104.57 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 120.66 -1.275 . . . . 0.0 107.845 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.9 mp -86.38 -53.03 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 119.664 -1.898 . . . . 0.0 111.159 -165.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.92 160.5 24.94 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.5 p -115.5 148.4 39.53 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.575 1.55 . . . . 0.0 108.522 166.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.264 26.9 mmmt 53.38 83.01 0.07 Allowed 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.42 2.288 . . . . 0.0 115.512 -168.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.2 t -128.43 143.8 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 126.581 1.953 . . . . 0.0 107.153 -164.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.2 148.55 28.76 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.693 1.235 . . . . 0.0 109.613 174.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.12 179.79 41.59 Favored Glycine 0 N--CA 1.429 -1.788 0 O-C-N 120.796 -1.19 . . . . 0.0 111.376 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.9 m -115.26 135.3 54.3 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 124.635 1.174 . . . . 0.0 109.129 -169.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 50.2 t -84.27 124.8 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 120.387 -1.446 . . . . 0.0 109.441 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -97.41 -57.74 2.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.482 -1.386 . . . . 0.0 108.986 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.9 t-105 -144.56 96.42 2.87 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.0 0.92 . . . . 0.0 109.16 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -98.1 129.7 44.91 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.805 -1.184 . . . . 0.0 108.013 167.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -100.18 105.84 17.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.269 -1.519 . . . . 0.0 109.781 -177.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.4 t -77.23 -26.02 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 126.006 1.722 . . . . 0.0 112.144 -173.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -66.06 -45.87 79.79 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.233 -1.542 . . . . 0.0 112.815 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -78.59 -45.9 20.59 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.936 -1.728 . . . . 0.0 110.74 164.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.96 49.23 1.5 Allowed Glycine 0 N--CA 1.43 -1.723 0 CA-C-O 122.948 1.305 . . . . 0.0 110.287 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -155.71 152.6 28.78 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -162.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.32 -151.22 18.73 Favored Glycine 0 N--CA 1.43 -1.709 0 O-C-N 120.125 -1.61 . . . . 0.0 109.82 169.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -140.15 167.03 23.08 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.449 -1.03 . . . . 0.0 110.263 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.536 HG21 ' CE1' ' A' ' 61' ' ' PHE . 4.5 mm -109.63 155.81 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 170.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -92.25 104.93 17.24 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.416 -1.428 . . . . 0.0 109.305 161.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.0 ttt85 -66.22 114.75 5.55 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.548 -1.345 . . . . 0.0 109.573 153.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -64.81 -39.02 92.9 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -167.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -43.82 -52.45 6.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 128.585 2.754 . . . . 0.0 117.126 -169.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -143.22 33.89 1.34 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.862 -1.774 . . . . 0.0 106.565 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 57.38 58.51 3.8 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.57 1.548 . . . . 0.0 115.016 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -102.62 132.01 49.01 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.271 1.429 . . . . 0.0 109.025 -168.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -90.16 106.38 18.44 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 123.525 0.73 . . . . 0.0 110.135 -167.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t -105.53 109.04 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 121.027 -1.046 . . . . 0.0 110.37 -171.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -81.32 133.62 35.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.161 -1.587 . . . . 0.0 114.282 -171.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.1 p -129.7 133.3 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 120.37 -1.456 . . . . 0.0 111.92 -175.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -108.58 148.25 30.6 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.815 1.646 . . . . 0.0 108.66 173.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -58.1 -17.84 20.97 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 119.437 3.125 . . . . 0.0 119.437 -172.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.0 t -81.7 -12.06 58.79 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.386 -1.446 . . . . 0.0 113.268 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.73 -15.73 58.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.868 -2.395 . . . . 0.0 112.028 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.6 mt -82.48 124.41 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 126.062 1.745 . . . . 0.0 110.07 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -74.06 168.48 19.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -171.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -94.46 -50.66 5.11 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.351 -2.093 . . . . 0.0 112.766 -169.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -74.89 148.24 40.31 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 120.528 -1.358 . . . . 0.0 112.892 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -152.87 155.58 32.34 Favored Pre-proline 0 N--CA 1.43 -1.457 0 O-C-N 120.461 -1.4 . . . . 0.0 108.656 174.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.9 -34.81 1.62 Allowed 'Trans proline' 0 N--CA 1.434 -1.99 0 CA-C-N 122.905 2.073 . . . . 0.0 111.592 169.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -163.61 160.52 23.02 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 126.016 1.726 . . . . 0.0 108.642 173.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -155.81 173.08 17.26 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.449 ' HB3' ' H ' ' A' ' 50' ' ' LEU . 38.6 m-85 -86.81 -147.64 0.13 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.458 -1.401 . . . . 0.0 111.454 170.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.449 ' H ' ' HB3' ' A' ' 49' ' ' TYR . 1.2 tm? -75.61 -55.74 5.36 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.93 -1.731 . . . . 0.0 108.278 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 -139.71 -83.21 0.26 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 121.326 -0.859 . . . . 0.0 109.499 160.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.6 p -90.22 174.44 7.6 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -167.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.4 t -106.07 -49.73 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 C-N-CA 126.13 1.772 . . . . 0.0 108.808 -175.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 162.68 -148.22 14.93 Favored Glycine 0 N--CA 1.431 -1.685 0 O-C-N 120.295 -1.503 . . . . 0.0 111.792 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -78.47 126.51 30.86 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.333 -1.686 . . . . 0.0 113.002 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.9 35.72 44.0 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 120.184 -1.573 . . . . 0.0 114.51 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.25 152.56 34.62 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.803 1.287 . . . . 0.0 113.337 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.1 p -94.11 146.09 24.22 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.726 1.611 . . . . 0.0 112.48 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.4 t -139.21 140.79 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -93.54 141.64 28.24 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.382 1.086 . . . . 0.0 111.749 165.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.536 ' CE1' HG21 ' A' ' 25' ' ' ILE . 12.6 p90 -156.06 172.73 17.91 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.873 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -99.07 156.53 16.89 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 162.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.67 89.89 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 119.876 -1.765 . . . . 0.0 107.381 172.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 m -124.85 139.34 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 120.816 -1.177 . . . . 0.0 108.026 -164.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -59.06 128.16 35.84 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.404 -2.06 . . . . 0.0 115.516 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -116.75 -112.33 2.69 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 125.319 1.437 . . . . 0.0 111.09 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -107.82 -89.57 0.45 Allowed 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 124.911 1.285 . . . . 0.0 112.561 -175.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -79.2 10.07 3.95 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 118.922 -2.361 . . . . 0.0 115.122 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.36 -167.09 38.11 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 107.057 -2.417 . . . . 0.0 107.057 -172.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.29 156.22 28.16 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.295 -1.121 . . . . 0.0 113.755 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -124.85 -172.36 2.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.557 1.543 . . . . 0.0 111.252 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.38 140.36 30.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.757 1.265 . . . . 0.0 110.24 -162.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -138.33 149.37 45.56 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.626 -172.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 52.96 50.94 16.86 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.367 2.267 . . . . 0.0 113.839 -176.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.1 t -78.26 124.04 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 120.652 -1.28 . . . . 0.0 111.603 -165.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.0 m -113.52 -122.09 0.29 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.227 -0.921 . . . . 0.0 110.713 -169.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.0 -84.12 0.37 Allowed Glycine 0 N--CA 1.43 -1.7 0 O-C-N 119.85 -1.781 . . . . 0.0 112.544 -170.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.41 161.6 39.85 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 121.804 2.802 . . . . 0.0 113.153 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.823 0 CA-C-O 118.93 -0.928 . . . . 0.0 111.839 -173.478 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 CA--C 1.489 -1.368 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -132.11 -168.3 2.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.275 -1.515 . . . . 0.0 109.027 171.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.264 57.8 mtpt 75.38 -98.9 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.245 1.818 . . . . 0.0 115.494 169.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.443 HG13 HG12 ' A' ' 64' ' ' VAL . 71.7 t -99.72 105.51 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 120.047 -1.658 . . . . 0.0 106.799 167.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -92.75 -54.85 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 119.875 -1.766 . . . . 0.0 110.299 -168.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -160.58 151.9 19.27 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.731 1.253 . . . . 0.0 113.603 -177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.5 p -108.06 150.02 27.69 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.282 1.833 . . . . 0.0 112.562 168.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.258 83.2 mttt 56.95 70.0 0.69 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.215 1.806 . . . . 0.0 114.872 -173.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.2 t -122.47 143.7 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 126.69 1.996 . . . . 0.0 108.732 -163.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.8 mp -128.97 168.69 15.64 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 122.318 1.056 . . . . 0.0 110.832 171.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -165.07 -147.61 5.19 Favored Glycine 0 N--CA 1.431 -1.696 0 O-C-N 120.326 -1.484 . . . . 0.0 110.168 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.3 m -118.51 133.21 56.04 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 172.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.2 t -95.65 126.15 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 120.318 -1.489 . . . . 0.0 110.437 173.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -118.25 -60.2 1.81 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.797 -1.189 . . . . 0.0 110.309 167.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -85.99 109.39 18.75 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.506 -1.371 . . . . 0.0 112.357 -175.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -151.86 129.29 11.36 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.382 -1.449 . . . . 0.0 109.018 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -97.65 107.25 19.71 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.549 1.539 . . . . 0.0 107.61 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.8 t -82.99 -45.5 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 120.319 -1.488 . . . . 0.0 113.747 -155.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -55.11 -61.2 2.47 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.225 1.41 . . . . 0.0 112.041 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -66.14 -44.89 82.88 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 172.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.2 62.15 0.92 Allowed Glycine 0 N--CA 1.429 -1.77 0 O-C-N 121.248 -0.908 . . . . 0.0 113.831 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -149.15 159.63 44.07 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 121.372 -1.075 . . . . 0.0 110.82 173.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.26 -153.71 23.45 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 120.205 -1.56 . . . . 0.0 111.349 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -147.18 151.02 36.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.841 1.305 . . . . 0.0 111.237 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 mt -105.51 159.51 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 120.206 -1.559 . . . . 0.0 108.475 -173.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -117.05 92.22 3.8 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.38 1.562 . . . . 0.0 109.721 167.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -63.48 149.35 46.33 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.427 1.891 . . . . 0.0 113.686 172.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -71.86 -19.65 61.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -76.25 -81.33 0.08 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.505 -1.997 . . . . 0.0 115.627 -163.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 t -114.17 -1.51 13.64 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.096 1.426 . . . . 0.0 108.652 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.3 mptt 77.57 62.29 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.845 3.258 . . . . 0.0 108.251 171.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -102.82 131.65 49.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 112.878 -1.965 . . . . 0.0 107.439 -165.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -85.72 109.46 18.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.967 -1.708 . . . . 0.0 110.854 -164.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.449 ' CG1' ' HB2' ' A' ' 72' ' ' ALA . 48.4 t -105.65 111.26 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.752 1.621 . . . . 0.0 107.39 -169.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -90.78 145.88 24.42 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.744 1.218 . . . . 0.0 111.606 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.34 133.85 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.566 1.65 . . . . 0.0 109.74 -174.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.419 ' CD2' ' H ' ' A' ' 38' ' ' GLN . 19.8 t-80 -119.58 162.5 18.84 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.574 1.55 . . . . 0.0 112.276 -175.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.419 ' H ' ' CD2' ' A' ' 37' ' ' HIS . 41.8 mt-30 -43.26 -55.65 3.9 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 129.301 3.04 . . . . 0.0 117.575 -173.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.6 t -80.96 -9.74 59.8 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.589 -1.319 . . . . 0.0 114.089 -172.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.38 -20.8 46.82 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.687 -1.883 . . . . 0.0 112.695 174.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.4 mt -79.03 124.15 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 126.005 1.722 . . . . 0.0 110.583 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -94.71 133.09 38.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.544 -1.347 . . . . 0.0 112.297 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -145.96 132.88 20.18 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.454 1.102 . . . . 0.0 110.05 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -76.73 -80.39 0.1 Allowed 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.442 1.497 . . . . 0.0 109.575 169.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -106.35 117.96 55.92 Favored Pre-proline 0 N--CA 1.431 -1.419 0 O-C-N 120.727 -1.233 . . . . 0.0 108.046 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.59 89.05 1.31 Allowed 'Trans proline' 0 C--N 1.3 -2.019 0 C-N-CA 123.065 2.51 . . . . 0.0 112.524 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -107.77 174.15 6.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 124.348 1.059 . . . . 0.0 109.927 175.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -61.83 -53.35 57.03 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.544 1.537 . . . . 0.0 115.074 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 66.32 159.74 0.13 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.239 2.616 . . . . 0.0 114.34 -171.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.3 tp -88.84 147.46 24.39 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.706 -1.871 . . . . 0.0 108.881 168.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -85.16 107.53 17.27 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.151 -1.593 . . . . 0.0 110.665 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.6 t -96.26 -55.77 2.84 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.928 1.291 . . . . 0.0 108.73 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.5 m -108.54 154.09 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 122.533 1.158 . . . . 0.0 109.295 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.1 -70.23 0.03 OUTLIER Glycine 0 N--CA 1.429 -1.784 0 O-C-N 119.887 -1.758 . . . . 0.0 111.351 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -74.04 107.1 6.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.599 -1.53 . . . . 0.0 110.522 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.08 39.75 31.6 Favored Glycine 0 N--CA 1.431 -1.684 0 O-C-N 120.582 -1.323 . . . . 0.0 114.513 -170.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.1 156.76 28.17 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 120.696 -1.473 . . . . 0.0 114.898 -175.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.43 148.1 31.7 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.705 2.002 . . . . 0.0 111.022 -175.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.8 p -155.15 145.36 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.325 1.85 . . . . 0.0 106.56 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -91.8 144.46 25.47 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 120.315 1.416 . . . . 0.0 111.88 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -151.08 169.85 20.83 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.899 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -112.94 133.17 55.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 168.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.4 t -89.32 87.12 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 120.353 -1.467 . . . . 0.0 109.585 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.443 HG12 HG13 ' A' ' 4' ' ' VAL . 2.1 m -130.06 107.35 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 120.282 -1.511 . . . . 0.0 109.396 -168.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -139.95 -111.29 0.15 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.61 -1.306 . . . . 0.0 109.456 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 137.28 -55.15 0.7 Allowed Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 114.059 0.384 . . . . 0.0 114.059 -169.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -101.75 -69.78 0.77 Allowed 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.324 -1.103 . . . . 0.0 112.624 -172.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -87.09 57.28 4.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.392 -1.443 . . . . 0.0 114.6 -170.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.43 -117.29 4.49 Favored Glycine 0 N--CA 1.43 -1.719 0 O-C-N 119.43 -2.044 . . . . 0.0 110.642 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.46 169.65 13.42 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 122.899 1.333 . . . . 0.0 112.951 169.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.497 ' HG3' ' H ' ' A' ' 72' ' ' ALA . 6.2 tt0 -145.84 178.8 7.9 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.405 2.282 . . . . 0.0 105.169 -176.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.497 ' H ' ' HG3' ' A' ' 71' ' ' GLU . . . -147.14 125.36 12.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.973 2.109 . . . . 0.0 107.061 -173.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.76 160.18 33.33 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 124.378 1.071 . . . . 0.0 108.296 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 60.1 45.76 11.45 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.936 2.094 . . . . 0.0 112.952 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.6 t -87.59 104.16 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-O 122.108 0.956 . . . . 0.0 111.806 -162.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.83 148.65 50.22 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.003 0.921 . . . . 0.0 109.51 -169.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -136.87 -172.81 12.66 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 120.212 -1.555 . . . . 0.0 111.968 -176.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.36 160.01 29.23 Favored 'Trans proline' 0 N--CA 1.434 -1.99 0 C-N-CA 123.081 2.521 . . . . 0.0 113.522 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.795 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 178.655 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ttt . . . . . 0 CA--C 1.489 -1.371 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.7 ptmm? -78.08 -29.24 49.01 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.223 -1.548 . . . . 0.0 112.549 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -78.25 150.12 33.48 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.334 -1.479 . . . . 0.0 111.934 169.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.653 HG12 ' H ' ' A' ' 65' ' ' GLU . 9.4 m -123.28 165.8 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 121.048 -1.032 . . . . 0.0 110.179 -176.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.41 HD13 HG11 ' A' ' 63' ' ' VAL . 4.2 mp -87.64 -65.34 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 119.468 -2.02 . . . . 0.0 111.082 -174.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.32 161.46 24.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.9 p -110.66 143.13 41.59 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.36 1.464 . . . . 0.0 110.22 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.27 92.2 mttt 60.95 73.15 0.49 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.225 2.21 . . . . 0.0 115.446 -170.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.7 t -126.11 159.22 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 129.557 3.143 . . . . 0.0 107.564 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.8 170.55 12.64 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.128 -1.608 . . . . 0.0 111.662 170.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.76 -170.26 34.0 Favored Glycine 0 N--CA 1.43 -1.725 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.7 m -116.98 127.89 54.64 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.821 1.296 . . . . 0.0 109.874 -166.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 t -91.85 147.32 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 127.015 2.126 . . . . 0.0 110.437 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -105.37 -86.95 0.46 Allowed 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.055 -1.653 . . . . 0.0 109.78 164.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 22.6 t-105 -155.1 140.29 17.54 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.725 -1.234 . . . . 0.0 108.317 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -97.77 155.84 16.85 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.791 -1.193 . . . . 0.0 113.614 -175.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -95.22 93.39 7.28 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.53 -1.356 . . . . 0.0 109.04 174.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.9 m -73.32 -30.64 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -172.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -56.49 -65.08 0.67 Allowed 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 125.312 1.445 . . . . 0.0 112.37 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -72.01 -35.17 69.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.546 -1.971 . . . . 0.0 113.174 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.84 51.61 1.63 Allowed Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -129.93 140.43 50.94 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 121.325 -1.103 . . . . 0.0 108.405 -170.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.05 161.15 32.98 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.503 -1.373 . . . . 0.0 111.147 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -142.09 157.84 44.44 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.946 -0.738 . . . . 0.0 109.464 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.3 mm -109.24 147.34 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 124.907 1.283 . . . . 0.0 108.634 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -92.93 93.89 8.62 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.907 -1.121 . . . . 0.0 109.037 169.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.19 133.56 37.75 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 174.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -82.54 48.0 1.25 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -171.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.95 -68.45 0.7 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.692 -1.88 . . . . 0.0 109.474 163.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -150.34 35.33 0.64 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 57.87 75.99 0.35 Allowed 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 127.234 2.214 . . . . 0.0 112.856 -159.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -103.06 128.35 49.96 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.561 -1.962 . . . . 0.0 106.675 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -82.11 122.14 27.47 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.651 1.691 . . . . 0.0 110.252 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.07 108.38 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 O-C-N 120.568 -1.333 . . . . 0.0 108.407 -173.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -76.06 140.05 41.72 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.76 -1.213 . . . . 0.0 113.661 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.8 t -128.44 126.2 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.766 -1.209 . . . . 0.0 108.416 -177.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -111.92 165.6 11.95 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.01 1.324 . . . . 0.0 110.592 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.1 mm100 -59.58 -36.98 77.32 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 m -69.86 -14.63 62.84 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.727 -1.858 . . . . 0.0 113.433 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.19 -25.4 58.22 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.536 -2.602 . . . . 0.0 114.909 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 89.1 mt -79.44 126.02 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 125.741 1.616 . . . . 0.0 111.597 -175.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -73.43 -74.91 0.16 Allowed 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 120.615 -1.303 . . . . 0.0 112.678 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -91.59 128.47 37.43 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 121.059 -1.025 . . . . 0.0 110.813 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -90.13 138.2 31.71 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.598 -1.314 . . . . 0.0 112.277 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -108.9 158.33 34.48 Favored Pre-proline 0 N--CA 1.431 -1.397 0 C-N-CA 125.625 1.57 . . . . 0.0 114.076 -163.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -83.18 -170.88 0.98 Allowed 'Trans proline' 0 C--N 1.3 -2.026 0 C-N-CA 122.59 2.193 . . . . 0.0 112.616 170.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -106.99 134.16 50.56 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 161.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -123.4 136.34 54.58 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -97.93 56.82 1.26 Allowed 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.505 -1.372 . . . . 0.0 110.899 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.4 tp -105.34 149.61 25.92 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.321 -1.487 . . . . 0.0 109.517 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -101.49 79.79 2.0 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.882 -1.762 . . . . 0.0 110.359 173.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.3 p -107.02 -85.57 0.51 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.82 1.248 . . . . 0.0 110.399 -172.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 m -108.42 -106.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 126.434 1.894 . . . . 0.0 111.983 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.58 -114.59 4.29 Favored Glycine 0 N--CA 1.43 -1.7 0 C-N-CA 124.926 1.25 . . . . 0.0 110.76 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -71.04 111.39 6.37 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.977 1.311 . . . . 0.0 109.753 174.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.75 -20.5 5.15 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 121.176 -0.952 . . . . 0.0 114.361 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.71 155.16 38.0 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.107 -1.819 . . . . 0.0 115.104 -174.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.72 143.31 39.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.719 2.008 . . . . 0.0 110.734 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.06 146.86 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -92.85 144.44 25.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -158.44 170.76 21.48 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.321 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -94.78 141.6 28.44 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.834 -1.791 . . . . 0.0 107.845 168.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.41 HG11 HD13 ' A' ' 5' ' ' ILE . 42.8 t -95.51 106.38 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 O-C-N 119.197 -2.19 . . . . 0.0 108.806 171.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.65 136.72 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 120.879 -1.138 . . . . 0.0 108.06 -170.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.653 ' H ' HG12 ' A' ' 4' ' ' VAL . 23.4 tt0 -120.64 166.33 13.83 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.631 -1.918 . . . . 0.0 111.407 -166.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.54 -44.68 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.892 -1.13 . . . . 0.0 111.791 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -123.67 -145.47 0.34 Allowed 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 124.682 1.193 . . . . 0.0 113.322 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -74.37 -18.85 60.62 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.88 -1.762 . . . . 0.0 114.476 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.99 139.07 8.7 Favored Glycine 0 N--CA 1.429 -1.79 0 O-C-N 120.413 -1.429 . . . . 0.0 109.551 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.22 164.32 22.38 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -172.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -120.53 -168.04 1.57 Allowed 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.872 2.069 . . . . 0.0 111.222 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.11 155.86 43.57 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -169.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -152.51 161.91 41.93 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -174.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 56.13 51.01 12.48 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 125.138 1.375 . . . . 0.0 114.522 170.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.1 t -95.07 108.5 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 124.569 1.148 . . . . 0.0 109.14 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.7 m -83.03 -82.85 0.14 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.301 -1.499 . . . . 0.0 111.729 -176.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.43 101.39 0.45 Allowed Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 126.248 1.88 . . . . 0.0 112.979 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.87 158.89 45.93 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 CA-C-N 123.985 3.893 . . . . 0.0 113.55 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.802 0 C-N-CA 124.37 0.986 . . . . 0.0 112.406 -179.513 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptm . . . . . 0 CA--C 1.489 -1.386 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.251 20.1 tptm 60.83 -72.2 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 118.129 2.64 . . . . 0.0 118.129 175.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.531 ' HA ' HG12 ' A' ' 64' ' ' VAL 0.269 90.9 mttt 76.79 88.27 0.08 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.979 2.112 . . . . 0.0 114.642 174.52 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.4 t -113.97 -72.54 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 121.02 -1.05 . . . . 0.0 113.574 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.464 HD13 HG12 ' A' ' 63' ' ' VAL . 3.4 mp -84.56 -69.6 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 119.35 -2.094 . . . . 0.0 107.505 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -149.67 153.78 37.54 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -171.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.9 p -110.59 149.31 30.59 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.29 2.236 . . . . 0.0 110.508 170.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.267 87.7 mttt 53.44 67.81 0.94 Allowed 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.567 1.692 . . . . 0.0 115.567 -172.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.8 t -120.39 142.73 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 127.742 2.417 . . . . 0.0 109.123 -163.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.19 149.43 24.67 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.678 1.228 . . . . 0.0 112.051 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.23 171.44 44.46 Favored Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.6 m -112.3 136.93 51.14 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.115 0.966 . . . . 0.0 110.876 -163.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.5 t -103.39 122.86 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 124.527 1.131 . . . . 0.0 108.53 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -154.53 99.74 2.2 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.144 -1.597 . . . . 0.0 109.195 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . 0.312 37.2 m95 77.83 154.11 0.14 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.908 2.083 . . . . 0.0 113.956 -170.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.81 -167.79 2.1 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.775 -1.203 . . . . 0.0 111.286 -165.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -127.41 64.1 1.34 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.442 -1.411 . . . . 0.0 109.781 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 m -67.57 -23.8 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 126.929 2.091 . . . . 0.0 115.704 -174.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -58.89 -48.77 80.26 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.438 -2.039 . . . . 0.0 114.393 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -93.25 -37.4 12.08 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.681 -1.262 . . . . 0.0 111.317 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.93 57.12 0.43 Allowed Glycine 0 N--CA 1.43 -1.709 0 O-C-N 120.064 -1.647 . . . . 0.0 113.162 173.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -139.43 166.89 23.36 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 124.522 1.129 . . . . 0.0 108.09 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -127.81 161.34 21.79 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 120.929 -1.107 . . . . 0.0 110.971 174.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -140.78 146.57 37.83 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 121.257 -1.143 . . . . 0.0 109.376 170.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mt -108.81 147.8 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 125.747 1.619 . . . . 0.0 108.427 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -101.73 95.2 6.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.096 0.95 . . . . 0.0 109.442 169.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -69.04 128.88 38.25 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.275 14.9 p30 -74.57 107.16 6.52 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -176.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -166.97 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.234 1.414 . . . . 0.0 108.224 173.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.0 t -139.84 43.14 1.96 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 102.725 -3.065 . . . . 0.0 102.725 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.6 mptt 51.12 73.39 0.3 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.177 2.191 . . . . 0.0 114.101 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -103.05 133.59 47.91 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.814 -1.804 . . . . 0.0 110.056 -169.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.89 114.28 26.8 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 123.761 0.824 . . . . 0.0 110.22 -164.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.5 t -114.04 113.2 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -173.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . 0.264 0.1 OUTLIER -85.81 145.26 27.3 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.054 -1.654 . . . . 0.0 112.296 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.3 p -137.45 142.82 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 122.449 1.119 . . . . 0.0 110.759 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -98.79 140.99 32.16 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.39 1.876 . . . . 0.0 108.558 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -56.42 -36.84 69.41 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -171.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 t -66.8 -18.01 65.16 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.43 -21.4 38.9 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.406 -2.059 . . . . 0.0 112.347 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.1 mt -83.75 145.48 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 125.653 1.581 . . . . 0.0 108.497 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.68 143.95 4.76 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -157.27 168.19 28.11 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.596 -1.315 . . . . 0.0 110.833 -165.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.4 m120 69.53 -49.13 0.61 Allowed 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 127.696 2.399 . . . . 0.0 116.025 175.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -75.68 109.71 8.71 Favored Pre-proline 0 N--CA 1.431 -1.41 0 O-C-N 120.427 -1.42 . . . . 0.0 110.858 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.37 164.8 26.14 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-N 122.65 1.982 . . . . 0.0 111.884 -171.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -121.52 93.33 3.97 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.149 0.976 . . . . 0.0 108.896 173.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -92.85 70.49 4.72 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.192 1.397 . . . . 0.0 113.793 -162.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -108.49 -171.62 1.89 Allowed 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 120.055 -1.653 . . . . 0.0 108.056 169.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.4 mt -82.16 -86.83 0.1 Allowed 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.97 -1.706 . . . . 0.0 109.068 167.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -91.12 136.44 33.08 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.06 -1.65 . . . . 0.0 113.513 -176.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.4 t -133.22 -169.38 2.26 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 124.692 1.197 . . . . 0.0 109.706 168.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.8 m -119.12 169.99 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 127.118 2.167 . . . . 0.0 110.41 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.26 -58.63 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.74 0 O-C-N 119.757 -1.839 . . . . 0.0 113.32 177.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -72.36 90.69 1.29 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.315 1.446 . . . . 0.0 110.261 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.04 12.84 17.11 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.189 -1.569 . . . . 0.0 113.616 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -77.51 158.32 29.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.249 -1.736 . . . . 0.0 115.397 171.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.81 148.47 24.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 121.013 -1.054 . . . . 0.0 109.407 175.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 m -138.37 157.74 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 125.573 1.549 . . . . 0.0 109.473 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -102.08 142.58 33.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.061 1.344 . . . . 0.0 111.634 171.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -161.35 -176.45 5.39 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 124.072 0.949 . . . . 0.0 110.704 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -113.67 148.17 36.82 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 120.559 -1.338 . . . . 0.0 108.106 168.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.464 HG12 HD13 ' A' ' 5' ' ' ILE . 42.8 t -100.89 85.54 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 119.361 -2.087 . . . . 0.0 109.846 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' A' ' 3' ' ' LYS . 3.7 m -136.12 85.56 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.484 -2.635 . . . . 0.0 115.406 -157.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -144.26 -77.82 0.21 Allowed 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.844 -2.41 . . . . 0.0 112.564 170.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.71 -49.19 0.87 Allowed Glycine 0 N--CA 1.431 -1.694 0 O-C-N 120.979 -1.075 . . . . 0.0 114.476 175.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -68.25 -54.82 15.02 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.457 -1.613 . . . . 0.0 113.67 -169.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -92.18 -59.17 2.16 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.451 -1.406 . . . . 0.0 109.673 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.13 -103.79 0.19 Allowed Glycine 0 N--CA 1.43 -1.715 0 O-C-N 120.527 -1.358 . . . . 0.0 110.528 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.93 149.83 50.63 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.967 -1.314 . . . . 0.0 113.275 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.9 -177.89 4.48 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 124.745 1.218 . . . . 0.0 108.994 161.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.09 154.08 44.64 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 121.947 0.879 . . . . 0.0 111.274 -168.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.37 143.8 32.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.423 1.089 . . . . 0.0 109.482 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 53.43 59.66 4.22 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.102 2.561 . . . . 0.0 115.21 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.6 t -92.17 127.81 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 120.959 -1.088 . . . . 0.0 111.752 -164.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.1 t -155.07 -179.39 8.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.412 1.101 . . . . 0.0 110.508 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -86.63 147.93 21.57 Favored Glycine 0 N--CA 1.43 -1.734 0 CA-C-O 117.246 -1.863 . . . . 0.0 112.02 -176.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -66.87 148.22 81.96 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 CA-C-N 123.328 3.564 . . . . 0.0 116.094 -172.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.801 0 CA-C-O 118.635 -1.092 . . . . 0.0 110.701 179.007 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.1 ttm . . . . . 0 CA--C 1.489 -1.371 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -107.77 168.74 9.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.345 -1.472 . . . . 0.0 110.032 158.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -48.45 103.29 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 129.494 3.117 . . . . 0.0 117.705 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.574 HG13 HG12 ' A' ' 64' ' ' VAL . 61.8 t 61.9 103.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 127.373 2.269 . . . . 0.0 113.784 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.563 HG21 HH12 ' A' ' 27' ' ' ARG . 4.2 mp -90.43 -50.55 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 119.762 -1.836 . . . . 0.0 111.051 -171.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.31 165.89 14.91 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.658 0.742 . . . . 0.0 112.492 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.1 p -107.79 159.71 16.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.203 1.801 . . . . 0.0 109.17 165.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.4 tptt 48.53 65.76 1.26 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -175.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 88.7 t -112.04 151.22 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 128.096 2.558 . . . . 0.0 108.158 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -108.78 156.88 19.11 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.862 1.792 . . . . 0.0 110.247 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.09 179.25 41.9 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 120.172 -1.58 . . . . 0.0 109.628 173.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 m -113.7 130.93 56.34 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.708 0.803 . . . . 0.0 110.335 -169.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.0 t -98.06 122.56 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 125.766 1.627 . . . . 0.0 110.986 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -110.95 -59.54 1.95 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.063 -1.648 . . . . 0.0 110.612 174.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.9 t90 -69.83 -79.29 0.06 Allowed 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.569 1.548 . . . . 0.0 114.798 -166.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.8 t80 75.1 114.69 0.06 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.718 2.407 . . . . 0.0 113.249 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.429 HD21 ' HB3' ' A' ' 20' ' ' ASN . 64.4 t-20 -110.99 124.64 52.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.064 -1.648 . . . . 0.0 109.822 -175.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.1 t -107.96 -47.58 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 120.684 -1.26 . . . . 0.0 110.769 171.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -63.77 -30.79 71.85 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -167.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.429 ' HB3' HD21 ' A' ' 17' ' ' ASN . 59.6 t30 -107.53 -25.29 11.44 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 121.345 -0.847 . . . . 0.0 111.851 166.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.56 -43.69 1.62 Allowed Glycine 0 N--CA 1.43 -1.709 0 O-C-N 118.983 -2.323 . . . . 0.0 114.236 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -75.71 105.72 6.9 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 124.792 1.237 . . . . 0.0 112.8 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.13 175.45 21.3 Favored Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 124.84 1.209 . . . . 0.0 111.325 -176.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -143.26 145.57 32.86 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 123.021 1.391 . . . . 0.0 113.433 171.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.2 mt -107.75 147.79 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 125.054 1.342 . . . . 0.0 108.964 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -93.92 87.85 5.52 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 122.674 1.226 . . . . 0.0 108.951 173.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.563 HH12 HG21 ' A' ' 5' ' ' ILE . 2.3 tmt_? -66.52 112.82 4.3 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.925 -1.734 . . . . 0.0 114.522 172.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -85.41 25.78 0.99 Allowed 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 117.43 2.382 . . . . 0.0 117.43 -160.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -73.37 -51.14 18.45 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.46 -1.4 . . . . 0.0 111.416 170.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.3 t -146.4 24.59 1.26 Allowed 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.09 76.37 0.29 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 127.516 2.327 . . . . 0.0 111.153 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -109.85 133.15 53.48 Favored 'General case' 0 N--CA 1.428 -1.525 0 O-C-N 120.555 -1.34 . . . . 0.0 109.383 -176.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -81.87 110.82 17.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.493 1.616 . . . . 0.0 110.021 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.46 112.78 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.71 -1.244 . . . . 0.0 108.224 -171.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -85.18 129.28 34.83 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -172.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.4 t -127.41 123.19 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 124.994 1.318 . . . . 0.0 110.451 -168.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -93.12 160.79 14.69 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.183 -0.948 . . . . 0.0 112.001 171.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -60.41 -29.32 68.9 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.0 m -61.89 -33.37 74.09 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 125.843 1.657 . . . . 0.0 113.475 175.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.41 -17.17 60.84 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.193 -1.567 . . . . 0.0 114.294 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 72.7 mt -88.25 112.49 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 125.24 1.416 . . . . 0.0 110.261 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -126.16 142.97 51.31 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 124.741 1.216 . . . . 0.0 110.983 176.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -144.9 127.72 16.33 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.55 -1.344 . . . . 0.0 110.817 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -89.76 -44.84 9.71 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 121.095 -1.003 . . . . 0.0 112.96 176.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -100.56 108.77 54.92 Favored Pre-proline 0 N--CA 1.43 -1.426 0 O-C-N 120.421 -1.424 . . . . 0.0 112.783 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.16 127.31 14.88 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 CA-C-N 124.051 2.483 . . . . 0.0 111.198 159.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -100.54 156.11 17.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.855 1.662 . . . . 0.0 110.962 -165.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -72.16 123.01 21.99 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.366 -2.084 . . . . 0.0 116.192 -167.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . 0.27 4.8 t80 75.85 166.81 0.27 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.751 2.82 . . . . 0.0 113.81 174.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.11 139.94 30.06 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 119.68 -1.887 . . . . 0.0 111.097 177.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.268 41.7 mtm105 71.4 112.76 0.06 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.257 1.823 . . . . 0.0 114.614 -174.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.4 t -81.23 -70.37 0.54 Allowed 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.35 -1.469 . . . . 0.0 110.792 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 83.5 t -110.63 -53.01 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 O-C-N 120.457 -1.402 . . . . 0.0 108.303 168.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 166.81 -124.65 1.24 Allowed Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -108.48 158.8 17.21 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 166.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.46 8.3 49.83 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 120.079 -1.638 . . . . 0.0 114.518 -177.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -75.71 166.5 23.46 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.334 1.454 . . . . 0.0 114.551 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.98 148.85 22.21 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.43 1.892 . . . . 0.0 112.776 175.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 p -147.2 153.14 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 126.995 2.118 . . . . 0.0 106.05 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -104.3 147.86 27.02 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 120.104 1.32 . . . . 0.0 110.707 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -159.78 169.67 23.13 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.256 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -97.28 147.47 24.11 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.051 -1.656 . . . . 0.0 107.202 170.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.0 t -106.86 95.71 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 O-C-N 119.204 -2.185 . . . . 0.0 109.323 175.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.574 HG12 HG13 ' A' ' 4' ' ' VAL . 0.9 OUTLIER -129.62 100.89 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 120.444 -1.41 . . . . 0.0 110.488 -162.15 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -160.25 -122.5 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.232 -1.542 . . . . 0.0 112.699 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.25 -145.48 4.14 Favored Glycine 0 N--CA 1.43 -1.723 0 C-N-CA 127.307 2.384 . . . . 0.0 110.036 -162.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -94.98 -34.87 12.2 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.72 -1.459 . . . . 0.0 114.208 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -66.08 -37.73 86.52 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.81 -1.182 . . . . 0.0 114.033 -167.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -162.81 -156.35 8.49 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 174.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.01 158.56 39.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.028 -1.278 . . . . 0.0 111.778 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -138.47 172.82 12.33 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 127.489 2.316 . . . . 0.0 106.374 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.03 154.63 42.72 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.702 -1.874 . . . . 0.0 107.762 -168.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -149.89 162.67 39.86 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 55.23 54.47 8.7 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.261 1.824 . . . . 0.0 113.563 173.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.3 t -87.69 127.49 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.796 -1.19 . . . . 0.0 110.353 -170.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.0 p -94.44 -176.28 3.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.987 1.375 . . . . 0.0 114.05 -168.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -150.72 75.33 0.25 Allowed Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 171.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.08 162.58 31.63 Favored 'Trans proline' 0 N--CA 1.433 -2.075 0 C-N-CA 122.52 2.147 . . . . 0.0 112.861 -170.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.796 0 CA-C-O 117.951 -1.472 . . . . 0.0 110.635 179.358 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptm . . . . . 0 CA--C 1.489 -1.385 0 N-CA-C 120.188 3.403 . . . . 0.0 120.188 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -72.36 -51.18 21.73 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.312 -2.118 . . . . 0.0 114.288 -168.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -79.14 -97.16 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.435 -1.416 . . . . 0.0 112.087 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.43 HG13 HG12 ' A' ' 64' ' ' VAL . 78.0 t 65.61 117.15 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 126.364 1.866 . . . . 0.0 115.498 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.3 mp -90.91 -57.46 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 119.633 -1.917 . . . . 0.0 110.392 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.49 160.74 26.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -168.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.8 p -106.58 157.59 17.57 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.592 2.757 . . . . 0.0 112.093 163.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.8 mttp 57.79 57.76 4.03 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.128 2.171 . . . . 0.0 114.602 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 t -115.97 152.19 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 C-N-CA 128.72 2.808 . . . . 0.0 107.741 -169.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -128.11 164.79 21.67 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 123.696 1.712 . . . . 0.0 114.15 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' A' ' 27' ' ' ARG . . . -168.79 -173.86 36.92 Favored Glycine 0 N--CA 1.431 -1.685 0 O-C-N 121.018 -1.051 . . . . 0.0 110.57 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.7 m -115.98 129.55 56.43 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.463 1.601 . . . . 0.0 108.365 -172.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.3 p -87.19 147.51 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 120.567 -1.333 . . . . 0.0 112.474 -177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.8 mmtt -102.47 -99.14 0.28 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 162.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -147.29 -170.82 3.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 172.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -124.58 166.61 15.78 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 126.157 1.783 . . . . 0.0 108.305 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -87.9 91.37 8.74 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 162.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.9 m -68.12 -31.0 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 126.965 2.106 . . . . 0.0 113.794 -171.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -62.04 -43.58 98.53 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 124.622 1.169 . . . . 0.0 112.68 -175.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -92.01 -36.53 13.34 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 119.144 -2.223 . . . . 0.0 113.603 166.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.57 34.64 3.03 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 121.521 -0.737 . . . . 0.0 114.198 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -123.65 162.61 22.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.783 -1.422 . . . . 0.0 110.411 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.42 171.67 36.78 Favored Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 169.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -118.23 155.6 30.25 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 118.146 0.973 . . . . 0.0 112.077 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.8 mm -104.47 155.87 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 169.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -110.81 96.67 6.31 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 119.637 1.108 . . . . 0.0 110.589 168.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.422 ' HA ' ' HA3' ' A' ' 11' ' ' GLY . 44.0 ttt180 -36.12 147.65 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 131.158 3.783 . . . . 0.0 117.446 164.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -66.0 -7.03 14.76 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.818 2.525 . . . . 0.0 117.818 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -82.94 -78.51 0.21 Allowed 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.875 -1.765 . . . . 0.0 112.502 -171.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 t -120.55 10.52 11.12 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 121.857 2.117 . . . . 0.0 107.244 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.2 mptt 60.09 67.53 0.85 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.714 2.406 . . . . 0.0 112.049 -174.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -107.73 159.4 16.51 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.064 -1.023 . . . . 0.0 109.452 -168.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -84.71 95.11 8.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 124.44 1.096 . . . . 0.0 112.643 -172.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.8 t -109.85 110.6 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -85.16 148.7 25.98 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 120.473 -1.392 . . . . 0.0 113.574 -168.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.442 HG22 ' HB3' ' A' ' 72' ' ' ALA . 81.8 t -136.68 133.59 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 125.097 1.359 . . . . 0.0 109.138 -171.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -114.47 165.2 12.99 Favored 'General case' 0 N--CA 1.432 -1.366 0 C-N-CA 125.247 1.419 . . . . 0.0 111.057 172.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -63.51 -36.52 84.04 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -169.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.0 m -74.99 -19.81 59.93 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.958 1.303 . . . . 0.0 112.107 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.26 -26.59 60.31 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.519 -1.988 . . . . 0.0 112.79 173.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.0 mt -76.45 114.65 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.702 1.601 . . . . 0.0 109.713 170.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -108.34 132.91 53.24 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.778 -1.201 . . . . 0.0 109.353 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -85.59 90.26 7.94 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.797 -1.189 . . . . 0.0 110.894 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -88.01 -60.85 1.85 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.915 -1.116 . . . . 0.0 108.824 177.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -118.53 68.58 7.92 Favored Pre-proline 0 N--CA 1.43 -1.445 0 C-N-CA 124.656 1.182 . . . . 0.0 112.956 -177.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.0 104.32 1.88 Allowed 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 123.869 2.418 . . . . 0.0 113.427 -177.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.8 mmm-85 -107.72 154.0 22.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.554 1.169 . . . . 0.0 112.897 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -92.5 -93.38 0.15 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 124.984 1.314 . . . . 0.0 111.078 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.1 t80 60.04 52.34 5.22 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.647 2.379 . . . . 0.0 115.369 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.5 tp 74.2 -60.51 0.52 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.46 2.304 . . . . 0.0 114.477 177.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -134.72 146.95 49.92 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.358 1.463 . . . . 0.0 108.924 175.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.3 m -88.76 -63.53 1.28 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.077 1.751 . . . . 0.0 107.473 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.4 m -105.85 -177.74 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 C-N-CA 124.889 1.275 . . . . 0.0 111.646 -170.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 148.59 124.61 1.4 Allowed Glycine 0 N--CA 1.431 -1.657 0 O-C-N 120.64 -1.287 . . . . 0.0 109.953 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.0 t70 66.71 -137.98 0.14 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.825 1.25 . . . . 0.0 109.907 -169.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.79 87.17 0.47 Allowed Glycine 0 N--CA 1.43 -1.753 0 O-C-N 120.814 -1.179 . . . . 0.0 112.43 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -64.17 169.58 4.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.094 -1.827 . . . . 0.0 114.545 171.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.12 136.75 36.16 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 122.207 1.003 . . . . 0.0 110.814 172.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.3 m -123.06 151.01 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -100.14 152.61 20.06 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 121.169 -0.957 . . . . 0.0 110.254 171.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -161.21 -179.31 7.34 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.844 0.83 . . . . 0.0 110.358 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -105.06 154.48 20.09 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 164.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 64.0 t -112.61 90.3 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 119.675 -1.891 . . . . 0.0 106.632 174.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.43 HG12 HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -115.81 87.69 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 124.217 1.961 . . . . 0.0 107.174 -165.081 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -85.56 124.59 32.28 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.584 -1.322 . . . . 0.0 113.738 -171.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -124.16 -41.94 0.38 Allowed Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 125.239 1.4 . . . . 0.0 112.797 173.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -89.45 -136.23 0.11 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.322 1.449 . . . . 0.0 111.826 -172.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -85.06 -13.82 49.21 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 126.523 1.929 . . . . 0.0 112.245 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -166.46 167.61 39.58 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 105.574 -3.011 . . . . 0.0 105.574 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.67 165.41 15.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -162.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -115.84 -174.83 2.6 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.037 -1.04 . . . . 0.0 111.221 164.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.442 ' HB3' HG22 ' A' ' 36' ' ' VAL . . . -144.93 144.95 31.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.543 1.164 . . . . 0.0 108.687 -169.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.74 160.68 38.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 55.85 48.62 17.72 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.011 1.724 . . . . 0.0 114.309 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.1 t -88.05 138.79 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 124.332 1.053 . . . . 0.0 111.026 -165.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.0 p -109.14 -158.53 0.65 Allowed 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 124.18 1.943 . . . . 0.0 113.011 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 168.62 -173.99 43.28 Favored Glycine 0 N--CA 1.429 -1.781 0 O-C-N 119.559 -1.963 . . . . 0.0 109.68 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.76 -32.14 6.04 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 123.402 2.735 . . . . 0.0 111.857 168.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.748 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.002 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.9 mtp . . . . . 0 CA--C 1.489 -1.368 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 58.7 mttm 62.82 46.05 5.31 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -145.78 -28.65 0.43 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.988 -1.07 . . . . 0.0 113.693 -175.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.26 141.22 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.824 -1.798 . . . . 0.0 110.986 -160.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.463 HD13 HG12 ' A' ' 63' ' ' VAL . 4.8 mp -97.56 -50.24 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 O-C-N 119.629 -1.92 . . . . 0.0 106.436 165.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -158.3 161.49 37.68 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 123.356 0.662 . . . . 0.0 111.408 171.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.5 p -120.87 149.42 42.62 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.586 -1.321 . . . . 0.0 110.597 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.265 54.9 mttp 59.06 73.12 0.49 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.185 2.194 . . . . 0.0 113.866 -171.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.49 149.71 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 126.892 2.077 . . . . 0.0 109.2 -163.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -109.05 159.63 16.69 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 123.787 1.756 . . . . 0.0 112.798 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.73 -178.36 44.55 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.4 m -117.14 129.51 56.01 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -172.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.6 t -72.23 135.87 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 120.796 -1.19 . . . . 0.0 111.435 -175.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -95.14 -100.69 0.16 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.347 -1.47 . . . . 0.0 110.202 173.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -130.16 157.17 43.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.871 -1.768 . . . . 0.0 111.37 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -104.03 142.09 35.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.51 1.524 . . . . 0.0 109.921 172.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -118.15 100.54 7.59 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.945 1.698 . . . . 0.0 109.058 -175.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.17 -29.81 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 120.645 -1.284 . . . . 0.0 113.409 -158.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -58.39 -59.8 4.78 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.83 -1.794 . . . . 0.0 113.34 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -78.48 -37.79 42.48 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.763 -1.211 . . . . 0.0 113.223 174.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.93 53.45 0.8 Allowed Glycine 0 N--CA 1.43 -1.735 0 CA-C-N 119.768 1.167 . . . . 0.0 114.17 175.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -125.32 175.02 7.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.723 -0.869 . . . . 0.0 110.253 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.9 176.28 35.77 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 107.64 -2.184 . . . . 0.0 107.64 163.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -149.86 153.76 37.26 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 122.699 1.238 . . . . 0.0 112.949 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.412 HD11 HG21 ' A' ' 36' ' ' VAL . 1.7 mt -124.28 147.33 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 125.634 1.574 . . . . 0.0 109.324 -172.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -99.29 93.81 6.13 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 168.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -67.03 130.51 43.37 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -82.66 68.04 8.96 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.221 1.409 . . . . 0.0 114.631 -167.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -132.42 -72.57 0.52 Allowed 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 120.427 -1.42 . . . . 0.0 109.253 170.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.0 t -131.91 38.63 3.52 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.4 mptt 57.83 69.71 0.71 Allowed 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.981 1.712 . . . . 0.0 114.227 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -103.02 141.94 34.95 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.515 -1.99 . . . . 0.0 109.623 -166.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -93.85 104.71 16.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -162.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.1 t -108.95 116.5 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.69 -1.256 . . . . 0.0 109.119 -167.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -81.12 134.47 35.65 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 125.111 1.364 . . . . 0.0 112.743 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 25' ' ' ILE . 43.1 t -126.42 123.1 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 120.438 -1.414 . . . . 0.0 111.013 -175.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -100.63 170.11 8.59 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.351 1.46 . . . . 0.0 112.305 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -68.85 -22.41 64.22 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.6 -1.938 . . . . 0.0 114.892 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.5 p -71.11 -25.15 62.47 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.74 2.016 . . . . 0.0 113.392 175.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.39 -32.33 29.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.611 -1.306 . . . . 0.0 113.195 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.83 139.82 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 C-N-CA 126.481 1.912 . . . . 0.0 113.275 -175.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -49.85 -51.86 37.03 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 119.04 2.978 . . . . 0.0 119.04 -173.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -139.12 141.07 38.1 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.275 -1.516 . . . . 0.0 108.652 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -124.82 143.13 50.98 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 121.292 -0.88 . . . . 0.0 110.724 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -107.28 115.43 59.75 Favored Pre-proline 0 N--CA 1.431 -1.404 0 C-N-CA 124.98 1.312 . . . . 0.0 110.357 -173.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -66.9 -41.37 10.4 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 C-N-CA 123.451 2.768 . . . . 0.0 114.289 171.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -107.54 -81.25 0.56 Allowed 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 118.763 0.71 . . . . 0.0 112.176 -173.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 173.9 10.67 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -165.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -69.38 164.27 23.33 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 -170.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.8 tp -89.09 166.2 14.02 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 125.1 1.36 . . . . 0.0 112.947 -175.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -72.2 160.57 32.2 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.308 -1.495 . . . . 0.0 112.078 170.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.8 m -72.27 147.06 46.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.411 -1.43 . . . . 0.0 113.699 -175.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.9 m -110.32 160.59 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 120.632 -1.292 . . . . 0.0 110.087 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.24 149.63 17.29 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 125.031 1.3 . . . . 0.0 111.396 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -86.88 102.88 14.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.696 -1.473 . . . . 0.0 109.779 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.3 21.22 20.65 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 121.406 -0.809 . . . . 0.0 113.179 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -76.21 158.38 31.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.995 -1.297 . . . . 0.0 112.947 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 p -103.1 160.09 14.95 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.616 1.567 . . . . 0.0 113.487 -175.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -154.93 141.35 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 O-C-N 121.385 -0.822 . . . . 0.0 109.547 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -93.04 142.96 26.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.743 1.258 . . . . 0.0 112.7 165.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -155.59 172.11 18.82 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.974 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -102.88 138.28 39.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 166.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.463 HG12 HD13 ' A' ' 5' ' ' ILE . 45.7 t -96.22 91.93 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 119.676 -1.89 . . . . 0.0 109.524 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.99 90.47 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 118.607 -2.558 . . . . 0.0 111.785 -159.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -144.81 -60.3 0.36 Allowed 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 122.659 1.219 . . . . 0.0 110.931 165.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.9 -48.38 1.32 Allowed Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 115.617 1.007 . . . . 0.0 115.617 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -80.12 -85.26 0.09 Allowed 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 -172.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -86.13 -30.47 22.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.285 -1.509 . . . . 0.0 114.333 -167.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -162.92 -127.53 0.88 Allowed Glycine 0 N--CA 1.43 -1.763 0 O-C-N 119.953 -1.717 . . . . 0.0 110.56 170.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.43 ' HB1' HG13 ' A' ' 63' ' ' VAL . . . -144.48 137.37 26.88 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 122.246 1.022 . . . . 0.0 113.119 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -117.83 -166.81 1.24 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.943 -1.098 . . . . 0.0 109.725 165.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.06 153.49 42.99 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 123.018 1.39 . . . . 0.0 110.863 -170.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.44 157.76 44.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 175.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 50.72 59.32 4.68 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 36.4 t -93.97 100.26 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 120.672 -1.268 . . . . 0.0 109.073 -170.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.0 p -99.32 -103.39 0.22 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.074 1.35 . . . . 0.0 111.951 -171.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.07 -168.95 31.83 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 125.531 1.539 . . . . 0.0 110.194 -173.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -71.28 168.88 22.15 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 C-N-CA 123.096 2.531 . . . . 0.0 112.619 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.731 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.337 . . . . . . . . 0 0 . 1 stop_ save_